Walden University

ScholarWorks
Walden Dissertations and Doctoral Studies

Walden Dissertations and Doctoral Studies
Collection

2015

Evaluation of a Mobile Health Intervention to
Improve Anti-Retroviral Treatment Retention in
South Africa
Ambereen Jaffer
Walden University

Follow this and additional works at: https://scholarworks.waldenu.edu/dissertations
Part of the Public Health Education and Promotion Commons, and the Social and Behavioral
Sciences Commons
This Dissertation is brought to you for free and open access by the Walden Dissertations and Doctoral Studies Collection at ScholarWorks. It has been
accepted for inclusion in Walden Dissertations and Doctoral Studies by an authorized administrator of ScholarWorks. For more information, please
contact ScholarWorks@waldenu.edu.

	
  
	
  
	
  
	
  
	
  
	
  

Walden University	
  
	
  
	
  
	
  

College of Health Sciences

This is to certify that the doctoral dissertation by
Ambereen Jaffer
has been found to be complete and satisfactory in all respects,
and that any and all revisions required by
the review committee have been made.
Review Committee
Dr. Peter Anderson, Committee Chairperson, Public Health Faculty
Dr. Louis Milanesi, Committee Member, Public Health Faculty
Dr. Lu Liu, University Reviewer, Public Health Faculty

Chief Academic Officer
Eric Riedel, Ph.D.

Walden University
2015
	
  
	
  

	
  

Abstract

Evaluation of a Mobile Health Intervention to Improve Anti-Retroviral Treatment
Retention in South Africa
by
Ambereen Jaffer

MPH, Boston University, 1998
BSc, University of California Los Angeles, 1996

Dissertation Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Philosophy
Public Health

Walden University
August 2015

	
  

Abstract
South Africa has one of the highest HIV prevalence rates globally, with nearly 2.5
million people accessing antiretroviral treatment (ART) at the end of 2013. Retaining
patients on ART has become a major problem in this country. When patients no longer
show up for ART for unknown reasons, they are considered “lost to follow-up” (LTF).
LTF is the highest contributor to ART attrition. This study, guided by the health belief
model, evaluated the effectiveness of a technology-based, mobile health (mHealth)
appointment reminder intervention on LTF among patients accessing ART services. The
study ascertained differences in 6- and 12-month LTF rates between patients enrolled in
the mHealth intervention (n = 832) and those in the standard of care comparison group (n
= 918). A quantitative, retrospective cohort approach was used to answer the research
questions using binary logistic regression analyses. The mHealth intervention was found
to be significantly linked to lower likelihood of 6- and/or 12-month LTF among patients.
There were 2 other key findings: a positive correlation between pregnancy and LTF, and
a positive correlation between viral load increases and LTF. This study added evidence to
the existing literature on the effectiveness of using mHealth-based interventions to
improve HIV/AIDS care. Based on these findings, professionals should pay special
attention to pregnant women and those clients with increasing viral loads to ensure they
are not LTF. Positive social change that may result from this study is better health
outcomes for patients on ART due to reduced risk of HIV related complications and other
illnesses. This awareness would improve the lives of the patients, and positively impact
their families, communities, and ultimately the global community, by reducing the overall
impact of HIV disease.
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Chapter 1: Introduction to the Study
Introduction
This study was a program evaluation of a mobile health (mHealth) - based patient

appointment reminder intervention to improve retention in antiretroviral treatment (ART). The
intervention was implemented in September 2012, at a large public sector ART clinic in an inner
city setting in Johannesburg, South Africa.
Globally, Sub-Saharan Africa is the worst hit with the HIV/AIDS epidemic, with over
70% of HIV-positive people living in this part of the world (UNAIDS, 2012). This region has
been very successful in enrolling individuals on ART (Micek et al., 2009). In South Africa there
were over 2.5 million individuals on ART in the public sector as of October, 2013 (Ojikutu,
2008; PEPFAR annual report, 2013). Most people on ART obtain their care and treatment at
public sector sites that are managed by the South African government.
As the ART programs have scaled up, the focus for most countries has moved from
initiating patients on ART to retaining them, since being on ART is a lifelong commitment
(Barnighausen et al., 2011). According to one study conducted in Sub-Saharan Africa, only 60%
of patients were still on ART 2 years after starting treatment (Rosen, Fox, & Gill, 2007). A few
studies have been published on interventions designed to improve patient retention, especially on
tracing and following up with patients who drop out the ART program (Rosen & Ketlaphile,
2010). While these programs have demonstrated improvement in ART retention rates, there is a
need for more interventions that account for the context of patients dropping out or the reasons
why patients become lost to follow-up (LTF) (Miller, Ketlaphile, Rybaseck-Smith, & Rosen,
2010). LTF is defined as the disappearance of individuals from ART for no known reason. The
US Government’s definition for LTF is patients who have not returned to their ART clinics for
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follow-up appointments or medicine pick up in more than 3 consecutive months (PEPFAR,
2007). It is the largest contributor to ART attrition, followed by death (Rosen & Ketlhapile,
2010).
One approach that may be useful withtackling the LTF issue is mHealth. mHealth is “the
practice of medical and public health via mobile communication devices” (Catalani, Philbrick,
Fraser, Mechael, & Israelski, 2013, p. 17), and it has numerous applications in the field of public
health (Rodrigues et al., 2012; Tomlinson, Rotheram-Borus, Swartz, & Tsai, 2013). mHealth is a
growing field. It is considered to have great potential for strengthening health service delivery
which can lead to positive health outcomes, especially in resource-poor countries (Free et al.,
2013), where the mobile phone is the fastest growing communication sector (Bahadur & Murray,
2010). The existing research and knowledge base around HIV/AIDS and mHealth primarily
pertains to pilot projects, with a few qualitative studies and a handful of clinical trials (Bahadur
& Murray, 2010). There is a gap in the literature on (a) outcomes of full-scale mHealth
interventions to reduce missed ART follow-up appointments and (b) LTF rates among patients
on ART. This study sought to obtain evidence on the outcomes of an intervention—implemented
following formative and pilot research phases—in an effort to reduce the gap in the literature.
Improving retention in HIV care and treatment by reducing LTF are priority areas for the
South African Department of Health (South African National Strategic Plan on HIV, STIs and
TB 2012-2016, 2012). The positive social change implication of this intervention and its
evaluation are significant as improved retention will lead to better patient health outcomes.
This chapter covers the following topics: a summary of the issue based on data from the
scientific literature, problem statement, purpose of the study, methodology, research questions
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and hypotheses, the theoretical framework, variables and their definitions, assumptions, scope,
limitations, and significance of this study to the field of HIV/AIDS.
Background
Globally, there has been a surge in access to ART over the last few years, with a 20-fold
increase in Sub-Saharan Africa (Micek et al., 2009). Access to ART has dramatically increased
in the last few years in South Africa since the government rolled out its ART program in 2004.
The country has the largest ART program in Sub-Saharan Africa with over 2.5 million people on
ART in the public sector as of October, 2013 (Ojikutu, 2008; PEPFAR annual report, 2013).
Treatment Retention
While great strides have been made initiating patients on ART, low patient adherence and
retention in HIV treatment have raised concerns about long-term outcomes (Maskew, MacPhail,
Menezes, & Rubel, 2007). Rosen et al., (2007), conducted a systematic file review of ART
programs in Sub-Saharan Africa and found that, overall, 25% of patients had dropped out by end
of Year 1 of ART initiation, with this number rising to 40% by Year 2 on ART. Researchers in
Malawi found that the median time between ART initiation and patients dropping out was 4.3
months (Yu et al., 2007). Dalal., et al (2007), found the median time between initiation on ART
and first missed appointment at a public sector, tertiary hospital serving the inner city of
Johannesburg, South Africa, to be 84 days (IQR 43-168 days, range 13-392 days).
LTF and death are the most commonly identified reasons for attrition from ART (Rosen
et al., 2007). Approximately 56% of the treatment attrition is a result of LTF and another 40% is
due to death (de Pee, 2010). LTF is a major issue for the South African ART program too. LTF
rates from a multi-site, patient file audit at public sector clinics in two provinces in South Africa
between 2006 and 2009 were found to be between 14-25%, with the largest proportion of
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patients becoming LTF within the first 6 months of starting ART (Jaffer et al., 2007). A large
public sector clinic with over 7,000 patients enrolled on ART in Johannesburg had a LTF rate of
16.4% among patients initiating ART over a 4-year period. Forty percent of the individuals at
this clinic became LTF in the first 3 months after starting on ART (Rosen & Ketlhapile, 2010).
LTF is a major public health issue because patients who discontinue ART are at high risk
of developing virological failure, acquiring opportunistic infections, and early mortality (Rosen
et al., 2007; Unge et al., 2010). Harries, Zachariah, Lawn and Rosen (2010), conducted a metaanalysis of 16 studies in Sub-Saharan Africa and found that 20-60% of patients who were
identified as LTF had died. Researchers in Malawi found that about 50% of the patients who had
been identified as LTF had died, most dying soon after they missed their clinic follow-up
appointment (Yu et al., 2007). Dalal et al., (2007), conducted a study at an ART clinic in a
tertiary government hospital in Johannesburg, South Africa and found that one in six patients
initiating ART were LTF. Once again, approximately 50% had died; a majority died within 30
days of missing their appointments (Dalal et al., 2007).
Missed appointments and LTF
Missed clinical appointments have been found to be a significant risk factor for
developing virological failure and AIDS-defining illnesses (Lucas, Chaisson & Moore, 1999;
Rastegar, Fingerhood & Jasinki, 2003), and death (Park et al., 2007). Viral resistance can
develop quickly in an individual with poor adherence to ART. It can occur after only 11-30%
missed ARV doses (Maskew et al., 2007). Missed appointments can also negatively impact
health service quality because they can increase cost and lower efficiency of service delivery
(Guy et al., 2012). Results from a South African study to ascertain the relationship between
missed appointments early in the treatment phase of patients initiating ART and the health
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outcomes of the patients indicated that in a 12-month period after initiating ART, only 65% of
individuals attended all follow-up visits as scheduled. Of these, 2.6% of the patients had died and
6.2% were LTF. In addition, a higher number of missed clinical appointments were found to be
associated with increased risk of mortality and LTF during the study period. The researchers also
found that patients who missed three or more ART or clinical appointments were at high risk of
low CD4 improvement. Furthermore, patients with three or more missed ART appointments
were at increased risk of not achieving viral suppression by 6 months compared to the patients
who did not miss any appointments (Brennan, Maskew, Sanne, & Fox 2010).
Regular clinic visits reflect good retention in care among patients on ART (Geng et al.,
2010). Poor retention in care is reflective of low treatment adherence and of treatment cessation.
Once treatment is interrupted, the effects of ART can quickly reverse and cause harm to the
patients (Geng et al., 2010). Patient tracking has been recommended by some researchers while
others have suggested some form of reminder system, which could reduce the rate of missed
appointments (Dalal et al., 2007; Kliner, Knight, Mamvura & Wright, 2013). Other researchers
have recommended implementing a patient tracer program, whereby patients missing their clinic
appointments are contacted and asked to return to the clinic in a timely manner (Yu et al., 2007).
Researchers studying the effectiveness of tracer projects have found improvements in patients
returning to the facility after being contacted by a patient tracer. In a Kenya-based study, the rate
of return of patients was found to be 65% and 49% in urban and rural areas respectively (Rosen
& Ketlhapile, 2010). However, this type of intervention can be resource intensive, based on
patient load per tracer, follow-up workers’ salaries, transportation, and communication costs
(Rosen & Ketlhapile, 2010). Therefore, there is ongoing search for alternate, efficient, and cost-
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effective ways of tracing or communicating with patients to help them maintain good
appointment adherence and retention in care.
Some of the reasons documented for missed appointments include forgetfulness,
confusion regarding follow-up appointment dates, relocation, illness, hospitalization,
transportation cost, side effects, death, and insufficient medication supply (Dalal et al., 2007;
Maskew et al., 2007). Forgetting appointments is a common reason given by patients in a variety
of health care settings (Guy et al., 2012; Kliner et al., 2013; Leong et al., 2006). The intervention
evaluated by this study aimed to reduce appointment forgetfulness among patients on ART by
sending them multiple reminders.
Mobile Health technology to improve health services
mHealth is defined as “the practice of medical and public health via mobile
communication devices” (Catalani et al., 2013, p.13). Mobile technology includes cell phones,
patient monitoring devices, personal digital assistants, and other equipment. (Bahadur & Murray,
2010). mHealth is a rapidly growing field. It is considered to have a great potential for
strengthening health service delivery and leading to positive health outcomes especially in
resource poor countries (Free et al., 2013). The acceptance of cell phones and their low cost has
led to the quick uptake of mHealth technology in health services (Rodrigues et al., 2012).
mHealth has great potential for success in South Africa since the country has one of the
highest proportions of mobile phones per capita, with over 90% of people having a mobile phone
subscription (Leon, Schneider & Daviaud, 2012). Researchers exploring the feasibility and
acceptability of mHealth related interventions in the South African population found a high level
of interest and acceptability (Crankshaw et al., 2010). The South African government has also
shown a keen interest in the use of mHealth technology in the public health care sector. In 2012,
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the National Department of Health (NDoH) circulated a comprehensive eHealth strategy, which
included the need for development, implementation, and evaluation of mHealth interventions to
strengthen the public health sector (NDoH, 2012). In addition, there is growing support by the
United States government, the World Health Organization, multinational companies, and other
private entities (such as the cell phone network providers) to develop, implement, and evaluate
innovative mHealth interventions to help strengthen the South African government’s response to
the HIV epidemic.
SMS-related interventions in HIV care and treatment
SMS or text messaging is a well-established technology that is used around the world. It
is a cheap and efficient method of two-way communication, which costs much less than a cell
phone call. Over the last few years, SMS has become the most prevalent mHealth technology
application (Bahadur & Murray, 2010; Leong et al., 2006). Bahadur and Murray (2010),
conducted a literature review between February and December 2008, to examine the use of SMS
in health care settings. They found SMS to be an efficient, cost-effective, and appropriate
technology for strengthening various health services sectors. However, Bahadur and Murray
noted that some researchers were skeptical about the evidence for the effectiveness of SMS,
since many of the reports or articles generated were from pilot projects or feasibility studies.
They concluded that while SMS has been found to be effective in the public health sector, there
is a need for further rigorous review of the benefits of this technology to improve health services
in South Africa (Bahadur & Murray, 2010). In addition, none of the studies reported by Bahadur
and Murray pertained to use of SMS to improve ART clinic attendance.
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SMS to improve adherence on ART
Patient adherence to ART is crucial for continued benefits of ART in avoiding the
development of viral resistance, reducing opportunistic infections, and early mortality (Rosen et
al., 2007). In addition, adherence to ART has been linked to improved health outcomes;
adherence is important to contain undue program costs (Lester et al., 2010). Since adherence is
crucial for ART success, a number of interventions have been developed and implemented over
the last few years. These have ranged from direct administration of ART, provision of financial
incentives, education, additional counseling regarding adherence, facilitation of social support,
and electronic and phone reminders (Rodrigues et al., 2012). In the last 3–5 years, a handful of
studies have been conducted in resource-constrained countries that explored the use of SMS in
improving ART adherence. These studies, which have included RCTs, have found an overall
positive correlation between SMS or other mHealth intervention and increase in adherence to
ART (Lester et al., 2010; Pop-Eleches et al., 2011; Rodrigues et al., 2012).
SMS for Clinic Appointment Reminders
Use of SMS to improve clinic appointment adherence in primary health care and other
settings has been recorded by some studies; however, studies looking at SMS for improving
ART appointment reminders have been minimal in the peer-reviewed or published literature.
SMS reminders have been found to be effective in improving follow-up appointment adherence
in numerous health care settings, including primary health care (Leong et al., 2006), medical
male circumcision (Odeny et al., 2012), pediatrics, ophthalmology, orthodontics, and preventive
health (Guy et al., 2012).
The importance of adherence to and retention in care of patients on ART is well
documented in the scientific literature, along with the need for interventions to tackle these
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issues. mHealth is a rapidly growing field and researchers have found strong evidence of
associations between mHealth and HIV treatment adherence in a handful of clinical trials.
However, there is a need for more information from program outcomes and clinical trials
(Bahadur & Murray, 2010). In addition, there is a gap in the peer- reviewed and grey literature
on studies that examine the effectiveness of SMS on improving ART clinic appointment
adherence among patients receiving ART services in South Africa.
This study was a program evaluation of an appointment reminder intervention, which was
rolled out at a large government funded ART clinic in Johannesburg, South Africa, with over
16,000 patients enrolled on ART since 2004. This study was important because it attempted to
fill the gap in the literature about the use and effectiveness of mHealth to strengthen the public
sector HIV/AIDS treatment programs in South Africa. The appointment reminder intervention
was developed after a comprehensive project development cycle, which included formative
studies (feasibility and acceptability studies), and a pilot phase.
Problem Statement
ART has been successfully scaled up globally and specifically in resource-limited
settings such as Sub-Saharan Africa, leading to improvements in health outcomes of HIVpositive individuals (Brennan et al., 2010). However as programs have scaled up, treatment
attrition has become an issue. LTF is the largest contributor to attrition, followed by death
(Rosen & Ketlhapile, 2010). People who are HIV positive are expected to take the antiretrovirals
(ARVs) for the rest of their lives to suppress viral replication (Ketlhapile, Rybasack-Smith &
Rosen, 2010). Thus, adherence to ART is also expected to be life-long (De Pee, Grede, Forsythe
& Bloem, 2012). As mentioned earlier, nonadherence to the ART regimen can lead to
development of viral resistance, opportunistic infections, treatment failure, and early mortality
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(Unge et al., 2010). Despite the known risks associated with nonadherence to ART, LTF and low
treatment adherence remain a major challenge (Brennan et al., 2010).
Following the emergence of evidence of high LTF rates in the HIV/AIDS programs;
studies have been undertaken over the last 5–7 years to (a) identify the LTF rates globally (Dalal
et al., 2007; Rosen et al., 2007; Yu et al., 2007), (b) understand the reasons for LTF (Miller et al,
2010), (c) ascertain the impact of LTF on patient health outcomes, and (d) determine outcomes
of interventions such as patient tracer programs using clinic and/or community-based individuals
to bring the patients back to the clinic (Rose & Ketlhapile, 2010). Studies have also been
conducted on use of innovative methodologies and technologies to improve adherence to ART
(Lester et al., 2010). Some of the conclusions and recommendations from these studies were as
follows:
!

Interventions are needed to respond to the reasons for LTF (Unge et al., 2010).

!

More evidence is needed on the effectiveness of interventions designed to
improve short- and long-term retention in ART (Barnighausen et al., 2011).

!

The work must move beyond pilots to ascertain the outcomes of implemented
interventions (Bahadur & Murray, 2010),

!

More evidence is needed from studies conducted in resource-limited settings,
since most evidence is from resource-rich settings (Barnighausen et al., 2011).

!

Ascertain the results from innovation- and context-based interventions, which are
developed based on the reasons for LTF (Unge et al., 2010).

Most of these conclusions reflect gaps in the current literature. The scope of this
evaluation study was limited to ascertaining the role of mHealth to reduce missed appointments
and lower resulting LTF. Nonetheless, both the appointment reminder intervention and its
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evaluation were based on some of the above mentioned recommendations and conclusions found
in the literature. The appointment reminder intervention was developed in response to the issue
of appointment forgetfulness among patients on ART. It was rolled out following a formative
and pilot research phase, and conducted in a resource limited setting. The intervention was
designed to prevent the occurrence of LTF among patients on ART; it was also a way for the
clinic to keep in touch with its clients.
Purpose of the Study
This quantitative, retrospective, cohort study analyzed existing secondary data. The study
purpose was to evaluate the effectiveness of a mHealth appointment reminder intervention to
improve retention in care of patients by reducing LTF rates among patients on ART. The intent
was to compare LTF outcomes between the intervention and comparison groups at two points in
time. The intervention group included individuals on ART who enrolled in the intervention
between September 1, 2012 and February 28, 2013. The comparison group consisted of
randomly selected individuals on ART at the clinic who were not enrolled in the intervention.
Individuals in both the intervention and comparison groups were assigned to one of six cohorts
based on their time on ART as at September 1, 2012. The six cohorts (listed below) were formed
based on historical LTF information found from a patient file review conducted at this clinic in
2009.
Cohort 1: Individuals initiated on ART between September 1, 2012 and February 28,
2013.
Cohort 2: Individuals initiated on ART from 1-6 months prior to September 1, 2012.
Cohort 3: Individuals initiated on ART from 7-12 months prior to September 1, 2012.
Cohort 4: Individuals initiated on ART from 13-24 months prior to September 1, 2012.
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Cohort 5: Individuals initiated on ART from 25-36 months prior to September1, 2012.
Cohort 6: Initiated on ART more than 36 months prior to September 1, 2012.
The independent variable was the presence or absence of the ART appointment reminder

intervention. The dependent variables were LTF at 6 and 12 months from September 1, 2012.
The two time periods were selected based on evidence from mHealth-based ART adherence
studies found in the literature. These studies found significant differences in adherence to ART
in the 6- and 12-month timeframes (Lester et al., 2010; Rodrigues et al., 2012). LTF for the
comparison group was determined to be June 1, 2013, and December 1, 2013 respectively (90
days after 6 and 12 months from September 1, 2012 – the start date of the intervention, based on
the PEPFAR definition of LTF). Age, gender, baseline CD4 count, concurrent illnesses, ART
regimen, and ART side effects were considered covariate variables for this study.
Research Questions and Hypotheses
This study was guided by the following research questions and hypotheses:
Research Question 1. Is there a difference in 6-month LTF rates between clients in the
ART appointment reminder intervention and clients in the standard of care comparison group
who did not receive the intervention, at Ward 21 in HCHC in Johannesburg, South Africa, after
controlling for the identified covariates?
Ho1. There are no statistically significant decreases in the likelihood of 6-month LTF for
clients on ART who received the appointment reminder intervention when compared to
clients in the standard of care comparison group.
Ha1. There are statistically significant decreases in the likelihood of 6-month LTF for
clients on ART who received the appointment reminder intervention when compared to
clients in the standard of care comparison group.
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Research Question 2. Is there a difference in 12-month LTF rates between clients in the

ART appointment reminder intervention and clients in the standard of care comparison group
who did not receive the intervention, at Ward 21 in HCHC in Johannesburg, South Africa after
controlling for the identified covariates?
Ho2. There are no statistically significant decreases in the likelihood of 12-month LTF for
clients on ART who received the appointment reminder intervention when compared to
clients in the standard of care comparison group.
Ha2. There are statistically significant decreases in the likelihood of 12-month LTF for
clients on ART who received the appointment reminder intervention when compared to
clients in the standard of care comparison group.
Basic demographic information, along with the ART initiation date, baseline CD4 count,
ART side effects, and concurrent illnesses were collected at the beginning of the study.
Theoretical Framework for the Study
The theoretical foundation for this study was the health belief model (HBM), which was
developed to explain the relationship between health practices, behaviors, and health service
utilization. Later, the model was revised to study people’s behavioral responses to health-related
conditions (Rosentock, Stretcher, & Becker, 1994; Janz & Becker, 1984). HBM is one of the
most widely used theories in the field of public health. It has been the basis of numerous
population studies to explain health-related behavior among different types of populations
(Rosenstock et al., 1994), as well as health promotion and disease prevention interventions
(Burke, 2014).
Initially, four perceptions formed the main constructs of HBM: perceived seriousness,
perceived susceptibility, perceived benefits, and perceived barriers. Later, three other constructs
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were added: cues to action, motivating factors, and self-efficacy. The latter three constructs
affect the initial four perception-related constructs (Hayden, 2009).
The construct of interest for this study was “cues to action.” A theoretical framework was
not incorporated in the intervention design. However, some assumptions were made based on the
literature review, that is, individuals who had agreed to partake in the appointment reminder
intervention had experienced the various HBM perceptions when they initiated on ART and
received adherence counseling from the clinic staff, which included information on following the
ART regimen, looking out for side effects, and the importance of treatment adherence. Another
assumption was that an individual’s decision to initiate ART indicated that its perceived benefit
had been recognized. Similarly, the individuals may have also perceived a benefit to the
intervention offered, and believed that they had the ability to adhere to their follow-up clinic
appointments.
The rationale for choosing the “cues to action” was that the appointment reminder was an
external trigger to help participants maintain or improve their clinic appointment adherence
behavior. As explained later in the chapter, the participants received three reminder “cues”
between appointments (usually 30 days); one message was sent 2 weeks before the appointment,
another a day before, and one the day after the appointment. In terms of the theoretical model,
the key question of this study was: how effective were the cues to action in leading to the desired
behavior or intervention?
Cues to action can be internal or external events, an exchange of information or
communication that can influence human behavior change. The cues can be developed to raise
awareness or provide specific advice to the target audience. Cues can also result from
experiences of or events occurring in the individuals’ circle of influence, for example, a similar
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illness in a family member (Hayden, 2009). According to the HBM, one or more cues are
generally required to serve as a “trigger” for initiation of healthy behavior (Olsen, Smith, Oei, &
Douglas, 2010).
According to Olsen et al. (2010), HBM has been heavily investigated to predict
adherence in several disease models, including for prostate cancer screening, mammography, and
general health promoting behaviors. However, very few studies have measured the cues to
action. Olsen et al. also mentioned that it is difficult to assess the effect of the cues prospectively,
that is, before the behavior change happens. Thus cues to action studies are often designed as
retrospective cross-sectional studies in order to understand the effects of the prompts on the
desired behavior modification (Olsen et al., 2010). This was a key point in this study’s
development phase, which was designed as a retrospective assessment of the appointment
reminder cue to improve clinic appointment adherence among individuals on ART. Some of the
HIV/AIDS-related studies based on HBM constructs and conducted in the international health
arena used different cues to action methodologies, such as drama or song, to increase HIV/AIDS
knowledge and to remind participants to adopt safer sexual behaviors (Bosompra, 2007).
Rochon et al., (2011) conducted a qualitative study to ascertain feasible communication
strategies that could influence ART adherence. The authors found that cues to action was one of
the acceptable and feasible constructs for communicating adherence messages to patients on
ART (Rochon et al., 2011). The results from the study indicated the acceptability and feasibility
of using cues to improve adherence on ART, thus strengthening the rationale for this study to test
whether appointment reminders would be effective in bringing about adherence (attending all
appointments) and thus lower LTF rates in the population.
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Nature of the Study
The rationale for designing this study as a retrospective cohort study was that it was an

outcome evaluation of an appointment reminder intervention, which was implemented in
September 2012. The goal was to ascertain the effectiveness of the intervention in reducing LTF
among patients on ART at the clinic. Retrospective project and clinic data was used in this study
to answer the research questions. A quantitative method of inquiry was chosen for this evaluation
as it would yield the information required to answer the research questions.
The key independent variable for this study was the presence or absence of the
intervention. Individuals enrolled in the intervention group should have received three reminders
for each appointment. Follow-up appointments were usually 1 month apart, although the clinic
could have scheduled appointments every 2 months for some stable patients. The study
covariates were age, gender, CD4 counts (first, baseline and current), ART regimen, concurrent
illnesses, ART side effects, and viral load. There were two dependent variables in this study.
These were LTF at 6 and 12 months after the intervention was implemented at the site. LTF
outcome was determined when a patient had not returned to the ART clinic or picked up their
ARVs for at least 3 consecutive months (PEPFAR SASI Manual, 2007). Individuals who died
during the study period were noted but not included in the analysis.
Fieldworkers were hired by the mHealth team to recruit participants in the intervention
and for data collection for the project. After a comprehensive training and mentoring phase, the
fieldworkers were placed at Ward 21 and asked to be present at the clinic every day. They
approached patients in the waiting room, ascertained if the patient was eligible to participate by
asking if they were on ART, explained the intervention to qualifying patients, and asked them if
they wanted to enroll. If the patients agreed to participate in the intervention, the fieldworkers
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walked them through an informed consent process. The consent form was approved by the Wits
University IRB, which is the regulatory body for the host institution that implemented the
intervention. The mHealth team developed data capturing tools and an electronic database for the
intervention. The field workers collected the information in the intake forms and transferred it to
the database at the end of each day. The clinic uses an electronic patient management and a
pharmacy dispensing system, which the project team accessed to obtain patients’ demographic,
clinical and follow-up appointment information. The team used patients’ clinic ID numbers as
identifiers in the intake forms and for the project database. They also assigned unique
intervention IDs for the individuals enrolled in the intervention.
Permission was obtained from WRHI to request for the retrospective program data from
September 2012 to June 2014. This would cover the twelve month plus 90 days follow-up period
for all the individuals who enrolled in the intervention between September 2012 and February
2013. Determination of LTF at 90 days after the end of six months of enrollment was based on
the PEPFAR definition of assigning the LTF status (PEPFAR SASI Manual, 2007). In addition,
permission was obtained to request for retrospective data from the clinic database for
demographic, clinical, and appointment information for the intervention and comparison groups.
The project data was in Microsoft Excel file format. Additional demographic and study
related data were included in this database as relevant. All study data was cleaned (i.e., reviewed
for errors) then exported to SPSS 21.0 for data analyses. All the study variables were assigned a
variable name, with the variable values coded (e.g. male = 1 and female = 0). Descriptive
statistics were computed for the study variables, inclusive of study covariates. The mean,
standard deviation, and minimum and maximum values were computed for ratio variables and
frequencies, and percentages were calculated for dichotomous and categorical variables.
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Spearman’s rho correlations and model chi-square analyses were conducted between each

of the study covariates and the two dependent variables. Covariates found to be associated with
the dependent variables with p-values of < 0.25 were included as predictor variables in the
logistic regression analyses, performed to address the study research questions. The p-value
criteria of < 0.25 for covariate association were used for analysis based on the assumption that a
covariate may not be significantly associated independently but may contribute to the model in
conjunction with other variables. Two binary logistic regression analyses were conducted for the
two dependent variables, LTF at 6 months and 12 months. Binary logistic regression was
selected for this study as the dependent variables were dichotomously coded and the relationship
between the intervention and the outcomes of LTF could be determined when covariate variance
was accounted for (Agresti, 2013). The model chi-square (χ²) determined the significance of the
overall regression model, while the classification table generated by the statistical tool
determined correct classification of the dependent variable categories based on the predictors in
the model (Agresti, 2013). The Hosmer-Lemeshow (H-L) statistic for logistic regression, which
answers the question, “how best does my model fit the data?” was used as the model goodnessof-fit statistic (Allison 2013). In the regression model, any probability value of significance (pvalue) less than or equal to 0.05 were considered statistically significant.
Definitions
The independent variable for this study was presence or absence of the appointment
reminder intervention. Presence of intervention was defined as individuals at the clinic who
enrolled in the appointment reminder intervention between September 1, 2012 and February 28,
2013. Absence of intervention was defined as all individuals who attended the clinic during the
study period but did not enroll in the intervention. This group of individuals received the
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standard of care provided by the clinic. Age and gender was collected as part of basic
demographic information. Below are definition of key study variables and covariates:
Age. Client age at initiation of ART was used as a measure of age. Age is a ratio variable
and was calculated in years.
Gender. Gender was a dichotomous variable where 1 = male and 0 = female.
ART Initiation Date. ART initiation date was the date the person started on ART at the
clinic and considered as time zero for ART follow up.
Baseline CD4 count. Baseline CD4 was defined as the most recent CD4 count available
within 3-6 months prior to ART initiation. CD4 count is the number of CD4 cells, a type of white
cell that fights infection, in the body. A low baseline CD4 count can put a person at a high risk of
getting sick. It can have an effect on adherence to ART appointment and loss to follow up. For
the purpose of this study, Baseline CD4 was the most recent CD4 count available within 3-6
months prior to ART initiation (The ART Cohort Collaboration, 2011)
ART regimen. This covariate was a categorical variable based on two types of ART
regimens commonly prescribed in the public sector sites in South Africa. Some patients in South
Africa receive a combination prescription if ARV side effects and other physiological or
psychological issues arise. The commonly prescribed regimens as per the National ART
Treatment Guidelines, 2004 are:
First line: Regimen1a - d4T / 3TC / efavirenz; Regimen1b - d4T / 3TC / NVP
Second line: Regimen 2 - AZT / ddI / lopinavir / ritonavir
Concurrent illnesses. This covariate was based on the presence of concurrent illnesses as
noted in the patient’s records. These were any other illnesses or diseases that manifested in the
patient and could have affected the patient’s clinic attendance and LTF outcome. For example,

	
  	
  	
  

20

tuberculosis, mental health issues, cancer, herpes zoster and other illnesses. The concurrent
illnesses was coded by the type of illness and number of occurrences.
ART side effects. This covariate was based on evidence of ART side effects as noted in
the patient’s records. These can cause unplanned delays in patient returning to the clinic for their
appointments, therefore it is important to note these. These were coded by type of side effect and
number of occurrences.
Loss to Follow up. Programmatically, Lost to Follow up is defined as the disappearance
of the individuals from ART for no known reason (Rosen et al., 2007). For the purpose of this
study a patient was considered lost to follow up if they had not been to the clinic or had not
picked up their ARVs for at least 3 consecutive months. (PEPFAR Strategic Information Manual
South Africa, 2007).
Virological failure. Plasma viral load above 1000 copies/ml based on two consecutive
viral load measurements after 3 months, with adherence support. (WHO, 2013); Virologic failure
happens when anti-HIV medications cannot reduce the amount of virus in the blood. While
taking medications, viral load drop or it repeatedly rises again after having dropped (NIH, 2014).
Assumptions
This study was based on the following assumptions:
!

The study population was representative of the population on ART in any urbanbased public health facility in South Africa. The population accessing services at
the clinic was considered to be heterogeneous which was reflective of the
catchment population of the clinic.

!

The participants felt comfortable about their confidentiality when enrolling in the
intervention and felt that they had an option to opt out. The fieldworkers were
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trained to review the patient confidentiality information with the participants, and
the participants were informed that they could opt out at any time. A separate
SMS number was specially created which participants could use if they wanted to
opt out of the intervention.
!

Individuals who had agreed to partake in the appointment reminder intervention
may have experienced the various HBM perceptions when they initiated on ART,
and they had received adherence counseling from the clinic staff which included
information on following the ART regimen, looking out for side effects, and the
importance of treatment adherence. An individual’s decision to initiate on ART
may indicate that the individuals saw the perceived benefit of ART. The
individual may have also seen a perceived benefit of the intervention offered and
believed that they had the ability to be adherent to their follow-up clinic
appointments.

The assumption regarding heterogeneity of the population was necessary to allow for
generalizability to other urban populations in South Africa. The clinic population includes
individuals from various social, economic and cultural backgrounds. Thus any strong tendencies
or circumstances pertaining to social, economic, environmental, mental and other factors among
individual participants that could grossly affect or skew the outcomes were not expected. The
assumption regarding freedom to opt out was necessary since individuals self-selected to receive
the appointment reminder intervention. The individuals should not have felt at any time that they
were coerced into enrolling in the intervention. The assumption about the perceived benefit of
being on ART was important as individuals needed to be at a particular level of readiness to
consider and take advantage of the intervention as a useful tool to improve their health outcomes.
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Scope and Delimitations
This study sought to ascertain the effectiveness of an appointment reminder intervention

in reducing LTF rates among patients on ART in a resource-constrained setting. The intervention
was developed based on the information found in the literature, which indicated a correlation
between missed appointments with LTF (Brennan et al., 2010; Geng et al., 2010). As mentioned
earlier, South Africa has made great strides in enrolling a large number of people on ART since
the national ART roll out started in 2004. However, patient attrition from ART negatively affects
the achievements, and the long-term effects of LTF have a worse impact on the individual’s
health as it puts them at undue risk of adverse events such as viral resistance and treatment
failure (Rosen et al., 2007).
The intervention population included all adults on ART including pregnant women at the
ART clinic, Ward 21, located at the HCHC in the inner city of Johannesburg, South Africa.
Ward 21 had over 16,000 individuals on ART when the appointment reminder intervention was
implemented. The study sample comprised all individuals who chose to enroll in the intervention
(intervention group) during the defined study period, and a randomly selected sample of
individuals on ART at the clinic but not enrolled in the intervention (comparison group).
Children under 18 years old were excluded from the intervention and the study because there are
different treatment guidelines and regimens for the pediatric population. The cues to action
construct of the HBM was deemed to be the most relevant for the study’s theoretical framework.
The study outcomes were generalizable to other urban settings in South Africa since the
appointment reminder intervention was rolled out as a health services improvement intervention,
and the fact that there was a treatment and a comparison group, along with the assumption that
the individuals assessing the services at the clinic were representative of typical urban based
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populations accessing public sector ART sites in South Africa. Some of the dynamics may be
different in a rural setting and may need a separate inquiry.
Limitations
This study was subject to the following limitations:
!

The lack of random selection of individuals to enroll in the intervention. The
intervention was rolled out as a health services improvement project and not as a
research study. It had been piloted and found to be effective in improving adherence
to clinic appointments at a primary health facility in the inner city of Johannesburg.
When the intervention was implemented, patients on ART attending the clinic were
approached and the intervention was offered to them. The intervention enrollment
period was from September 2012 to December 2013. Based on the recruitment
design, the participants self-selected to receive the intervention, and thus there was a
risk of selection bias. All individuals enrolled in the intervention between September
2012 and February, 2013 (the study period), who received the intervention as planned
without major information missing were assigned to the intervention group. A partly
purposeful, partly random stratified approach was used to select individuals on ART
at the clinic but not exposed to the intervention, for assignment to the control group.

!

Following lessons learned from the pilot phase, the mHealth team made a major
modification to the original project design. Instead of offering only the appointment
reminder intervention to individuals newly (< 30 days) initiated on ART, all
individuals on ART (regardless of time on ART) were offered the appointment
reminder intervention along with weekly treatment adherence reminder messages for
one year. While this modification was based on the lessons learned, it could have
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affected the evaluation outcomes. It is impossible to confidently state if differences
noted between the intervention and control groups were due to the appointment
reminder or the adherence reminder intervention. An evaluation of the adherence
reminder program may assist to distinguish the differences between the two
interventions.
!

Only a quantitative methodology was used. A mixed method would have been a more
appropriate methodology as a qualitative component could have explained some of
the participant behavior, decisions or nuances leading to the outcomes noted. These
items were not easy to ascertain from a quantitative methodology alone. To this
effect, the researcher has discussed with the mHealth team about them conducting a
complimentary qualitative study using a sample of the study cohort to make the
evaluation results more comprehensive. This study may be conducted at a later date.

!

Since the study design required use of retrospective data, it was not possible to
control the quality of the collected data. The mHealth team had incorporated some
quality assurance mechanisms such as quality checks by the project coordinator, but it
was not possible to ascertain how successful the team was at implementing these as
planned or as stated in the recruitment Standard Operating Procedures.

!

Given the sheer size of the HIV epidemic in South Africa, HIV is the focus of the
government, donors and other international agencies agendas. For example, the
minister of health started country wide HIV counseling and testing campaigns in
2010. These campaigns were in their second year in 2012 and were being scaled up
by the NDoH as only 31% of HIV positive individuals were enrolled in ART (HSRC
report, 2012). The South African public is constantly exposed to messages regarding
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HIV prevention, testing and treatment from the government, donors, non-government
organizations, community-based organizations and others. In addition, it is likely that
given the high prevalence of HIV a large proportion of the population in South Africa
has been affected by HIV directly or indirectly. Therefore, it is possible that the other
experiences and exposures may have acted as cues to action for the study participants,
and could have possibly driven the outcomes towards the null hypothesis.
!

At the intervention design phase it was found that the South African public has a
tendency to change their phone sim cards or their cell phone numbers frequently so
the project would potentially not be able to send messages as planned. Two events
that may have assisted in controlling this issue were that the government instituted a
requirement for cell phone users to register their sim cards using their government
issued identity card or passport numbers. This may have reduced the behavior of
frequent changing of sim cards. Another intervention the team put in place in
response to this issue was that they asked the clinic and pharmacy staff to ask the
patients for updates to their contact information at each visit.
Significance

LTF is a major problem that affects the HIV/AIDS treatment programs globally,
However, its impact are strongest in Sub-Saharan Africa and some developing countries because
of the high HIV prevalence rate and poor access to and availability of health services. This
evaluation and the related intervention have the potential to provide positive social change at a
local, national policy and possibly global level. I expected the evaluation outcomes to provide
evidence to fill some of the gaps in the literature around LTF, and use of mHealth as a viable tool
in the field of HIV/AIDS.
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As described in Chapter 2, there is a high acceptability of mHealth interventions by

various stakeholders and the technology has the ability to reach a large number of populations in
a short amount of time. In addition, mHealth-related interventions can offer individualized
messages to the target population based on their needs. mHealth is an innovative way to promote
health messages and improve health services in the developing and developed country contexts,
simply because of the high cell phone penetration and its use globally.
Individuals who start on ART have to be followed regularly to make sure that they are
adhering to the treatment regimen, and to identify any side effects or other issues arising at an
early stage. mHealth is a tool that can assist with this need. The literature review conducted as
part of this dissertation highlighted that while mHealth is a fast growing field, there are still gaps
in the literature pertaining to the effectiveness of this technology in the field of HIV/AIDS. There
is also an identified need for evidence-based information from mHealth based HIV/AIDS
interventions, which have been fully implemented versus pilot projects (Bahadur & Murray,
2010). This is where the outcomes of this study could potentially contribute to the field. The
appointment reminder intervention that this study evaluated was one of three interventions
implemented and managed by the mHealth team at WRHI. The other two projects will be
evaluated by the WRHI staff at a later date. Once the evaluations have been completed, the plan
is to present the collective results to the South African NDoH and relevant funders. The
information is meant to be used by the NDoH to inform policy and as relevant for possible roll
out of the interventions at a national level. For the funders and other international agencies, the
outcomes also provide viable options that could be replicated in other countries or serve as
platforms for further funding and query.
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Summary
In this chapter, a summary of the information found in the scientific and some grey

literature around the issue of LTF and the current gaps was presented. This was followed by an
overview of the methodology, the indirect and direct variables, the research questions and the
relevant hypotheses, and the theoretical framework that the study was based on. An objective
view of the study scope, limitations, and threats were provided. Cross cutting the various
sections was the point about how the study could potentially impact positive social change and
contribute to the field of HIV/AIDS using innovative solutions.
Chapter 1 provided a general overview of the study, including the topic of concern and
the research methods. Chapter 2 includes findings from the literature review, gaps in the
literature, the theoretical framework, and the need for this study.
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Chapter 2: Literature Review
Introduction
The purpose of this study was to evaluate the effectiveness of a mHealth patient

appointment reminder intervention to improve retention in care of ART patients by reducing
LTF rates.
ART has been successfully scaled up globally—especially in resource-limited settings
such as Sub-Saharan Africa—leading to improvements in health outcomes of HIV-positive
individuals (Brennan et al., 2010). However as programs have scaled up, treatment attrition has
become a major issue. LTF, defined as the disappearance of the individuals from ART for no
known reason is the largest contributor to attrition, followed by death (Rosen & Ketlhapile,
2010). HIV positive individuals who are started on ART are expected to take the antiretrovirals
(ARVs) for the rest of their lives to suppress viral replication (Ketlhapile et al., 2010). Nonadherence to the ART regimen can lead to development of: viral resistance, opportunistic
infections, treatment failure and early mortality (Unge et al., 2010). Despite the known risks
associated with non-adherence to ART, LTF and low treatment adherence remain a major
challenge (Brennan et al., 2010). More evidence is needed on the effectiveness of interventions
designed to improve short- and long-term retention in ART (Barnighausen et al., 2011).
This chapter includes: a summary of the information found during the literature review,
the theoretical framework suggested for the study, a review of the problem under query, and
evidence to support the need for this study to address the gap in the literature.
General information on the HIV epidemic both globally and in sub-Saharan Africa is
provided at the beginning of this chapter followed by roll out and scale up of ART in SubSaharan Africa and specifically in South Africa. The issues of long-term sustainability of patients
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on ART and LTF are discussed next followed by linkages between missed appointments and
reduced adherence to ART, and retention in care. The role of mobile health (mHealth)
technology in improving health services and particularly retention in care forms the second part
of this chapter. The discussion starts with an overview of mHealth technology, followed by a
review of mHealth studies to improve clinic appointment adherence. Use of SMS for
appointment reminders to improve clinic attendance is the central component of this dissertation
therefore it forms a large portion of the second half of this chapter. The chapter ends with a
summary of the key information and gaps found in the literature; the need for the study, and
provides a segue to Chapter 3.
The primary source of information for the literature review was peer-reviewed journals;
however, some reports were also accessed, such as the WHO Bulletin, and United States and
South African government documents. In addition, grey literature in the form of white papers,
program reports, and conference presentations was accessed. The use of grey literature was kept
to a minimum.
The literature search was carried out in two phases. Phase 1 involved searching PubMed,
Medline, and EBSCO HOST databases using the following keywords: HIV/AIDS in South
Africa, Scale up of ART, HIV treatment retention in care, Loss to Follow up of patients on ART,
interventions for Loss to follow up, mHealth technology, mHealth and HIV, mHealth and
appointment reminders, and SMS for appointment reminders. Phase 2 of the literature search
involved review of the references found in the Phase 1 papers and conducting a search by
specific titles. Phase 2 was found to be most effective in identifying specific articles on clinic
appointment reminders. Note that the terms SMS and text messaging have been used
interchangeably throughout this document.
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mHealth is the overarching topic of interest however, the dissertation research question

drills down to the use of SMS technology in improving patient retention on ART at public sector
clinics in South Africa. Some general observations from the literature review are that since
mHealth is a relatively new field, the articles found were mostly published in the last ten years.
Numerous published studies pertained to the use and outcomes of mobile technology in the
health arena, however, most of the studies were conducted in resource rich countries and in areas
other than HIV care and treatment. Many of the mHealth articles were reviews and metaanalyses of previously published papers and grey literature versus new research. The new
research found included a substantial amount of pilots and feasibility studies. That said, some of
the new research were trials from Sub-Saharan Africa, and pertained to use of SMS in improving
adherence to ART.
Theoretical Foundation
The theoretical foundation for this study was the Health Belief Model. This model was
developed in the 1950s by three social psychologists: Godfrey Hochbaum, Irwin Rosenstock and
Stephen Kegels, who were working for the United States Public Health service at the time. The
model was originally developed to provide a systematic way to explain the reasons for failure of
individuals to engage in preventive health measures. HBM was developed to explain the
relationship between health practices, behaviors and health service utilization. Later, the model
was revised to study people’s behavioral responses to health-related conditions (Rosentock,
Stretcher & Becker, 1988; Janz & Becker, 1984).
HBM is one of the most widely used theories in the field of public health. It has been the
basis of numerous population studies to explain health related behavior among different types of
populations (Rosenstock et al., 1994), and health promotion and disease prevention interventions
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(Burke, 2014). HBM is referred to as an “interpersonal” theory. That is, it uses the individual’s
personal/internal knowledge and beliefs regarding the issue under study. It ascertains health
behavior of individuals by examining the perceptions and attitudes individuals have towards
illness and negative outcomes of certain actions (Burke, 2014). According to Hayden 2009, the
essence of HBM is that health behavior is influenced by personal beliefs. This is reflected in the
constructs that form the foundation of this model.
Initially, four perceptions formed the main constructs of HBM. These were: perceived
seriousness, perceived susceptibility, perceived benefits, and perceived barriers. Later, three
other constructs were added which were: cues to action, motivating factors, and self-efficacy.
The latter three constructs affect the initial four perception related constructs (Hayden, 2009).
The constructs lead to what has been coined as “Likelihood of Action” or behavior change (Janz
& Becker, 1984).
Perceived Seriousness relates to a person’s perception about the intensity or severity of a
disease. While this perception often stems from information from medical resources, it may also
result from an individual’s perception of how the disease would negatively affect their wellbeing
and their life in general (Hayden, 2009).
Perceived Susceptibility is based on an individual’s perceived risk or susceptibility to
acquire the disease. The behavior change can be directly proportional to the intensity of the
perceived risk. That is, the stronger the perceived risk, the higher the probability of risk reducing
behavior. On the flip side, the opposite can also be true. That is, when people believe that they
are not at risk or have low susceptibility, then they may have more or continue with unhealthy
behaviors. Public health practitioners have found that behavior change often occurs when there is
a combined high perception of threat and severity of disease (Hayden, 2009).
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Perceived Benefits is when a person sees the value or usefulness of the new behavior in

reducing the risk of developing the disease outcome. This has been found to be particularly
important for uptake of health screening related interventions such as colorectal cancer screening
and others (Hayden, 2009).
Perceived barriers is related to the individual’s perception of the barriers in bringing
about the particular behavior change. The barriers could be personal, environmental,
psychological, social, economic, cultural and others (Hayden, 2009).
Cues to action are internal or external events, information exchange, communication and
other items, which can influence behavior change among individuals. The cues may be
developed to raise awareness or provide advice or include personal symptoms or similar illness
in a family member or a friend. The cues can be anything that can trigger a person to change
behavior. The items or events listed above can act as cues for individuals to undertake a behavior
change (Hayden, 2009). According to the HBM, one or more cues are generally required to serve
as a “trigger” for initiation of healthy behavior (Olsen et al., 2010).
Motivating factors also known as modifying variables relate to the fact that the four
original constructs of individual’s perceptions and thus behavior change can be modified by
external or internal variables such as education, personal experience with the disease, culture,
motivation and others (Hayden, 2009).
Self-efficacy is the “belief in one’s own ability to do something” (Hayden, 2009). It is
based on the fact that individuals generally do something new if they believe that they can or
have the capability to do it. For example, based on a perceived benefit, a person may believe that
a new behavior may be beneficial, however, if the person does not believe that they are able to
carry out the behavior change, then the chances of behavior change would be low.
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As mentioned earlier, HBM has been applied in numerous public health settings and

populations to study the correlation between the HBM constructs and desired behavior change.
According to Conner and Norman, (1996) and Janz and Becker, (1984), the applications can be
divided into three broad areas: 1) Preventive health behaviors including health promotion and
health risk behaviors to avoid illness or injury. 2) Sick role behaviors, which refers to actions
taken after a medical diagnosis of disease has been made and complying with a recommended
medical regimen to restore health (Janz & Becker, 1984). 3) Clinic visit which includes clinical
or health service utilization for any health reason. Janz and Becker (1984) conducted a review of
46 HBM related studies which they divided into one of the above listed three areas. Studies
under the preventive health behaviors area included influenza and swine flu surveys, seatbelt use,
exercise, nutrition, dental and medical checkups, drinking and driving, and others. Screening
behavior related studies on Tay-Sachs disease screenings, practice of breast self-examination,
and others. Sick behavior role studies included regimen compliance studies such as for
hypertension, insulin and non-insulin dependent diabetic regimens, end stage renal disease, and
others. Clinic visit studies were focused on use of clinical services for illness or disease
symptoms, pediatric visits, preventive, acute and emergency clinical visits, and others. Overall,
Janz and Becker found substantial evidence in the studies, which supported HBM constructs as
key contributors to the prediction or explanation of the participants’ behaviors being investigated
in each of the studies (Janz & Becker, 1984).
The construct of interest for this study was “cues to action”. A theoretical framework was
not incorporated in the intervention design however, during the study design phase some
assumptions were made based on the information found via the literature review. These were: the
individuals who had agreed to partake in the appointment reminder intervention had experienced
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the various HBM perceptions when they initiated on ART and received adherence counseling
from the clinic staff which included information on following the ART regimen, looking out for
side effects, and the importance of treatment adherence. An individual’s decision to initiate on
ART indicated that the individual saw the perceived benefit of ART. The individual may have
also seen a perceived benefit of the intervention offered and believed that they had the ability to
be adherent to their follow-up clinic appointments.
The rationale for choosing the “cues to action” was that the appointment reminder was an
external trigger to assist the individuals to achieve the clinic appointment adherence behavior. As
explained later in the chapter, the participants received three reminder “cues” in the time
between appointments (usually 30 days); one message was sent a week before the appointment,
another a day before and one the day after the appointment. The key question for the study in
terms of the theoretical model was: how effective were the cues to action in leading to the
desired behavior or intervention outcome? Figure 1 shows the basic elements of the proposed
appointment reminder intervention HBM and the cue to action construct possibly leading to the
desired behavior of clinic appointment adherence.
The cues to action construct of the HBM has been studied in various areas either as a
component of the overall HBM constructs or as an independent entity. One study found in the
literature was on the effect of the HBM constructs on weight loss related behavior among middle
school girls. The researchers found cues to action to be the most important variable for predicting
behavior intentions of weight loss among the study population (Park, 2011). Another study
assessed predictors of intent to receive the H1N1 influenza vaccine among a convenience sample
of college students and grocery store patrons. The investigators found that participants were
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more likely to receive the vaccine if a physician provided the cue or recommended the vaccine
(Coe, Gatewood, Moczygemba, Goode, & Beckner, 2012).

Figure 1. Elements of the HBM for the mHealth appointment reminder intervention.
(Adapted from Burke E, n.d)
Another study focused on the cues to action construct for starting CPAP in obstructive
sleep apnea and adherence over time (Olsen et al., 2010). According to Olsen et al., HBM has
been heavily investigated to predict adherence in several disease models including for prostate
cancer screening, mammography, and general health promoting behaviors, however, very few
studies have measured the cues to action. Olsen et al. also mentioned that it is difficult to assess
the effect of the cues prospectively, that is before the behavior change happens. Thus cues to
action studies are often designed as retrospective cross sectional studies to understand the effects
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of the prompts on the desired behavior modification (Olsen et al., 2010). This was a key point
during the study development phase, and it was designed as a retrospective assessment of the
appointment reminder cue to improve clinic appointment adherence among individuals on ART.
Some of the HIV/AIDS related studies based on HBM constructs conducted in the international
health arena used different methods of communication cues to action methodologies, such as
drama or song to increase HIV/AIDS knowledge and to remind the participants to adopt safer
sexual behaviors (Bosompra, 2007). A qualitative study was conducted to ascertain feasible
communication strategies which may influence ART adherence. The authors found that cues to
action was one of the constructs that was acceptable and feasible to use to communicate
adherence messages with patients on ART (Rochon et al., 2011). Mattson (1999) conducted a
study to review the role of persuasive communication cues by HIV test counselors in changes in
safe sex behavior of individuals getting tested for HIV. The pre- HIV test results did not show
any correlation between the HBM constructs and safe sex attitude among participants. However,
post-HIV test results which took place after an HIV test and a persuasive communication session
was conducted with the counselor, indicated higher perceptions of susceptibility, severity and
improved health behavior attitude. This highlighted the importance of communication cues in
affecting knowledge and attitudes among individuals
Starks et al. (2008) conducted a qualitative study at a hospital in Beijing, China to better
understand what patients on ART need, to obtain optimal treatment adherence. They
hypothesized that four crucial components, which work interactively but result from various
factors from individuals’ lives, have an effect on ART adherence. These were: (a) Access to
ART (a structural factor around availability of ART, (b) Knowledge about ART (cognitive factor
around regimen, side effects viral resistance, etc.), (c) Motivation to take the medication (a
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psychological factor), and (d) Prompts or cues to remember to take the medication on time
(internal or external cues). The study participants raised stigma and discrimination, side effects
of ART, cost of lab tests, transportation to the clinic and time away from work as major barriers
to treatment adherence. Most of the participants were comfortable with their ART knowledge
and knew how the ARTs worked, how to manage side effects, consequences of missed doses,
etc. The motivation to take the meds was also high as they were aware of the health benefits of
ARVs and they had a strong desire to live longer. The participants used a mix of internal
(personal schedules) and external (alarm and electronic tools, or other people) cues to remind
them to take the medication. The results from the Starks et al study indicated the acceptability
and feasibility of using cues to improve adherence on ART, thus strengthening the hypothesis for
this study that the appointment reminders would be effective in bringing about the behavior of
appointment adherence in the study population.
Literature Related to Key Variables and Concepts
HIV Epidemic
Sub-Saharan Africa region is the worst hit by the HIV epidemic compared to the rest of
the world. Approximately 25 million out of 35 million people globally living with HIV are in
this part of the world (UNAIDS, 2012). South Africa ranks as one of the most affected countries,
with a national antenatal HIV prevalence of 30%, in a population of approximately 47 million
(South African National Strategic Plan on HIV, STIs and TB 2012-2016, 2012). In 2008, 5.5
million people were living with HIV in South Africa and over a million people needed be on
ART (Ojikutu et al., 2008). At the end of 2013, 6.1 million people were living with HIV in South
Africa (PEPFAR annual report, 2013)
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Globally, there has been a surge in access to ART over the last few years with a 20-fold

increase in Sub-Saharan Africa (Micek et al., 2009). The South African government rolled out its
ART program in 2004. The government with support from international donors, and local and
international development agencies has made great strides in enrolling a large number of people
on ART in a short period of time. South Africa currently has the largest ART program in SubSaharan Africa with over 2.5 million individuals on ART in the public sector as of October 2013
(Ojikutu et al., 2008; PEPFAR annual report, 2013).
Loss to Follow-up
As the ART programs have scaled up, the focus for most countries has moved from
initiating patients to retaining them on ART since being on ART is a life time commitment. Once
on ART, patients have to strictly adhere to their daily medication regimen, which can be multiple
pills at various times during the day, and the patient is required to return to the clinic for followup appointments for clinical management and medicine refills (Miller et al., 2010; Ketlhapile et
al., 2010). While great achievements have been made in initiating patients on ART, there are
concerns about the long-term outcomes in terms of patient adherence and retention in HIV
treatment (Barnighausen et al., 2011; Maskew et al., 2007). A systematic review of ART
programs in Sub-Saharan Africa showed only 60% of patients still on ART two years after
starting treatment (Rosen, et al., 2007). This was similar to the rates found in treatment of other
chronic diseases globally. Rosen et al., 2007, found that 25% of patients had dropped out by year
one of ART initiation, with this number rising to 40% by year two on ART. Researchers in
Malawi found that the median time between initiation of ART and patients stopping follow-up
clinic attendance was 4.3 months (Yu et al, 2007). The median time between initiation on ART
and first missed appointment at a public sector tertiary hospital serving the inner city of

	
  	
  	
  

39

Johannesburg, South Africa was found to be 84 days (IQR 43-168 days, range 13-392 days)
(Dalal et al., 2007).
Rosen et al. (2007) placed the reasons for attrition from ART into four main categories.
Death and LTF were the most common followed by patients intentionally stopping their
treatment, and patients transferring to other ART facilities without informing their former ART
clinic (Rosen et al., 2007). LTF is defined as the disappearance of the patient from the ART
program for no reported reason (Rosen & Ketlhapile, 2010). Researchers and countries use
different time frames to identify patients as LTF. These can range from 30-90 days past the
missed follow-up clinic appointment date (Yu et al., 2007). LTF rates from a multi-site patient
file audit at public sector clinics in two provinces in South Africa between 2006 and 2009, were
found to be between 14-25%, with the largest proportion of patients becoming lost to the system
in the first 6 months of starting ART (Jaffer et al, 2007). A large public sector clinic with over
7000 patients enrolled on ART in Johannesburg had a LTF rate of 16.4% among patients
initiating ART between April 1, 2004 and March 31, 2008. Forty percent of the individuals
became LTF in the first three months after starting on ART (Rosen & Ketlhapile, 2010).
LTF is the major cause of treatment attrition. Patients who discontinue ART are at high
risk of: developing virological failure, acquiring opportunistic infections and early mortality (et
al., 2007). Harries et al., 2010, conducted a meta-analysis of sixteen studies in Sub-Saharan
Africa and found that between 20-60% of patients who were identified as LTF had died.
Researchers in Malawi found that about 50% of the patients who had been identified as LTF had
died, most dying soon after they missed their clinic follow-up appointment (Yu et al., 2007).
Dalal et al., 2007, conducted a study at an ART clinic in a tertiary government hospital and
found that one in six patients initiating ART were LTF. Once again, approximately 50% had died
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with a majority of patients dying within 30 days of missing their appointments (Dalal et al.,
2007). Some of the reasons found for LTF included ART costs, unavailable transport or transport
costs, long waiting times at the clinic, stigma, family pressures, illness, transferring to other ART
facilities, and others (Dalal et al., 2007). Health services factors identified for missed clinic
appointments included poor communication, poor waiting areas, and duration between
appointments. Patient related factors included transportation difficulties, health beliefs and
forgetfulness (Kliner et al., 2013). The mHealth intervention that was evaluated during this study
was developed to improve communication with patients, reduce waiting times (resulting from
patients arriving on the day and time of their scheduled appointment), and reduce appointment
forgetfulness among the patients.
According to the South African HIV/AIDS care and treatment guidelines outpatient HIV
care program starts at the PHC level. That is, individuals have to get their pre-test counseling,
HIV testing and post-test counseling at a PHC. If the individuals test positive, then their blood is
drawn to ascertain their CD4 count. It can take between 5-7 working days to receive the CD4
count result. The current standard of care requires the individuals to return to the clinic to receive
their CD4 results. ART commencement eligibility is ascertained via a WHO guideline staging
and the individual’s CD4 count. The current eligibility for immediate ART initiation are as
follows:
!

Any HIV positive child 0-5 years

!

Any HIV positive pregnant woman

!

Any HIV positive individual with active TB disease

!

Any individual with a baseline CD4 <350 cells/ml3
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If individuals are found to be eligible to start on ART, they are enrolled in pre-ART care,

provided adherence and ART initiation counseling, and initiated on ART. The patients are
required to return to the clinic once a month for follow-up appointments for clinical monitoring
and ARV refills (South African National Strategic plan on HIV, STIs, and TB 2012-2016; South
African HIV/AIDS treatment and PMTCT guidelines, 2011 and 2013).
Results from patient file reviews in South Africa have indicated that at each key phase of
the clinical cascade, there is a risk of patient attrition (Jaffer et al., 2009). The attrition can
happen at two key phases in the clinical cascade. One is the pre-ART and the other is the postART phase. Results from retrospective file reviews conducted at public sector ART sites in
South Africa indicated between 50- 60% attrition or loss to initiation during the pre-ART phase,
and between 14-20% loss to follow up in the post-ART phase (Jaffer et al, 2007). Figure 2,
derived from the UNAIDS 2014 report shows that in Sub-Saharan Africa, 45% of individuals
who have HIV get tested to find out their HIV status. Of the individuals who are eligible for
ART, only 39% get initiated on ART, and retention after ART initiation is under 30%.
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Figure 2. Proportion of HIV positive individuals who get tested to find out
their HIV status, initiate on ART and are retained on ART in Sub-Saharan Africa.
Source: UNAIDS Report, 2014; extracted from Abdool Karim, 2014.
Missed appointments and LTF
Regular follow-up clinic attendance is crucial for positive clinical outcomes of patients as
the patients receive their ARV refills at the end of the visit. Missed clinical appointments have
been found to be a significant risk factor for development of virological failure and AIDS
defining illnesses (Lucas et al., 1999; Nyandiko et al., 2013; Rastegar et al., 2003), and death
(Park et al., 2007). Viral resistance can develop quickly in an individual with poor adherence to
ART. It can occur after 11-30% missed ARV doses (Maskew et al., 2007).
There is evidence in the literature on linkages between repeated missed appointments and
low treatment adherence in patients with chronic illnesses (Levine et al., 1987), and between
missed appointments and LTF of patients on ART (Jaffer, 2009). Missed appointments also have
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negative impacts on health services, as they can increase cost and lower efficiency of service
delivery (Guy et al., 2012). Moreover, missed appointments can lead to delays in diagnosis of
treatment related side effects or other illnesses, thus delaying timely management of diseases,
leading to unanticipated burden on the health system where resources are already limited (Car,
Guro-Urganci, de Jongh, Vodopivec-Jamsek & Atun, 2012; Rosen et al., 2007).
Brennan et al. (2010) conducted a retrospective cohort study at one of the largest ART
clinics in South Africa with more than 17,000 patients enrolled on ART in 2010. They looked at
the relationship between missed follow-up ART clinical appointments in the first six months of
ART initiation and the outcome of mortality, LTF, immunologic response to ART, and
virological suppression due to ART. The researchers found that of the 4476 individuals who had
initiated on ART during the study twelve month observation period, only 65% attended all
follow up visits as scheduled. Approximately, 2.6% of the patients had died and 6.2% were LTF.
In addition, higher missed clinical appointments were found to be associated with increased risk
of mortality and LTF during the study period. Immunologic response was ascertained by
improvement in CD4 count compared to the CD4 count immediately before initiation on ART.
The researchers found that patients who missed three or more ART or clinical appointments were
at high risk of low CD4 improvement. Furthermore, patients with three or more missed ART
appointments were at increased risk of not achieving viral suppression by six months compared
to the patients who did not miss any appointments. This study was one of the first to look at the
relationship between missed appointments early in the treatment phase of patients initiating ART
and the health outcomes of the patients, in a resource limited setting (Brennan et al., 2010).
Some of the reasons for missing appointments include forgetfulness, confusion regarding
follow-up appointment, relocation, illness, hospitalization, transportation cost, side effects, death
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and insufficient medication supply (Dalal et al., 2007; Maskew et al., 2007). Forgetting
appointments is a common reason given by patients for missing outpatient clinic appointments in
a variety of health care settings (Leong et al., 2006; Guy et al., 2012; Kliner et al., 2013)
Regular clinic visits reflect good retention in care among patients on ART. Retention in
care is needed for continued access to ART and appropriate monitoring of side effects, toxicities,
and treatment failure (Geng et al., 2010). Good retention also translates into continued social and
clinical support. Poor retention in care is reflective of low treatment adherence and treatment
cessation. Once treatment is interrupted, the effects of ART can quickly reverse and cause harm
to the patients (Geng et al., 2010). Streamlined and active patient tracking has been
recommended by some researchers while others have suggested some form of reminder systems
which may reduce the rate of missed appointments (Dalal et al., 2007; Kliner et al., 2013). Other
researchers have recommended implementing a patient tracer program whereby patients missing
their clinic appointments are contacted and asked to return to the clinic in a timely manner (Yu et
al., 2007).
Since LTF was highlighted as a critical issue by some key studies especially by Rosen et
al., 2007 and Dalal et al., 2007, some countries in Sub-Saharan Africa developed and
implemented patient follow-up or tracker programs. Some of the projects involved hiring a social
worker or counselor who contacted patients missing clinic appointments by phone or home
visits. Other projects used a community based approach, whereby community workers
approached the patients identified as LTF (Rosen & Ketlhapile, 2010). Researchers studying the
effectiveness of tracer projects have found success in improving patients returning to the facility
after being contacted by a tracer. In a Kenya based study, the rate of return of patients was found
to be 65% and 49% in urban and rural areas respectively (Rosen & Ketlhapile, 2010). The
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researchers of this study also examined the cost effectiveness of a patient tracer project. They
found that the average cost of returning a patient to the clinic was $432/year. This was equivalent
to the cost of almost one year of the first line ART regimen for one person. The researchers
questioned that in an environment of reduced donor funding and resource poor settings, is it
appropriate to spend this much money to return a patient to care when there are patients
waitlisted to initiate on ART? The researchers later suggested using a junior tracer person and
also indicated that the cost would reduce to $18 if the cost of the patient tracer project was
distributed among all patients accessing ART services (Rosen & Ketlhapile, 2010).
While a patient tracer program has been found to be an effective and useful intervention,
it can be resource intensive based on patient load per tracer, and follow-up workers’ salaries,
transportation and communication costs. Therefore, there is ongoing search for alternative ways
of tracing or communicating with patients to assist them with maintaining good appointment
adherence and retention in care. The intervention evaluated in this study used a low cost way of
communicating with patients on ART to promote clinic appointment adherence. No studies were
found in the peer reviewed or grey literature that examined the association or effectiveness of
SMS on improving ART clinic appointment adherence among patients receiving ART services in
South Africa. Additionally, improving retention in HIV care and treatment by reducing LTF are
priority areas for the South African Department of Health (South African National Strategic Plan
on HIV, STIs and TB 2012-2016, 2012). The department is looking for solutions to improve
long-term retention in care of patients on ART, following the huge success of initiating over 2.5
million people on ART in the last ten years.
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Mobile Health technology to improve health services
Mobile technology includes cell phones, patient monitoring devices, personal digital
assistants, and other equipment. (Bahadur & Murray, 2010). mHealth applications range from
communication between health care provider and patient, delivery of services, patient education,
data collection at point of care, disease outbreak monitoring and reporting, training of health
workers in remote settings, HIV medication and treatment adherence support, and appointment
reminders. (Rodrigues et al., 2012; Tomlinson et al., 2013). The methods of communication with
cell phones include: text messaging or SMS, voice messaging, phone calls, World Wide Web
based social media platforms, Unstructured Supplementary Service Data (USSD), and smart
phone applications.
mHealth is a rapidly growing field. It is increasingly being used to improve delivery of
health services in both resource limited and rich settings (Leong et al., 2006; Peron et al., 2010).
mHealth is considered to have a great potential for strengthening health service delivery and
leading to positive health outcomes especially in resource poor countries (Free et al., 2013). The
acceptance of cell phones and their low cost has led to the quick uptake of mHealth technology
in health services (Rodrigues et al., 2012). One of the main reasons for mHealth popularity and
growth is a result of the extensive cell phone penetration globally. In 2009, more than four
billion or two-thirds of the world’s population owned cell phones. Over 60% of these phones
were in developing countries or emerging economies (Free et al., 2013; Bahadur & Murray,
2010). In most developed countries, there are more cell phones than the population. In
developing countries, mobile phone is the fastest growing communication sector. This is due to
poor infrastructures for landline phones, greater mobility with cell phones, easier access, low
startup cost, flexible payments, relatively low cost of communication especially as it pertains to
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text messaging, access to the Internet, Unstructured Supplementary Service Data (USSD)- a
widely used mobile communication technology between the phone user and mobile network, and
other modes of mobile communications (Bahadur & Murray, 2010). Eighty percent of the
world’s population lives in areas with an active mobile phone network thus making mobile
phone technology a viable option for reaching a large number of people (Bahadur & Murray,
2010).
mHealth has great potential for success in South Africa as the country has one of the
highest proportions of mobile phones per capita, with over 90% of people having a mobile phone
subscription (Leon et al, 2012). The rural and remotest parts of the country also have high
cellular network coverage (Crankshaw et al., 2010). The South African Government has shown a
keen interest in the use of mHealth technology in the public health care sector. In 2012, the
National Department of Health (NDoH) circulated a comprehensive eHealth strategy which
included the need for development, implementation and evaluation of mHealth interventions to
strengthen the public health sector (NDoH eHealth strategy, 2012). In addition, there is growing
interest and support by the United States government, the World Health Organisation,
multinational companies and other private entities such as the cell phone network providers to
develop, implement and evaluate innovative mHealth interventions to help strengthen the South
African government’s response to the HIV epidemic. This is evident from the increase in funding
these agencies have been making available in South Africa over the last 2-3 years. Studies
exploring the feasibility and acceptance of using mHealth in the South African population have
indicated a high level of interest and acceptability (Crankshaw et al., 2010).
The project evaluated by this study used mHealth technology via SMS to strengthen ART
follow-up appointments and thus reduce LTF in public sector facilities. The project was piloted
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between November 2011 and October 2012 at a primary health care facility based ART clinic in
the inner city of Johannesburg with approximately 2000 patients enrolled on ART. Following the
positive outcomes of the pilot, there was a request by the funding agencies and the DoH to scale
up the SMS for ART appointment reminder at a larger secondary level community health center
in the inner city. This facility, Hillbrow Community Health Center (HCHC), had over 16,000
patients enrolled in ART at the time of program implementation. This is one of the largest ART
sites in Sub-Saharan Africa serving South Africans and a large number of immigrant and hard to
reach populations such as sex workers, pregnant women, and others. The ART clinic (WARD
21), at HCHC was started in April 2004, when the NDoH rolled out the national ART program.
A patient file audit was conducted in 2008 to ascertain the patient outcomes at the facility, four
years post ART roll out. This site had similar issues of patient LTF, as noted earlier in this
chapter. Historical clinical and loss to follow up data from Ward 21was used in the study. This
information, along with the project and retrospective patient clinical data provided an appropriate
evidence base to draw conclusions from.
SMS Related Interventions in HIV Care and Treatment
SMS or text messaging is a well-established technology, which is recognized and utilized
around the world. It allows a person with a cell phone to send a short message, about 160
characters, to another person on their cell phone. The message delivery is immediate if the
recipient’s phone is switched on and in a network area. The recipient has the option to respond
immediately or wait. SMS is a cheap and efficient method of two way communication which
costs much less per text message versus per minutes expenses for a cell phone call (Leong et al.,
2006; Bahadur & Murray, 2010).
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Over the last few years, SMS has been identified and used as the most prevalent mHealth

technology application. Bahadur and Murray (2010) conducted a literature review between
February and December 2008, to examine the use of SMS in health care settings. Out of 212
articles and reports reviewed, 28 were found to meet the study criteria. The authors found studies
which indicated that SMS had: improved service delivery through appointment reminders,
improved communications between health care workers, increased: diagnosis, prevention,
adherence to treatment, treatment monitoring, contact tracing, and others. The authors concluded
that most of the studies were conducted in developed countries. SMS was found to be an
efficient, cost effective and appropriate technology for strengthening various health services
sectors. However, Bahadur and Murray noted that some researchers were skeptical about the
evidence around the effectiveness of SMS since many of the reports or articles generated were
from pilot projects or feasibility studies versus rigorous enquiry. The authors concluded that
while SMS has been found to be effective in the public health sector, there is a need for further
rigorous review of the benefits of this technology to improve health services in South Africa
(Bahadur & Murray, 2010). In addition, none of the studies reported by Bahadur and Murray
pertained to use of SMS to improve ART clinic attendance. This is where this study was
important. Retrospective clinical and program data from the appointment reminder intervention
was used to examine the effectiveness of SMS technology in reducing LTF in the public sector in
South Africa.
Acceptability and Feasibility of Cell Phone Use in HIV Care and Treatment
In the last five years there has been a growing interest in the use of SMS technology to
strengthen the HIV/AIDS health services sector. Chib, Willkin, Ling, Hoefman & Biejma, 2012
conducted a study in Uganda in 2009 to look at the effectiveness of an incentive based
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HIV/AIDS health education intervention using SMS to: increase knowledge around HIV/AIDS,
improve awareness among the participants about their local HIV testing facilities, advocate HIV
Counseling and Testing (HCT), and increase uptake of HCT among the participants. The
messages in the form of thirteen multiple choice and true/false questions were sent to 10,000
mobile phone subscribers with the help of the local telecommunication company, over a one
month campaign period and in one district. The information was provided by “Text to Change”,
a Dutch not for profit organization which provides health education services via mobile phones,
in Africa. The questions pertained to: HIV/AIDS knowledge, testing, and HCT services in the
area. The subscribers were given an option to opt out, however, none did. Subscribers, who
answered the questions correctly, received a free HCT service and were enrolled into weekly
drawings for free mobile phones or airtime. The authors reported that 233 out of 10,000 (2.3%)
subscribers accessed HCT services at the local clinic during the campaign period. This paper
only examined HIV knowledge among the subscribers as the researchers did not collect data to
look at association between the campaign and testing behavior. Approximately a quarter, 2,363
of the 10,000 people who were sent messages responded. Of these, 1,954 answered the quiz
questions with most people only answering one or two of the questions. Thirty individuals
answered all thirteen questions. On an average, the respondents got 68% of the questions correct.
The researchers only looked at existing HIV knowledge versus changes in HIV knowledge. Only
the subscribers who answered the questions were provided with the correct answers. While the
researchers set out to look at correlations between SMS and service uptake, they did not collect
the relevant data to answer the question. This type of a study design also indicates the limitations
of blast messaging to the subscribers. The researchers indicated limited success and
recommended making SMS a constituent of an integrated mass media campaign versus a
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standalone intervention, one should question if the study design had an impact on the results.
(Chib et al., 2012).
Apunyu and Hoefman (2010), who were co-authors on the Chib et al., (2012), study
conducted another study in a different district in Uganda in 2010. The aim of the study was
similar to the previous one; however, the study methodology was different. The researchers used
a survey methodology using “Text to Change” services. Information regarding the survey was
broadcasted via radio talk shows on two radio stations serving the district followed by short radio
messages broadcasted seven times a day (five times in the local language and twice in English),
to encourage people to participate. People were informed that they could opt in to participate in
the survey by sending a SMS to a toll free number. Additionally, flyers were distributed in the
main town and community health workers collected phone numbers face to face. As with the
previous study, participation in this study was incentivized. 8272 individuals subscribed to
participate in the study. Of these, 1,222 did not respond to any SMS messages. Therefore,
analysis was done on the remaining 7,050 participants. Fifty three-percent of participants
answered the HIV knowledge and family planning questions. Over 50% of respondents answered
an average of 74% of question correctly. More women answered correctly versus men (p < .001).
The AIDS information Centre located in town also offered free HCT during the survey period.
The center noticed a momentary increase in HCT uptake after announcement of free testing.
Eighty percent of the initial respondents had heard about the survey by radio. Ninety six percent
of the participants stated that they had improved their HIV knowledge from participating in the
survey. The researchers did not conduct a pre and post study so one does not know if there was
an actual change in HIV knowledge. The authors mentioned that the participants had a relatively
higher HIV knowledge compared to the national average (ascertained by national surveys). They
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also stated that the SMS survey was highly valued by the participants and the acceptability was
high. The AIDS information center had an increase in HCT uptake however; the authors did not
provide information differentiating the survey participants from the general population. There
was a high acceptability of the SMS survey and a large number of the participants indicated that
their HIV knowledge increased however, the authors do not provide any evidence showing a
correlation between the intervention and increase in HIV knowledge and HCT uptake among the
participants. One should also consider the possibility of participant bias on the outcomes noted.
A group of researchers conducted a cross sectional study to examine the use of and
feasibility of cell phones for ART clinic appointment reminders and adherence messages in
Durban, South Africa (Crankshaw et al., 2010). Primary analysis was on the existing patterns of
cell phones and willingness to be contacted by the clinic, by gender. Three hundred individuals
over eighteen years of age were enrolled in the study between October and December 2007, from
an ART clinic located in an urban/peri-urban state subsidized district hospital. Approximately
81% of the participants owned a cell phone. The female (67%) to male (33%) proportions among
the participants was similar to the gender proportions of individuals accessing services at the
clinic. Over 60% of the participants were unemployed and more than 52% had a secondary level
education. Approximately 41% of the participants had been on ART for less than six months,
followed by 26% and 33% for 7-12months and more than 12 months respectively. The
researchers found that regardless of gender, 99% of the participants were willing to receive
phone calls from the clinic, and 96% were willing to receive text messages. However, while the
participants considered the reminders as useful, they did not consider it critical to the success of
their treatment. Significant gender differences were found for questions pertaining to patterns of
cell phone use. More women: switched off their phones during the day (p = 0.002), sometimes
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did not take phone calls in certain places (p < 0.0001), shared a phone with someone (p = 0.002),
and left the phone sometimes where someone could pick it up and read the messages (p = 0.005).
Most of the participants stated using the cell phone alarm to remind them to take their
medications. The researchers also found other factors, which they mentioned, should be
considered when designing mHealth interventions. These included items such as theft or damage
to cell phones, which could affect long-term sustainability of the project and may affect
participant confidentiality. A solution to the sustainability issue was to update the contact details
at each clinic visit. Another issue highlighted was the unavailability of the participant to receive
the call. Text messaging was found to be more viable as the messages could be accessed by the
participants any time. Another point raised was the need to involve the patients when developing
the messages. This study had several advantages in that it involved a representative sample of
patients accessing ART in a high HIV prevalence area in South Africa. The researchers found
that the participants were similar as far as time on ART and gender breakdowns were concerned.
Disaggregation of the data by gender highlighted hidden nuances that can impact the outcome of
an appointment reminder intervention. Some of the limitations of this study were that the
information was based on responses from the participants. Actual behaviors associated with the
use of cell phone were not ascertained. As the researchers mentioned in the article, there could be
some degree of courtesy bias for willingness towards reminders. This could have overestimated
the positive response noted. There is also a possibility of recall bias for responses to cell phone
use questions. In addition, the authors caution the readers against generalizing the results to other
populations. The clinic where the study took place has a small fee for ART services. This is
different from other public sector clinics where services are provided free of charge. The clinic
may be supporting populations with some socio-demographic differences compared to the
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population receiving services at public sector clinics. In conclusion, the authors found a high
acceptability of appointment reminders in South Africa, and highlighted the importance of
conducting acceptability and feasibility studies prior to development and implementation of
interventions.
The three studies reported above show varying levels of acceptability for cell phone calls
or SMS in HIV care and treatment. The Apunyu and Hoefman (2010) study highlighted the
advantage of individuals opting in to participate in an activity versus the Chib et al. (2012), study
which used blast messaging to enroll individuals. Crankshaw et al., (2010), showed the need for
formative studies prior to development and implementation of interventions. The appointment
reminder intervention that was evaluated during this study was developed using a project
development cycle. The intervention was developed following a focus group based acceptability
and feasibility study in the target population. The participants were asked about acceptable SMS
content too. The intervention was piloted for a year at a primary health care based ART clinic
and then rolled out to the current ART clinic, which provides free services. People accessing
services at the clinic were approached by program staff and enrolled after a consent process.
Informal process evaluations were undertaken over the last two years to ascertain appropriate
implementation of the planned intervention. An outcome evaluation was the next relevant step in
the project’s development cycle. It ascertained if the intervention was effective in improving
adherence to clinic appointments and reducing LTF among patients on ART who received the
appointment reminder intervention versus a comparison group, which did not receive the
intervention.
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SMS to Improve Adherence on ART
As mentioned earlier, patient adherence to ART is crucial for continued benefits of ART
in avoiding development of viral resistance, reducing opportunistic infections, and early
mortality (Rosen et al 2007). In addition, adherence to ART has been linked to improved health
outcomes and is important to contain undue program costs (Lester et al., 2010). According to
Pop-Eleches et al., (2011), it is important to prevent adherence related treatment failure,
especially in resource constrained settings as the cost of second line regimen can be up to 17
folds higher than the first line regimen, that is, if the second line regimen is even available in the
country. Since adherence is crucial for ART success, a number of interventions have been
developed and implemented over the last few years. These have ranged from direct
administration of ART, provision of financial incentives, education, additional counseling
regarding adherence, facilitation of social support, and electronic and phone reminders
(Rodrigues et al., 2012). In the last 3-5 years, a handful of studies exploring the use of SMS in
improving ART adherence have been published.
Lester et al., 2010 conducted a Randomized Control Trial (RCT) in Kenya between May
2007 and October 2008 to study the effectiveness of SMS on ART adherence. According to the
researcher, this was the first clinical trial to report use of mHealth in improvement of clinical
level outcomes in patients on ART. This trial is seen as a landmark study in the field of
HIV/AIDs and mHealth. The trial was conducted at three ART clinics, involving 538 patients
who were equally randomized to the intervention or the control group. The intervention group
received weekly SMS messages from the clinic nurse with a simple question asking how they
were. The participants were supposed to respond within 48 hours if everything was OK or if
there were problems. If the response mentioned “problems”, then the nurse called the
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participants to inquire. The control group received the standard of care. The primary outcomes of
interest were self-reported ART adherence at the 6 and 12 months follow-up visits, and viral load
suppression at twelve months. Secondary outcomes included attrition at twelve months due to
death, transfer to other non-study clinic, withdrawal from the study or loss to follow up. The
researchers also examined differences on outcomes noted by gender, type of residence (urban or
rural), disease staging, phone ownership and others. One of the major strengths of this study was
the review of the viral load at twelve months. While self-reported adherence is the most
commonly used method of ascertaining treatment adherence, there is a high risk of reporting
bias. In this study, the participants were considered adherent if they mentioned taking more than
95% of their prescribed pills in the thirty days prior to their six and twelve month visits. Viral
load ascertainment requires a blood draw and it indicates the actual viral count in the blood.
According to Lester et al., (2010), “viral load is an important composite endpoint for monitoring
adherence and takes into account pharmacological, biological and socio-behavioral factors.” In
this study, viral suppression was 400 copies per mL or less at the twelve month follow up.
Participants with more than 400 copies per mL were classified as having virological failure. The
study was powered to note a 10% improvement from baseline, between the two groups. The
researchers found that significantly more patients in the intervention group reported adherence of
> 95% (p = 0.006) versus the control group. The difference was significant even after adjusting
for baseline covariates (p = 0.0028). In addition, more patients in the SMS group had suppressed
viral loads of < 400 copies per mL at twelve months (p = 0.04) versus the control group. After
adjustment, there was weak evidence of improved viral load suppression in the intervention
versus the control group (p = 0.058). There were no significant associations with the secondary
outcomes. At the end of the study, 98.5% of the participants in the intervention arm wanted the
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intervention to continue, and 98% mentioned that they would recommend the SMS intervention
to a friend. Many patients mentioned that they felt “like someone cares”. Results of this study
showed that mHealth interventions can improve clinical health outcomes of patients on ART and
participants found the intervention valuable. The researchers also mentioned that the SMS
intervention was inexpensive as each SMS message was USD 0.05 which totaled $20 per month
for 100 people. The calls per care providers averaged $3.75 per month indicating that the
interventions can include a human touch at a low cost. The researchers further indicated that
based on these statistics, this intervention may have been cheaper than the cost of a community
adherence intervention, which involves individuals to make home visits and requires travel and
personnel time. The authors also presented a hypothetical example for scale up of the
intervention in Kenya using the example of close to 300,000 individuals who received ART in
2009, supported by U.S. government funding. They estimated that if the SMS intervention was
scaled up in 2009, approximately 26,000 additional people could have had fully suppressed viral
loads (Lester et al., 2010).
Another study conducted in a rural setting in Kenya examined the correlation between
SMS and ART adherence (Pop-Eleches et al., 2011). The RCT was conducted at a single public
sector rural health clinic between June 2007 and August 2008 with 720 participants. All the
participants were provided with a mobile phone with basic features, and they were told to use the
phone as they wanted. However, the participants were asked to bring the phones to the monthly
follow-up visits. A replacement phone was not provided if the participants lost or damaged the
phone. The participants were also asked to take one of their three ART regimen medications to
the pharmacy, where the medication was transferred to a container with a medication event
monitoring system (MEMS) cap, which captured information on the number of times the
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container is opened. A third of the participants were randomly assigned to the control group,
which did not receive any SMS messages. The remaining participants were randomly but evenly
allocated to one of the four intervention groups. The four interventions were based on four
different types of short and long one–way SMS reminder messages based on adherence barriers
identified by other studies. The barriers included forgetfulness and social support issues. The
short messages just reminded the participants to take their medications while the long messages
provided some supportive language. The participants had to return to the clinic on a monthly
basis to get their MEMS cap recording. The researchers gave money to the participants to pay for
charging of the cell phones at public charging stations as there was poor access to electricity and
most participants could not afford it. In addition, small amount of money was added on each
phone every two months. The study was powered to detect a 15% difference between the
intervention and control group. Adherence was measured based on a proportion of number of
actual container opening over prescribed opening over a 12-week period. The primary study
outcome queried was adherence of > 90%. Secondary outcome included treatment interruption of
greater than 48 hours (ascertained by MEMS opening), during each analysis period of twelve
weeks. Baseline demographic information was similar among all participants. Approximately
16% of the participants were lost to follow up at the end of the study with no significant
difference in the loss to follow up rates between the four intervention and control groups (p =
0.48). The study results showed that the patients receiving weekly reminders had a higher
likelihood of achieving 90% adherence to ART – almost 13-16% higher compared to the control
group that did not receive any reminders. The control group had a drop in adherence from 6046% over the 48 weeks of observation. Instances of treatment interruptions of more than 48
hours were also lower in the group that received the weekly reminders. The investigators did not
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find a difference in the effectiveness of the longer or shorter text messages in improving the ART
adherence. The investigators also found that while the group receiving the weekly reminders had
improved adherence, this was not the case with the group receiving the daily reminders. One of
the reasons provided for the reduction in effect was “Habituation” i.e. the possibility of over
stimulus. The researchers concluded that they had provided robust evidence that SMS reminders
may improve ART adherence in resource constrained settings, and the low cost of setting up the
system and sending SMS may be beneficial in these types of settings. Pop-Eleches et al., further
stated that their study was one of the first with evidence of the beneficial effects of mHealth in
the field of HIV care and treatment and suggested the need to test it in other areas in the field
such as appointment reminders, treatment side effects and other communications between the
patients and their care providers (Pop-Eleches, 2011).
Rodrigues et al. (2012), conducted a quasi-experimental cohort study in India between
2010 and 2011 to examine the effects of weekly mobile phone reminders on adherence to ART
in the short term (6 months) and long term (12 months). Interactive Voice Response (IVR) and
SMS technologies were used in this study. The cohort included individuals who were (a) HIV
infected adult patients followed up as outpatients at the clinic, (b) had access to a cell phone, (c)
had been initiated on ART for at least a month at the time of enrollment in the study, and (d) on
the first line ART regimen. The intervention had two components and it was provided to all the
participants, once a week for six months. The first component was an interactive IVR call with
one question that the participants had to respond to. The question was “have you taken all your
medicines yesterday?” The second component was a non-interactive SMS, which included a
simple picture of a lamp and did not have any text. The participants were trained to respond to
the IVR and access the SMS message. One hundred and fifty individuals enrolled in the study.
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The researchers collected general demographic and some clinical marker information such as
baseline CD4 count, regimen type, duration on ART and other. Retention in the study at month
12 was found to be high at 94%. The results indicated a positive effect of the intervention on
adherence. The participants gave forgetfulness as the most common reason for non-adherence
however, this reduced significantly between baseline (17%), one month (10%), three months
(6%) and six months (3%) (p< .001). The participants preferred IVR (34%) to SMS (11%),
however, a larger portion preferred both methods (44%) (p < .001). There was significant
improvement in adherence over time, 85% at baseline to 94% at twelve months (p = 0.016) for
individuals falling in the “adequately adherent” category at each time point. While this study
indicated an improvement in adherence, it was reported by the participants, which can be biased
(Rodrigues et al., 2012).
The last three studies indicate a positive correlation between SMS messages or reminders
and treatment adherence using various ways of measuring adherence. As mentioned earlier in the
chapter, loss to follow up rates among patients initiating ART in South Africa are high (Jaffer et
al., 2007; Rosen & Ketlhapile, 2010). In addition, missed clinic appointments are linked to
reduction in treatment adherence among patients on ART (Levine et al, 1987; Rosen et al., 2007;
Car et al., 2012). Therefore, it is imperative to improve ART patients’ attendance to ART clinics
(Pop-Eleches, 2011). However, no studies were found during the literature search which were
based in Sub-Saharan Africa, and which had examined the effects of SMS reminders on ART
clinic appointment adherence and LTF. This study provided the evidence needed. In the study,
LTF outcomes at six and twelve months were compared between the intervention and the
comparison groups. The intervention group comprised of all individuals on ART who had
enrolled in the appointment reminder intervention between September 1, 2012 and February 28,
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2013. The comparison group was selected from the clinic population that had not enrolled in the
appointment reminder intervention. A partly purposeful, partly random stratified approach was
used to align the comparison and the intervention group. The standard of care provided to all the
individuals remained the same, and the health providers were not aware of who was and was not
enrolled in the intervention. The intervention was planned such that the group received
appointment reminders three times between their clinic appointments (usually 30 days); one
message two weeks before and one a day before the scheduled appointment, followed by one
message the day after the appointment. The first two messages were simple reminders that the
person has an appointment on a particular date. The third message varied based on if the patient
showed up for their appointment. If they showed up then they received a message thanking them
and information for the next appointment was included. If they did not attend the clinic then the
message urged them to return to the clinic as soon as possible. The evaluation of this intervention
was sufficiently powered to provide evidence if the SMS reminder was effective in improving
the desired behavior of clinic attendance and ideally lower LTF rates.
SMS for Clinic Appointment Reminders
Due to the lack of studies in the literature which examined use of SMS technology to
improve ART clinic attendance, especially in resource limited countries, the literature search
included review of studies which pertained to use of SMS for appointment reminders in a
number of health care settings in resource rich and limited countries. The search was focused on
use of SMS in outpatient clinic settings because ART services in South Africa are often offered
in outpatient settings.
One of the earlier studies on use of text messaging to improve primary clinic attendance
was conducted in Malaysia by Leong et al., 2006. The study was a three-arm multicenter
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randomized control trial with a total of 993 participants. The primary hypothesis was that text
message reminders were more effective than no intervention in improving primary clinic
attendance. Secondary hypothesis of the study was that text message reminders would be more
cost effective than the cell phone calls. The trial took place at seven primary health care facilities
(five private and two public). The three arms were text message reminders, mobile phone call
reminder, and no reminders. In both the intervention arms, a reminder was sent around 24-48
hours before the clinic appointment and the messages were kept similar. The researchers had a
strict definition for non-attendees. Any participant who did not come to the clinic on the day of
the appointment was marked as a non-attendee. If the participants came earlier or on another day,
changed the appointment date, cancelled or did not come at all for their appointment they were
marked as non-attendees. The attendance rate of the individuals in the text message reminder
group was significantly higher (59%) versus the control group (48.1%, p = .005). Similar rate
was found for individuals who received a cell phone reminder (59.6%) versus the control group
(48.1%, p = .003). However, there was no significant difference between the groups receiving
the text message versus the group receiving phone reminders (p = .874). The researchers also
found that while there were significant differences between the intervention and control groups,
approximately 40% of the participants were classified as non-attendees. A reason for this high
non-attendee rate could be due to the strict definition for non-attendees. Close examination of the
data reveled that about 48% of the attendees did not come to the clinic on their appointment
days, but they did return on another day. The authors also found that text messaging was much
cheaper than the cell phone call. In conclusion, both the text message and phone reminders were
found to be more effective versus no messages and the text messages were more cost effective
than the cell phone reminders.
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Another study was conducted in Kenya by Odeny et al., (2012), to measure the

effectiveness of text messages on improving the seven day follow-up appointment rate for
patient undergoing a male circumcision procedure. According to the researchers, this was the
first randomized control trial which looked at the outcomes of SMS to improve clinic attendance
in a resource limited country. Male circumcision has been found to be effective in lowering the
risk of men acquiring HIV (Gray et al., 2012; Weiss, Quigley & Hayes, 2000). It is a
recommended procedure by the World Health Organization (WHO) and Joint United Nation
Programme on HIV/AIDS (UNAIDS), which is being adopted by various countries
(WHO/UNAIDS 2011). Circumcision is a simple procedure, however there is a risk of
development of postoperative adverse events (Muula, Prozesky, Mataya & Ikechebelu, 2007). A
seven-day post procedure appointment is standard of care and it is important as the health care
providers can monitor the healing process, development of any adverse events, and reinforce
postoperative care. However, the seven-day clinic attendance rates are low in many countries
(Odeny et al., 2012). The trial was conducted in a large district in Kenya that had an average
baseline seven-day follow up rate of 43%. For this trial, men were approached during their postoperative recovery period. A total of 1200 men were enrolled between September 2010 and April
2011 and equally randomized to either the intervention (SMS) or the control group (no message).
The text messaging was one-way (researchers to the participants), except for the initial SMS,
which the participants were asked to send to the research team at the time of enrollment in the
study. The participants were reimbursed for this SMS. Individuals in the intervention group
received a SMS each day for seven days at the participant selected time and language. The
participants were counted as attended the seven-day postoperative appointment as long as they
attended within three days before or after the scheduled appointment date. The study was
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powered for a 9.5% change in the attendance rate (43% to 52.5%). Outcome data was available
for approximately 99% of individuals in both the intervention and the cohort group. Overall,
62.5% of the participants returned for their follow-up appointment. Further analysis indicated
that the rate of return although modest, was significantly higher in the intervention (65.4%)
versus the control group (59.7%) (RR1.09, 95% CI 1.00-1.20; p = 0.04). Secondary association
such as distance to clinic and follow up attendance rate was found to be significant. Association
between education level and follow up rate was also noted however it was not significant. The
authors discussed limitations in terms of lack of generalizability as they had to exclude almost
49% of the individuals initially screened as they were younger than 18 years. Individuals who
did not have cell phones with them at the time of enrollment or who did not own a cell phone
were also excluded from the study so it is not possible to compare between the group of people
who did or did not have a phone as data was not collected on the latter group. The authors
pointed out that the intervention arm still had over 30% of the patients who missed their
appointment, even after receiving a SMS. This phenomenon has been noted in other studies,
including the Leong, 2006 study described above. The authors noted the need for studies, which
would query into the reason for participants missing appointment in the intervention arm. The
text messaging was found to be cost effective and not human resource intensive once the
individuals were enrolled in the study as thousands of pre-programmed messages were sent out
electronically. This would support scale up of this intervention to a larger population.
Guy et al., 2012, conducted a meta-analysis of published and unpublished studies, which
presented outcomes comparing appointment attendance among patients who had received SMS
reminders and those who had not. The researchers looked at overall clinic attendance outcomes
stratified by study design and level of health care facility (primary, secondary, tertiary). Eighteen
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studies met the review criteria, of these eight were RCTs and ten were controlled observational
studies. All of the studies were conducted prior to 2010. The primary outcome of the studies was
the attendance rate, which was the proportion of patients in the intervention and control arms,
coming to the clinic on their appointment date. The studies pertained to clinical program areas
such as outpatient clinics at hospitals and primary health care facilities. Services included
pediatric, ophthalmology, orthodontics, and preventive health. The final group of studies for the
meta analysis did not include ART or HIV/AIDS services. Most of the studies (13 of 18) sent
generic SMS reminders. Three of the studies used personalized messages and two did not
specify. The SMS reminders were mostly sent less than 24 hours (n = 10) prior to the
appointment, a few of the studies sent the reminders 24-48 (n = 3) and more than 72 hours (n =
4), prior to the appointments. Analysis showed a high (> 94%) heterogenicity among the
observational trials (p < .01), versus RCTs, which had 0% (p = .84) heterogenicity. Therefore the
meta-analysis was restricted to only the RCTs. The researchers found that the SMS intervention
in RCTs increased the likelihood of patients attending their appointment by 50% versus the
control groups which did not receive any reminders. This was found for all the services areas.
The authors concluded that there substantial evidence that SMS reminders may improve
attendance rates in a variety of health care settings and thus may be a viable technology to
improve health services.
A randomized control trial was conducted at a clinic in Geneva between April and June
2008, to ascertain the effectiveness of patient reminders on missed appointment rates and to get a
demographic profile of the individuals missing appointments. 2130 patients were part of the trial.
The researchers used a "sequential reminder intervention" for the treatment group, using three
modes of reminders starting at 48 hours prior to the clinic appointment. The first mode of
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appointment reminder was phone call either to a land line or a mobile phone, followed by SMS
or text message if there was no answer to the phone calls after three tries, and finally sending a
postal reminder if the participant did not respond to the previous two mechanisms or did not have
a land line or a mobile phone. The control group did not receive any reminders. The researchers
reported that the intervention led to an overall significant reduction in the rate of missed
appointment from 11.4% to 7.8%. Subgroup analyses indicated that the reductions noted were
only significant in the general outpatient and smoking cessation appointments. They were not
significant in the HIV and dietician clinics (Perron et al., 2010).
Kunutsor et al. (2010), conducted a cross-sectional and prospective study at two rural
sites in Uganda to ascertain access to and use of cell phones and assess the feasibility of SMS or
cell phone calls to improve clinic attendance among patients on ART and ultimately adherence to
ART. The researchers identified and approached individuals attending the ART clinic. They
conducted a survey on a random sample of 276 people. Of these 176 individuals had access to a
cell phone (either they owned one or were using their friend or relative’s), and agreed to be
contacted for the study purposes. These individuals also met the study eligibility criteria which
included 18 years and older and had been on ART for at least three months. Structured
questionnaire was used to collect the baseline information on participants, which included,
social, demographic and basic ART treatment data, access to cell phone and extensive questions
on the patterns of phone use. Study participants were prospectively followed up for 28 weeks to
ascertain if they attended their ART refill appointment every four weeks. Participants missing
their appointments were contacted immediately by SMS or cell phone call – based on the
method, the participant had chosen, and reminded to attend their appointment. Participant
adherence to ART was also calculated every four weeks via a pill count and rated as “optimal” if
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found to be 95% and up, and “sub-optimal” if less than 95%. A total of 560 appointments were
scheduled during the study period. The clinic visits were classified as “on schedule”, “early” or
“missed”. The rate of attendance was 85%, 4% and 11% respectively. Fifty participants had
missed their scheduled appointments during the study. Forgetfulness was the highest reason for
missing appointment followed by illness, having enough medication, financial and travel issues,
and confusion over the appointment dates. The participants predominantly chose to receive a
phone call versus SMS due to inability to read the messaged resulting from illiteracy or language
issues. Forty (80%) of participants who missed their appointment returned to the clinic after the
phone call. The average return time was 2.2 days. Four (8%) of the participants had transferred
out, died or classified as loss to follow up. Six (12%) of participants did not return to the clinic.
Reasons cited by these individuals included financial constraints or being too sick to attend.
Mean treatment adherence level differences pre and post phone call were found to be statistically
significant. The researchers concluded that the use of mHealth technology, in this case, cell
phone calls were found to be effective in improving clinic attendance and there was high
acceptability for this type of an intervention in a resource limited setting. They acknowledged
that other studies in developed countries found SMS to be effective however, in the rural Uganda
setting, cell phones were preferred. While this study provides evidence of feasibility and
acceptance of mHealth intervention to improve clinic attendance and adherence to treatment, it
lacked a control group. Also, the researchers did not collect information on whether the patients
would have returned to the clinic without the call. Generalizability to the rest of the Ugandan
population is questionable too. The researchers suggested a need for a RCT to determine if the
outcomes noted in this study could be replicated in other resource limited countries.
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Based on the outcomes of the studies included above, there is reasonable evidence that

SMS are well accepted and effective in improving clinic appointment outcomes in various health
care services settings. The evaluation of the appointment reminder intervention provided
evidence on the effectiveness of using text messages in improving clinic attendance and thus
lowering the LTF rates among patients on ART at a busy public sector ART clinic. Retrospective
clinical and intervention data was used in this study.
Summary and Conclusion
Results from various studies conducted globally have highlighted LTF and retention in
care as major threats to the effectiveness of ARVs in controlling the replication of the virus in
HIV positive individuals, and the success of the ART programs. Need for innovative solutions
and interventions to control these issues have also been identified by various stakeholders. There
are numerous published articles on the use and effectiveness of mHealth technology in
improving health services in developed countries; however, there are not a lot of studies in the
developing country context. Furthermore, there is a gap in the literature on program effectiveness
studies pertaining to use of SMS, particularly looking at health related outcomes (Chib et al.,
2012), especially in the field of HIV/AIDS. Authors have stated in numerous articles that many
of the mHealth studies were based on pilots and lacked rigorous enquiry. Apunyu and Hoefman
(2010) go as far as to say that many studies present anecdotal evidence, and they lack sufficient
grounded evidence when discussing effectiveness of the interventions.
This study evaluated a mHealth appointment reminder project underway since September
2012 at a large public sector ART site in Johannesburg, South Africa with over 16,000 patients
enrolled on ART. The evaluation queried if appointment reminders sent via SMS were effective
in reducing missed appointments among individuals enrolled in the intervention versus
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individuals not enrolled in the intervention. The 6 and 12 months LTF rates between the two
study groups were the key outcomes of interest in this study. The appointment reminders also
acted as cues to action for the participants. The effectiveness of the cues in leading to the
expected behavior was reviewed during the evaluation.
As mentioned earlier, improving patient retention in care is a priority for the South
African NDoH. The appointment reminder project was one of three mHealth interventions
implemented in Johannesburg. The NDoH has been informed about these projects and the
evaluation outcomes will be shared with the government for possible integration in the national
strategy to improve retention in ART.
The next chapter includes information on the rationale for the study design, which was
developed in line with the gaps identified during the literature search and the recommendations
for future query by the various researchers. The research methodology is tailored to maximize
the data available, given the retrospective nature of the evaluation, the intervention design and
historical LTF data information available from the clinic.
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Chapter 3: Research Method
Introduction
The purpose of this study was to evaluate the effectiveness of a mHealth ART

appointment reminder intervention to improve retention in care of patients on ART at a large
public-sector ART clinic in Johannesburg, South Africa. This chapter provides a review of the
study research methodology. It starts with the research design and rationale section, which
includes a description of the mHealth intervention. This is followed by information on the study
research design, variables that were analyzed to respond to the research questions, the research
methodology and data analysis plan. The chapter ends with information on threats to validity and
ethical procedures.
Research Design and Rationale
Intervention
This study evaluated a mHealth ART appointment reminder intervention that was
implemented at a public sector ARV clinic (Ward 21) located in the Hillbrow Community Health
Center (HCHC) in Johannesburg, South Africa. HCHC offers secondary level health services in
the inner city of Johannesburg, including maternal child health, TB, HIV, family planning,
sexually transmitted illnesses management, plus minor surgeries and labor and delivery services.
HCHC is also a referral center for public sector primary health care centers in the area and serves
as a step-down facility for a tertiary level teaching hospital in Johannesburg. Ward 21 is an
outpatient clinic and it is one of the largest clinics in Sub-Saharan Africa that provides free ART
services.
The ART appointment reminder intervention was one of three mHealth intervention
projects developed in response to pre- and post- ART patient attrition issues discussed in Chapter
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2. All three interventions were pilot tested and revised based on the findings before being scaled
up to the HCHC and two other primary health care (PHC) facilities in the HCHC’s network.
One of the interventions was focused on provision of CD4 count by cell phone to ART
naïve patients. This intervention was rolled out at the two PHCs only, since in South Africa, the
outpatient HIV diagnosis and initial CD4 assessment primarily takes place at the PHC level. The
other mHealth intervention pertained to ART adherence reminders. This intervention was
originally planned to be offered to patients who had been on ART for more than 6 months. The
mHealth team altered the project design at the time of roll out, and offered the adherence
reminders to all patients on ART at the implementation sites. As part of this intervention, the
participants received weekly adherence messages for 1 year. These messages had been field
tested by one of the partnering mHealth organizations and included social, cultural, behavioral,
nutritional and other messages to improve ART adherence. The CD4 by cell phone and ART
adherence interventions mentioned above will be evaluated by other individuals and thus are not
the focus of this study. The outcomes of the various evaluations, including this study, will be
used to provide a comprehensive evidence base on the effectiveness of mHealth interventions in
responding to the three key areas of concern affecting the HIV/AIDS care and treatment program
in Sub-Saharan Africa and other countries.
The ART appointment reminder intervention was implemented at Ward 21 in September
2012, following positive outcomes from a pilot study conducted at one of the primary health
clinics in this clinic’s network. The intervention was originally planned for individuals newly
initiating ART (less than 30 days). However, based on the pilot results, the project design was
altered to offer and enroll everyone regardless of how long they had been on ART, to both the
appointment and adherence reminder interventions. The content of the SMS messages for the
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two interventions were distinct. Once enrolled in the ART appointment reminder intervention,
the participants received an introductory e-mail, which was followed by three e-mail messages
reminding the individuals of their scheduled appointments. These emails were sent 2 weeks prior
to the appointment, 1 day prior to the appointment, and 1 day after the appointment. The preappointment messages were simple reminders that the client had an appointment on the
particular date. The message after the appointment date varied based on whether the individual
kept the clinic appointment or not. If the individual attended the clinic appointment, they
received a message that thanked them for adhering to their appointment and reminded them of
the next appointment date. If the individual missed their appointment then they received a
message that informed them of the missed appointment and urged them to schedule another
appointment. Figure 3 shows the messages sent to the participants.

Figure 3. Appointment reminder intervention messages sent to the participants.
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Research Design and Rationale
A large proportion of the existing primary research and knowledge base in the HIV/AIDS
and mHealth field are pilot projects; there are few qualitative studies and even fewer clinical
trials. There is an identified gap in the literature on studies conducted to evaluate the
effectiveness of mHealth interventions in an HIV treatment setting, and specifically related to
LTF. This study assisted in reducing the gap in the literature. The evaluation was based on a
retrospective cohort study design to answer the question:
Is there a difference in 6 and 12 month LTF rates between clients in the ART
appointment reminder intervention and clients in the standard of care comparison group
who did not receive the intervention, at Ward 21 in HCHC in Johannesburg, South Africa
after controlling for the identified covariates?
The retrospective cohort nature of this evaluation, which used a baseline plus specific
follow up period was consistent with the research design required to advance knowledge in the
field of HIV/AIDS treatment. Six and twelve month LTF outcomes were ascertained among
patients on ART at the clinic who had self-selected to enroll in the appointment reminder
intervention between September 2012 and February 2013, and for a representative comparison
group, which did not receive the intervention. This group only received the standard of care.
HIV treatment programs in South Africa and other countries are at highest risk of losing
patients to LTF in the first 6 months of ART initiation (Dalal et al., 2007; Jaffer et al., 2007;
Rosen & Ketlhapile, 2010; Yu et al., 2007,). The historical LTF statistics from this clinic
indicated that this is not the case at Ward 21. Unpublished results from a 2008 patient file audit
of over 6000 client files of clients who had initiated ART between April 2004 and March 2008
indicated a different LTF pattern at this clinic, as shown in Figure 4. The reasons for the
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difference in LTF rates compared to other sites are unknown. The mHealth team took this
information into consideration when implementing the appointment reminder intervention, and
therefore decided to keep the recruitment criteria open to include patients who were either newly
initiating ART (< 30 days) or who had been on ART for several months or years.

Figure 4. Distribution of patients lost to follow up at Ward 21, HCHC for
period April 2004 to March 2008.
Major time and resource constraints were not expected since the study design required a
retrospective review. Data collected by the program staff for project monitoring purposes,
existing patient level data available at the clinic and if needed, the pharmacy databases were used
as sources of information, therefore resource constraints were minimal. However, one of the
disadvantages of using existing program data was that there was no guarantee that appropriate
quality assurance measures were implemented during data collection and reporting. The actual
time required to clean the data set in preparation for analyses was determined after the data was
made available to the researcher.
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Presence or absence of the appointment reminder intervention was the independent

variable of this study. The dependent variables were LTF at six and twelve months after
enrollment in the appointment reminder intervention during the specified study period of
September 1, 2012 to February 28, 2013, and from September 1, 2012 for the comparison group.
  

Methodology
Population
The population for this study were the over 16,000 patients, 18 years and above, who had
initiated on ART at either Ward 21 or at another facility and transferred to Ward 21, and were
accessing follow up ART services at the clinic at the time of the implementation of the
appointment reminder intervention. ART has been available to persons in the clinic’s catchment
area since 2004, and the population accessing services at this clinic is quite heterogeneous in that
individuals from various ethnic, socioeconomic and cultural backgrounds reside in the clinic
catchment area.
Sampling and Sampling Procedures
The intervention sample for this study comprised of all individuals eighteen years and
older on ART at Ward 21 who enrolled in the intervention between September 1, 2012 and
February 28, 2013 (N = 806). Information from figure 2, was used to categorize the study
participants into six cohorts based on their duration on ART. The six cohorts and the estimated
number of people in each of the intervention cohort according to the mHealth team were as
follows:
Cohort 1 (n = 91). Initiated on ART between September 1, 2012 and February 28, 2013.
Cohort 2: (n = 123). Initiated on ART between 1-6 months prior to Sept 1, 2012.
Cohort 3: (n = 86). Initiated on ART between 7-12 months prior to Sept 1, 2012
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Cohort 4: (n = 193). Initiated on ART between 13-24 months prior to Sept 1, 2012
Cohort 5: (n = 150). Initiated on ART between 25-36 months prior to Sept 1, 2012
Cohort 6: (n = 163). Initiated on ART >36 months prior to Sept 1, 2012
The comparison sample for this study was identified using partly purposeful, partly

random stratified approach where by the demographic profile of the intervention group (age and
gender), and time on ART was used to create matching criteria to align the comparison and the
intervention groups. Comparison group comprised of individuals who were on ART and received
the standard of care at the clinic but who did not receive the intervention. The researcher
expected a higher chance of missing or incorrect information in the comparison group as the
clinic’s data quality practices were not clear. Therefore, the sample size of the comparison
groups was estimated approximately 20% higher than the sample size of the intervention group.
Consequently, the number of individuals in each of the comparison group cohorts were
oversampled to accommodate for missing or incorrect information.
SPSS version 21was used to randomly select the individuals for the six comparison
cohorts. Drawing the study samples from the same clinic population assisted in reducing
variations and confounding, although there was a possibility of selection bias as the individuals
had self-selected to enroll in the intervention. The inclusion criteria for the study was all adult
(18 years and above) male and female (including pregnant) patients. The only exclusion criteria
was patients under 18 years of age.
A power analysis via G*Power (Faul, Erdfelder, Lang, & Buchner, 2007) was conducted
to determine the necessary sample size required per cohort group for a logistic regression
analysis, which was used to address the study research questions. For the power analysis,
specific input parameters were entered which were: effect size, set at medium, ʄ² = .30, power set
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at .80, and the significance (p) set at < 0.05. Based on these parameters, the total sample size per
group required to achieve adequate statistical power was N = 176. The actual sample sizes for the
intervention and comparison groups exceeded this value.
Procedures for Recruitment, Participation, and Data Collection
The mHealth team at the host institution, Wits Reproductive Health and HIV Institute
(WRHI), in Johannesburg obtained IRB approval from the Witwatersrand (Wits) University to
implement the mHealth interventions and conduct formative, evaluative and other research
activities in relation to these projects. As part of the Wits University IRB requirement, the team
was required to acquire approval from the Provincial Department of Health to conduct the
mHealth projects at the DoH ART clinics and to access the clinic and pharmacy patient records
for the intervention and subsequent evaluations. Copies of the Wits IRB and DoH approval
letters were included as supporting documents in the Walden IRB package. Individuals enrolled
in the post-ART interventions had the option to opt out at any time. Patients opting out received
a follow up call from the project staff to confirm the decision, and to ascertain the reason for
opting out.
The mHealth team recruited fieldworkers and placed them at Ward 21 after a rigorous
training and mentoring phase, which emphasized on patient recruitment methods, patient
confidentiality, data quality, quality assurance, and other items. The field workers were present
at the clinic every day. They approached patients in the waiting room, ascertained if the patient
were on ART, explained the intervention, and asked the patients if they wanted to enroll. If the
patients agreed to participate in the intervention, the fieldworkers walked them through an
informed consent process. The consent form was approved by the Wits University IRB. It
included items such as participants giving permission to receive SMS appointment reminders, be
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contacted by phone (if needed for follow-up), and for use of their clinical information for
program improvement, research and evaluation activities.
The mHealth team had developed data capturing tools that included patient intake and
follow up forms and an electronic database. The field workers collected the information in the
intake forms and transferred it to the database each day. An electronic patient management and a
pharmacy dispensing system is used at the clinic, and the program team accessed this system to
obtain patients’ demographic, clinical, and follow-up appointment information. The mHealth
team used patients’ clinic ID numbers as identifiers in the project database. As per Wits IRB
requirements, the patient level information was accessed only by key project personnel and was
stored appropriately to maintain patient confidentiality.
Approval was obtained from WRHI to request retrospective program data from
September 2012 to June 2014. This covered the twelve month plus 90 days follow-up period for
all the individuals who enrolled in the intervention between September 2012 and February 2013.
Figure 5 provides information on the timelines to ascertain LTF status at six and twelve months
after enrollment in the intervention. Determination of LTF at 90 days after the end of six and
twelve months of enrollment was based on the PEPFAR definition of assigning the LTF status
(PEPFAR SASI Manual, 2007). In addition, permission was obtained to receive data from the
clinical and the pharmacy databases for demographic, clinical, and appointment information for
the intervention and comparison groups. For the comparison group, the six and twelve months
LTF status were determined from September 1, 2012.
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Figure 5. Data analysis timeline to ascertain loss to follow up in the study cohorts, six and
twelve months after enrolling in the intervention.

Instrumentation and Operationalization of Constructs
Operationalization of Variables
Independent Variable. The key independent variable for this study was the presence or
absence of the ART appointment reminder intervention. This independent variable was
dichotomously coded where 0 = standard of care and 1 = ART appointment reminder
intervention. Clients should have received all three of the reminders per appointment period to be
included in the intervention group.
Covariates. Covariates are variables, which may not be part of the main study inquiry
however, they can influence the dependent variable (Field, 2012). The covariates for this study
were identified based on information found in the literature from studies on mHealth and
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adherence to ART (Lester et al, 2010; Pop-Eleches, 2011; Rodrigues et al, 2012). The study
covariates and their operational definitions are presented below:
Age. Client age at initiation of ART was used as a measure of age. Age is a ratio
variable and will be calculated in years.
Gender. Gender is a dichotomous variable where 1 = male and 0 = female.
Baseline CD4 count. CD4 count is the number of CD 4 cells, a type of white cell that
fights infection. A low baseline CD4 count can put a person at a high risk of getting sick. It can
have an effect on adherence to ART appointment and loss to follow up. A CD4 count is a ratio
variable, as it can range from 0 cells/mm3 to 1,500 cell/mm3. A normal CD4 count ranges
between 500 to 1,500 cells/mm.3 In South Africa, ART is recommended when the CD4 count is
below 350 cells cell/mm3 (Carter and Hughson, 2014; South African ART Guidelines, 2013).
The baseline CD4 count is the count taken three months before ART initiation.
ART regimen. This covariate is a categorical variable based on four different types of
ART regimens, and it is coded where 1 = Regimen 1A, 2 = Regimen 1B, 3 = Regimen 2, and 4 =
Other Regimen.
Concurrent illnesses. This covariate was based on the presence of concurrent illnesses as
noted in the patient’s records. This variable was dichotomously coded where 0 = no concurrent
illnesses and 1 = yes, concurrent illnesses.
ART side effects. This covariate is based on evidence of ART side effects as noted in the
patient’s records. This variable was dichotomously coded where 0 = no ART side effects and 1 =
yes, presence of ART side effects.
Dependent Variables: LTF. There were two dependent variables in this study, both of
which pertained to LTF. Programmatically, LTF is defined as the disappearance of the
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individuals from ART for no known reason (Rosen et al., 2007). For the purpose of this study a
patient was considered LTF if they have not been to the clinic or picked up their ARVs for at
least 3 consecutive months. (PEPFAR Strategic Information Manual South Africa, 2007). Data
on individuals who had died during the study period were noted but not included in the analysis.
There were two LTF dependent dichotomously coded variables: (a) 0 = no, no loss of client at
follow up at 6 months and 1 = yes, loss of client at follow up at 6 months and (b) 0 = no, no loss
of client at follow up at 12 months and 1 = yes, loss of client at follow up at 12 months. The two
time periods were selected based on evidence from mHealth based ART adherence studies found
in the literature. These studies found significant differences in adherence to ART at the six and
twelve month timeframes (Lester et al, 2010; Rodrigues et al, 2012).
The study data was planned to be derived from four sources: (a) ART appointment
reminder intervention data from the project database; (b) patient demographic and clinical data
from the Electronic Medical Records (EMR), of patients who initiated on ART between
September 2012 and February 2013 and for the relevant comparison groups by cohort; (c) patient
appointment dates from the EMR or electronic pharmacy dispensing system for patients who
initiated on ART between September 2012 and February 2013 and for the relevant comparison
groups by cohort; and (d) the 2009 HCHC File Audit Report (unpublished).
Data Analysis Plan
The purpose of this study was to evaluate the effectiveness of a mHealth patient
appointment reminder intervention to improve retention in care of patients initiating ART at a
large public sector ART clinic in Johannesburg, South Africa.
Research question 1. Is there a difference in six month LTF rates between clients in the
ART appointment reminder intervention and clients in the standard of care comparison group
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who did not receive the intervention, at Ward 21 in HCHC in Johannesburg, South Africa after
controlling for the identified covariates?
Ho1. There are no statistically significant decreases in the likelihood of 6 month LTF for
clients on ART who received the appointment reminder intervention when compared to clients in
the standard of care comparison group.
Ha1. There are statistically significant decreases in the likelihood of 6 month LTF for
clients on ART who received the appointment reminder intervention when compared to clients in
the standard of care comparison group.
Research question 2. Is there a difference in 12-month LTF rates between clients in the
ART appointment reminder intervention and clients in the standard of care comparison group
who did not receive the intervention, at Ward 21 in HCHC in Johannesburg, South Africa after
controlling for the identified covariates?
Ho2. There are no statistically significant decreases in the likelihood of 12 month LTF for
clients on ART who received the appointment reminder intervention when compared to clients in
the standard of care comparison group.
Ha2. There are statistically significant decreases in the likelihood of 12 month LTF for
clients on ART who received the appointment reminder intervention when compared to clients in
the standard of care comparison group.
The project data was obtained in Microsoft Excel file formats from the mHealth project
staff. Additional demographic and study related data was be included in this database as relevant.
All study data was cleaned (i.e., reviewed for errors) then exported to a SPSS 21.0 data file for
data analysis. All of the study variables were assigned a variable name, with the variable values
coded (e.g., male = 1 and female = 0). Cases were reviewed for missing at random (MAR) and
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not missing at random (NMAR) data, and multiple analyses were conducted on the NMAR data
(Agresti, 2013). Descriptive statistics were computed for the study variables, inclusive of the
study covariates. The mean, standard deviation, and minimum and maximum values were
computed for ratio variables and frequencies and percentages calculated for dichotomous and
categorical variables. Outliers were addressed by replacing the outlier with the next highest or
lowest value (Agresti, 2013). Spearman’s rho correlations and chi-square analyses were
conducted between each of the identified study covariates and the dependent LTF variables.
Covariates found to be associated with the dependent variables with p-values of < 0.25 were
included as predictors in the logistic regression analyses performed to address the study research
question. The p-value criteria of < 0.25 for covariate association was used for analysis as it is
possible that a covariate may not be significantly associated independently but may contribute to
the model in conjunction with other variables.
A benefit of using logistic regression is that the assumptions of normality, linearity, and
homogeneity of variance are not relevant to this type of statistic as thus data need not be
examined for violations of these assumptions (Agresti, 2013). Two binary logistic regression
analyses were conducted for the two dependent variables (LTF at 6 months and LTF at 12
months). Binary logistic regression was selected for this study as the dependent variables were
dichotomously coded and the relationship between the intervention and the outcomes of LTF
could be determined when covariate variance were accounted for (Agresti, 2013). The model
chi-square (χ²) determined the significance of the overall regression model, while the
classification table generated by the statistical tool determined correct classification of the
dependent variable categories based on the predictors in the model (Agresti, 2013). The HosmerLemeshow (H-L) statistic for logistic regression, which answers the question, “how best does my
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model fit the data?” was used as the model goodness-of-fit statistic (Allison 2013). If the p-value
produced from the statistic was low (< .05) then the model was rejected. If the p-value was high,
then the model passed the test as a good fit (Allison 2013; Agresti, 2013). Any probability value
of significance (p-value) generated in the regression model, which was less than the level of
significance (0.05) was considered statistically significant.
Threats to Validity
It is important to note the potential threats that can affect the validity of the study. The
most common threats are to the internal, external and statistical conclusion validity. Threats to
internal validity compromise the researcher’s confidence to indicate if a relationship exists
between the independent and dependent variables. Information presented below was developed
based on the list of threats to internal validity by Michael (2014). History should not be a threat
to this study as both the intervention and control groups were from the same clinic and had
initiated on ART during a similar time period. If an unexpected event occurred during the study
period, which may affect the outcome noted, it would have affected both the groups and thus
should not have an effect on the differences noted between the two groups. Maturation was not a
threat to this study as both the groups experienced the same progression of their illness at the
same rate. Selection bias was a possible threat to the internal validity of this study as the
participants self-selected to enroll in the intervention. Experimental mortality or the attrition in
number of participants over the study period could have been a minor threat to this study,
however, the full extent of this threat could only be ascertained once data was received for
analyses. That said, the mHealth project manager has mentioned to the researcher that
individuals asking to opt out of the intervention were few. The project collected information on
the reason for opting out which was reviewed as part of this study. Testing was not part of this
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intervention therefore it was not a valid threat. The dependent variables were measured using the
project and clinic data for both the groups, thus instrumentation was not a threat for this study.
Design contamination could have been a possible threat to this study, especially since all
individuals were approached and the intervention was explained and offered to everyone. In
addition, all individuals enrolled in the appointment reminder intervention also received weekly
adherence messages. It was difficult to confidently state if the outcomes observed were a result
of the appointment reminder or the adherence messages. It was not possible to control for the
adherence intervention as the study used retrospective data. It would have been a better practice
if the groups of individuals who received the two interventions (appointment reminder and
adherence messages) were kept separate as originally planned. Full extent of this issue may
become apparent at the time of data analysis. Compensatory rivalry and resentful demoralization
did not affect this study as the intervention was offered to all the patients on ART (Michael,
2014).
According to Michael (2014), threats to external validity can compromise confidence in
making the study results generalizable to other populations. Some important threats to external
validity are: i) interaction of testing, ii) interaction effects of selection biases and the
experimental treatment testing reactivity, iii) reactive effects of experimental arrangements, and
iv) multiple-treatment interference.
Interaction effect of testing occurs when a pre-test interacts with the intervention under
study and alters the outcomes such that the results cannot be generalizable beyond the study
population (Michael, 2014). This phenomenon was not a threat to this study as the participants
were not tested during the course of the intervention. Interaction effects of selection biases and
the experimental treatment takes place when some aspect of the group based on the selection of
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the participants interacts with the intervention, which would not have happened if the
participants were randomly selected (Michael, 2014). This was a potential threat to this study as
the participants self-selected to receive the intervention. Reactive effects of experimental
arrangement also known as the Hawthorne effect is a phenomenon experienced by some
participants who may alter their behaviors because they are part of a study (Michael, 2014). This
could have been a viable threat to this study. It is possible that the participants receiving the
intervention altered their treatment adherence. Multiple treatment interference occurs when
subjects are given multiple doses of the treatment or, as is the case in a repeated measures study
design. This makes it difficult for the researcher to generalize the results to the actual effect of a
single treatment (Michael, 2014). While this study population will be measured repeatedly for
adherence to appointments and LTF, multiple treatment interference was not a viable threat to
this study population based on the planned intervention, which sent a set number of reminders to
the participants every month.
Threat to construct or statistical conclusion validity (SCV) comes into play when
inappropriate or inadequate statistical analysis are used for data analysis or measurement of
variables, which produce results that would have been different if the correct data analysis tool
were utilized (Garcia-Perez, 2012). A threat to SCV can lead the researcher to incorrect
conclusions about the relationship between the indirect and direct variables. They can lead to two
main types of errors: (a) the researcher concludes that there is no relationship when in reality
there is a relationship or (b) the researcher concludes that there is a relationship when in reality
there is no relationship. These are similar to the Type I and Type II errors that can be
encountered in hypothesis testing. Some of the common threats to SCV according to a WEB
center for social research methods article (2014) include: (a) slow reliability of measures, (b)
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poor reliability of treatment implementation, (c) random heterogeneity of respondents, (d) low
statistical power, and (e) violated assumptions of statistical tests.
Low reliability of measures comes up if the measurement tool is not appropriate. That is,
there is poor layout or design of the tool or questions that may not be appropriate for the study.
Poor reliability of treatment implementation is particularly important in an evaluation setting.
This occurs, when the program is not implemented as planned or there are inconsistencies in the
actual implementation. This can make it difficult to ascertain relationships between the
independent and dependent variables. Random heterogeneity of the respondents pertains to the
different types of people who may be participating in the study, which would increase variance
in the responses. Some of the variability may be useful for the study while others could
potentially cause hindrance in observing any relationships. The above three items may mask
actual relationship; however, the strongest threat to SCV is low statistical power. This affects the
strength of any relationship or associations. Violated assumptions of statistical tests are
important as a researcher can make incorrect assumptions when conducting data analysis; for
example, assuming that the data is normally distributed when it is not (WEB center for social
research center, 2014).
Some of the recommendations based on the above mentioned threats to SCV include:
using robust statistical power, ensuring appropriate reliability, implementation of the
intervention, and good understanding about the data and use of appropriate statistical tests. The
sample size for the intervention group was pre-determined for this study and individuals on ART
at the clinic who had not received the intervention were randomly sampled for inclusion in the
comparison group. The total sample size was large enough to provide a strong power for this
study. The intervention did not use any tools to measure study variables, it used actual data from
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the clinic and pharmacy. Therefore, the study was not at risk for inappropriate reliability.
Appropriate implementation of the intervention could be an area of concern for this study. The
WEB center for social research center (2014), has recommended that to achieve good
implementation of intervention researcher should have standardized protocols and train the
program staff to implement the intervention uniformly and appropriately. The mHealth team had
trained and mentored the field workers and other program staff on appropriate participant
recruitment, patient confidentiality, follow up, and data quality, so the effect of this threat were
minimal to this study. In addition, the team had developed Standard Operating Procedures and
recruitment flow charts for the fieldworkers to use in their day-to-day project tasks. To avoid
violated assumption of statistical tests, the researcher shared the analysis plan with the
dissertation committee before starting the analysis.
Ethical Procedures
As mentioned earlier, the project team had submitted an application to the Wits
University IRB to implement the three mHealth interventions and evaluate them. As part of the
Wits IRB application, the project had to obtain a letter of approval from the provincial DoH
leadership to implement the project at the DoH sites in the inner city of Johannesburg. The Wits
IRB application was approved in 2012, and the approval letter was included in the Walden
University IRB application. Letters of permission to access the project and clinic data were
obtained for this study from WRHI and included in the IRB application and/or the final
dissertation as required.
Ethical concerns in relation to recruitment materials and processes, data collection, and
intervention activities were not expected given the retrospective nature of this study, and since
no new data was collected as part of this evaluation study. The appointment reminder project was
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described as a low risk intervention by the WRHI mHealth team in the Wits University IRB
application, which means that the participants had low risk of adverse events resulting from
participating in the project. The mHealth team used specific measures to protect patient
confidentiality in line with the Wits University IRB requirements. As mentioned earlier, the
project used patient clinic IDs to link with the clinical information and for follow up activities, in
an effort to protect participant confidentiality. Once the Walden IRB approval was received (IRB
approval number 10-15-14-0108616), the WRHI mHealth team made the project data available
to the researcher. In addition, specific demographic and clinical information on the patients in
both the intervention and comparison group from the clinic’s EMR and pharmacy databases was
requested by the researcher. Walden IRB required the researcher to not have access to the
patient’s clinic ID numbers. The researcher was the only person to have access to the raw data
for the study. The study database was password protected and stored on the researcher’s personal
computer at home. The study database will be deleted from the computer five years after the
completion of the dissertation or as required by the Walden University IRB.
This study was conducted at the researcher’s previous place of employment. As the head
of department for the Monitoring and Evaluation (M&E) team at WRHI from 2006 - 2013, the
researcher supervised five portfolios in the department. However, all the portfolios were
managed by program managers. While the researcher provided technical assistance to the
mHealth portfolio and supervised the program managers, the mHealth program manager had
recruited the mHealth team members and managed the day-to-day functioning of the portfolio.
The researcher was not involved with the training of the intervention staff and did not have
access to the project data prior to the evaluation, except for the routine program monitoring
outputs reported by the team via quarterly reports. The researcher left WRHI to relocate to the
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US in March 2013 and has not had any management or technical connections to the M&E team
since.
WRHI leadership promotes and supports its staff to pursue higher educational degrees.
Four M&E staff members are pursuing or completed their Masters degrees in the last five years.
One of the program managers already has a PhD and three of the remaining four are currently
pursuing their PhDs – two of the dissertation topics are mHealth related, therefore there is no risk
of power differential regarding this dissertation. Furthermore, based on the independent mHealth
dissertations underway, the two program managers and the researchers expect to provide a wellrounded evidence base on the effectiveness of mHealth in strengthening HIV/AIDS care and
treatment in South Africa.
Summary
This evaluation was based on a retrospective cohort study design using quantitative
analysis. The effectiveness of appointment reminders sent via SMS, in reducing missed
appointments among individuals enrolled in the intervention versus individuals not enrolled in
the intervention was ascertained by this study. Loss to follow up rates at six and twelve months
post ART initiation were also reviewed for the above two groups. The appointment reminder
intervention is one of first mHealth projects to be implemented in South Africa and the results
from the evaluation are expected to have an effect on the expansion of other mHealth and HIV
projects in South Africa.
While this chapter provided information on the study methodology and data analysis
plan, the next chapter includes actual data from the study, analysis of the data, study observations
and explains any deviations or alterations to the information in this chapter.
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Chapter 4: Results
Introduction
The purpose of this study was to evaluate the effectiveness of a mHealth patient

appointment reminder intervention to improve retention in care of patients initiating ART at a
large public sector ART clinic located in a community health center in Johannesburg, South
Africa. The two research questions queried differences in LTF rates at 6 and 12 – months
between clients enrolled in the ART appointment reminder intervention and clients in the
comparison group. The hypotheses were that there were no statistically significant differences in
the LTF rates at 6 and 12 months, between the intervention and the comparison groups.
This chapter starts with information on the research questions, and the null and alternate
hypotheses. This is followed by tables with descriptive statistics on the basic demographics and
various study covariates of the two study groups. Chi-square and regression analyses between the
covariates and the dependent variables form the next part of this chapter. A model chi-square
analysis for the full study population is presented first, followed by cohort-level chi-square and
regression analyses for each of the six cohorts in the study. The chapter ends with a summary of
the findings and introduction to Chapter 5.
Data Collection
As mentioned in Chapter 3, the project data requested from the host organization was for
the period September, 2012 to June, 2014. However, the organization was able to provide data
for this period only for the intervention group. Data for the comparison groups was available
through January 2014. In 2011, the national DoH made a decision to roll out a standardized
HMIS called Tier.net at all the public sector HIV clinics in the country. The accompanying new
policy mandated all sites to shut down any existing HMIS and switch to the new DoH one. Ward
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21, the study site, was allowed a 2-year grace period to shift to the new system as the existing
HMIS in use at the clinic was more advanced than Tier.net. In December 2013, the DoH asked
the site to switch over to Tier.net immediately, thus the time period for the data for the
comparison group was shortened to January, 2014. Nonetheless, the truncated period did not
impact this study and it was possible to make LTF decisions at the 12-month mark for all the
patients in the intervention and the comparison groups. The researcher also noted that individuals
who were identified as LTF at 6 months continued to be LTF at 12 months.
According to the preliminary information from the intervention implementation team,
806 individuals were expected to be in the intervention group. As mentioned in chapter three, the
comparison group cohorts were to be oversampled by approximately 20%. In actual, a total of
832 individuals qualified to be included in the intervention group during the study enrollment
period of September 1, 2012 to February 28, 2013. The actual size of the comparison group was
918, for a total study population of 1750 individuals. Participants were randomly selected for the
comparison group based on the gender and age breakdown of the six intervention group cohorts.
Data cleaning was conducted before the analyses; any individuals who did not have an ART
initiation date or were LTF before September 2012 were removed from the dataset.
The study sample size was N = 1750 participants (832 in the intervention group and 918
in the comparison group), of whom n = 1135 (64.9%) were female and n = 615 (35.1%) were
male. The demographic and descriptive characteristics of the sample population are summarized
in Table 1. The mean age of participants was 37.34 years (Md = 36.00, SD = 8.25), and
participants ranged in age from 18 to 79 years. Of the n = 832 participants in the intervention
group, n = 523 (62.9%) were female and n = 309 (37.1%) were male. The mean age of
intervention group participants was 37.41 years (Md = 36.50, SD = 8.11), and intervention
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participants ranged in age from 18 to 67 years. Of the n = 918 participants in the comparison
group, n = 612 (66.7%) were female and n = 306 (33.3%) were male. The mean age of the
comparison group participants was 37.28 years (Md = 36.00, SD = 8.38), and the participants in
this group ranged in age from 19 to 79 years. Of the 1135 females in the study group, n = 61
(5.4%) were pregnant. Of these, n = 27 were in the intervention group and n = 34 were in the
comparison group.
Table 1
Study Participants by Group (N = 1750)
Intervention
n = 832

Comparison
n = 918

Frequency

Percentage

Frequency

Percentage

Female

523

62.9

612

66.7

Male
Cohort
1
2
3
4
5
6
Pregnant

309

37.1

306

33.3

88
102
77
184
190
191

10.6
12.3
9.3
22.1
22.8
22.9

107
136
84
196
204
191

11.7
14.8
9.15
21.3
22.2
20.8

No

496

94.6

578

94.1

Yes

27

5.4

34

5.9

Mean

SD

Mean

SD

37.41

8.11

37.28

8.38

Gender

Age

A chi-square (χ²) test of independence showed that there was a slight but significant
association between gender and the intervention and comparison group classification, χ² = 2.77,
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p = .01. An independent samples t-test showed that the intervention and comparison groups of
participants did not significantly differ on age, t (1748) = 0.34, p = .73. Table 2, shows
breakdown for gender by the intervention and comparison group cohorts and table 3, provides
the age breakdown information by each cohort in the two study groups.
Table 2
Study Participants Gender by Intervention and Comparison Group Cohorts (N = 1750)

Cohort 1

Cohort 2

Cohort 3

Cohort 4

Cohort 5

Cohort 6

Intervention

Comparison

(n=832)

(n=918)

Frequency

Percentage

Frequency

Percentage

Female

55

62.5

72

67.3

Male

33

37.5

35

32.7

Female

60

58.8

89

65.4

Male

42

41.2

47

34.6

Female

43

55.8

58

69.0

Male

34

44.2

26

31.0

Female

120

65.2

128

65.3

Male

64

34.8

68

34.7

Female

123

64.7

132

64.7

Male

67

35.3

72

35.3

Female

122

63.9

133

69.6

Male

69

36.1

58

30.4
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Table 3
Study Participant Mean Age by Intervention and Comparison Cohorts (N = 1750)
Intervention

Comparison

(n = 832)

(n = 918)

Mean Age

SD

Mean Age

(years)

SD

(years)

Cohort 1

35.25

8.17

36.29

9.44

Cohort 2

36.28

8.64

36.03

8.09

Cohort 3

37.21

8.50

37.74

9.08

Cohort 4

36.39

7.43

36.14

8.29

Cohort 5

37.24

7.98

37.75

7.64

Cohort 6

40.25

7.75

39.18

8.17

Results
Descriptive Statistics: Study Population
Analyses were done to ascertain the first, baseline and most current CD4 counts of the
individuals in the study groups. First CD4 counts were found for n = 1519 (87%) of the study
population. Baseline CD4 counts were available for n = 1395 (80%) of the study population. It
was noted that of the n = 355 (20%) of individuals with missing baseline CD counts,
approximately n = 162 (50%) had transferred into this clinic after initiating ART at another
clinic. If the individuals’ record was missing a baseline CD4 count, but had a first CD4 count,
then the difference between the date of the first CD4 count and ART initiation date was
ascertained. If the first CD4 count date was less than six months prior to the ART initiation date,
then the first CD4 count value was used as the baseline CD4. The median first CD4 count for the
entire study population was 148 cells/mm3 while the median baseline CD4 count for the entire
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study population was 137 cells/mm3. Current CD4 counts were available for n = 1708 (98%) of
the study population. The median current CD4 count for the entire study population was 384
cells/mm3. Median baseline and current CD4 counts by intervention and comparison group
cohorts are presented in table 4. In cases where a value was missing for variables first reported
CD4 or baseline CD4 or current CD4, a mean value substitution was done. The median figures
presented above for first, baseline and current CD4 count data were before the mean value
substitutions were done.
Table 4
Baseline and Current CD4 Median by Intervention and Comparison Group Cohorts (N = 1750)
Intervention (n = 832)

Comparison (n = 918)

Baseline CD4

Current CD4

Baseline CD4

Current CD4

(cells/mm3)

(cells/mm3)

(cells/mm3)

(cells/mm3)

All cohorts

137

391

137

379

Cohort 1

157

299

188

271

Cohort 2

202

350

181

311

Cohort 3

165

325

157

323

Cohort 4

130

385

136

366

Cohort 5

124

403

106

425

Cohort 6

111

485

120

514

Note: The median CD4 values in table 4 are based on data before mean value substitutions were done
for missing CD4 data. For the rest of the analyses for this study, the mean value adjusted first, baseline
and current CD4 values have been used.

Current viral load was one of the study covariates. This information was available for
95% (n = 1672) of the study population. Viral load is one of the markers used to detect ART
success or the ability of the ART to keep the virus level under control. Viral load is measured in
terms of virus copies per milliliter of blood. Viral load of < 49 virus copies/ml of blood is
considered undetectable (http://www.aidmap.com). A viral load of > 49 virus copies /ml of
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blood should be a red flag for health care providers to query possible ART adherence issues or
possible ART failure. A viral load of < 49 virus copies/ml of blood is referred to as undetectable
while a viral load of > 49 virus copies/ml of blood is considered to be in the detectable range. Of
the 1672 individual who had current viral load information available, n = 1455 (87%) had an
undetectable viral load. The virus was detectable in n = 126 (15%) and n = 91 (10%) of the
individuals in the intervention and comparison groups respectively.
A large variation in the viral load range in individuals with detectable viral load values
was found. Median substitutions were done in some cases as there were some major outliers,
which were affecting the mean values. A median value was more representative of the values in
the large sample, but even this led to values in the regressions that were not interpretable (b =
0.000). Transforming the median current viral load into a z-score led to more useful information,
which was used for all the regression analyses.
For the purpose of this study, current ART regimen was defined as the ART regimen the
patient was on between June 2012 (three months prior to the study period) and January 2014 (the
study end period). The South African government released new guidelines for ART regimens in
2013 (The South African Antiretroviral Treatment Guidelines, 2013). According to the new
guidelines, the regimens were re-categorized as regimen 1 and 2 versus the previous guidelines
(included in chapter 3), which had the categorization of regimen 1A, 1B and 2. The updated
2013 guidelines were used during data analysis. ART regimen data was available for all 1760
individuals in the study. Most of the individuals were on the first line regimen n = 1465, (83.7%)
during the study period. The remaining 285 (n = 16.3%) individuals were on the second line
regimen. Changes in regimen during the study period were not noted during analysis. Table 5,
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includes ART regimen information disaggregated by the six cohorts in both the intervention and
the comparison groups.
Table 5
First and Second ART Regimen by Intervention and Comparison Goup Cohorts (N = 1750)
Intervention Group (n = 832)

Comparison Group (n = 918)

First ART

Second ART

First ART

Second ART

Regimen

Regimen

Regimen

Regimen

n

%

n

%

n

%

n

%

All cohorts

685

82.3

147

17.7

780

85.0

138

15.0

Cohort 1

86

97.7

2

2.3

101

94.4

6

5.6

Cohort 2

97

95.1

5

4.9

128

94.1

8

5.9

Cohort 3

66

85.7

11

14.3

80

95.3

4

4.8

Cohort 4

153

83.2

31

16.8

168

85.7

28

14.3

Cohort 5

144

75.8

46

24.2

165

80.9

39

19.1

Cohort 6

139

72.8

52

27.2

138

72.3

53

27.7

Table 6, provides descriptive statistics for individuals who transferred into the clinic after
initiating ART at another clinic and for individuals who initiated on ART at the study clinic but
transferred out to another clinic. Individuals transferred in and transferred out may not be the
same. Individuals who had transferred out were considered retained on ART.
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Table 6
Transfers In and Transfers Out by Intervention and Comparison Group Cohorts (N = 1750)
Intervention Group

Comparison Group

(n = 832)

(n = 918)

Transferred in Transferred out Transferred in Transferred out
n

%

n

%

n

%

n

%

All Cohorts

205

24.6

35

4.2

80

8.7

49

5.3

Cohort 1

2

2.3

5

5.7

4

3.7

3

2.8

Cohort 2

9

8.8

0

0.0

2

1.5

8

5.9

Cohort 3

10

13.0

1

1.3

3

3.6

5

6

Cohort 4

34

18.5

11

6.0

14

7.1

6

3.1

Cohort 5

48

25.3

11

5.8

9

4.4

8

3.9

Cohort 6

102

53.4

7

3.7

48

25.1

49

5.3

Descriptive statistics were ascertained for individuals who had ART side effects:
lipodystrophy, lactic acidosis and/or peripheral or poly neuropathy listed in their records. These
were the three most commonly noted side effects found during the 2009 patient file audit
conducted at this clinic, thus these side effects were used in this study. Similarly, a few of the
more commonly associated co-morbidities with HIV, namely tuberculosis, herpes zoster and
kaposi sarcoma identified via a patient file audit conducted at this clinic in 2009 (unpublished
report), were included in the analyses. Tables 7 and 8 include the descriptive statistics for the
side effects and the co-morbidities found in the patients’ clinical records. Three individuals had
more than one side effect or co-morbidity concurrently reported during the study period.
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Table 7
Lipodystrophy, Lactic Acidosis, and Peripheral/Poly Neuropathy Rates by Intervention and
Comparison Group Cohorts (N = 1750)
Intervention
Group
(n = 832)
LIPO

Comparison
Group
(n = 918)

LA

PNP

LIPO

LA

PNP

n

%

n

%

n

%

n

%

n

%

n

%

All
cohorts

26

3.1

1

0.1

15

1.8

88

9.6

14

1.5

53

5.8

Cohort 1

0

0.0

0

0.0

1

1.1

0

0.0

0

0.0

1

0.9

Cohort 2

3

2.9

0

0.0

5

4.9

0

0.0

0

0.0

4

2.9

Cohort 3

1

1.3

0

0.0

1

1.3

0

0.0

0

0.0

0

0.0

Cohort 4

2

1.1

0

0.0

1

0.5

3

1.5

0

0.0

0

0.0

Cohort 5

7

3.7

0

0.0

5

2.6

28

13.7

7

3.4

16

7.8

Cohort 6

13

6.8

1

0.5

2

1.0

57

29.8

7

3.4

28

14.7

Note. LIPO = Lipodystrophy; LA = Lactic Acidosis; PNP = Peripheral/Poly Neuropathy.
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Table 8
Tuberculosis, Herpes Zoster, and Kaposi Sarcoma Rates by Intervention and Comparison Group
Cohorts (N = 1750)
Intervention
TB

Comparison

HZ

KS

TB

n

%

n

%

n

%

n

40

4.8

19

2.3

1

0.1

Cohort 1

11 12.5

6

6.8

0

Cohort 2

13 12.7

2

2.0

Cohort 3

4

5.2

3

Cohort 4

3

1.6

Cohort 5

5

Cohort 6

4

All cohorts

HZ

KS

%

n

%

n

%

22

2.4

7

0.8

1

0.1

0.0

12

11.2

3

2.8

1

0.9

0

0.0

6

4.4

3

2.2

0

0.0

3.9

1

1.3

0.0

0.0

0

0.0

0

0.0

2

1.1

0

0.0

1

0.5

0

0.0

0

0.0

2.6

3

1.6

0

0.0

2

1.0

0

0.0

0

0.0

2.1

3

1.6

0

0.0

1

0.5

1

0.5

1

0.1

Note. TB = Tuberculosis; HZ = Herpes Zoster; KS = Kaposi Sarcoma.

Most of the individuals enrolled in the intervention were retained in the program at the
time of this evaluation. Only n = 8 (1%) individuals in the intervention group opted out.
Testing of Covariates and Logistic Regression Analyses
A series of chi-square analyses were conducted between the variables age, gender, ART
regimen type, transferred in, intervention (independent variable), side effects (i.e., lipodystrophy,
lactic acidosis, and peripheral/poly neuropathy), concurrent illnesses (i.e., tuberculosis, herpes
zoster, kaposi sarcoma), first CD4 count, baseline CD4 count, current CD4 count, z-score viral
load, and the two dependent variables: LTF at 6 and 12 months, to determine if there were any
significant associations between the covariates and the dependent variables. The variables:
gender, pregnancy, ART regimen type, transferred in, intervention, lipodystrophy, lactic
acidosis, peripheral/poly neuropathy, tuberculosis, herpes zoster, kaposi sarcoma, and opt out
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were coded as nominal and dichotomous. Similarly, the two dependent variables, LTF at 6 and
12 months were also coded as nominal and dichotomous. Associations between the nominal and
dichotomous variables listed above, and the dependent variables were ascertained using chisquare (χ²) and phi (φ) statistics. This was a slight deviation from the information included in
chapter 3, which stated use of Spearman chi square. The variables: age, first CD4 count, baseline
CD4 count, current CD4 count and z-score viral load were coded as nominal but were not
dichotomous. Associations between these variables and the dichotomous dependent variables
were determined using a chi-square (χ²) and Cramer’s V or Cramer’s phi statistic (φc). Covariates
found to be associated with the dependent variables with p-values of < 0.25 were included as
predictor variables in the logistic regression models in an effort to answer the two study research
questions. The following ranges for the phi and Crammer’s V statistics were used to interpret the
strength of associations/effect size between the independent/ covariate and the dependent
variables (http://faculty.quinnipiac.edu/libarts/polsci/Statistics.html):
If phi (φ) =
+.70 or higher. Very strong positive relationship
+.40 to +.69. Strong positive relationship
+.30 to +.39. Moderate positive relationship
+.20 to +.29. Weak positive relationship
+.01 to +.19. No or negligible relationship
-.01 to -.19. No or negligible relationship
-.20 to -.29. Weak negative relationship
-.30 to -.39. Moderate negative relationship
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-.40 to -.69. Strong negative relationship
-.70 or higher. Very strong negative relationship
If Cramer’s V (φc) =
.25 or higher. Very strong relationship
.15 to .25. Strong relationship
.11 to .15. Moderate relationship
.06 to .10. Weak relationship
.01 to .05. No or negligible relationship
Results from the model chi square analyses for the full study sample are presented in

Tables 9 and 10. Below are the relevant (p < .25) associations found. The independent variable,
intervention, was negatively associated with LTF at 6 months, χ² (1, N = 1750) = 68.40, φ = .20, p < .001 and at 12 months, χ² (1, N = 1750) = 29.43, φ = -.13, p < .001,suggesting that
individuals in the comparison group had a higher chance of LTF versus individuals in the
intervention group. However, the phi statistic indicated a weak association between the two
variables. Gender was negatively associated with LTF at 6 months χ² (1, N = 1750) = 4.51, φ = .05, p < .05, and with LTF at 12 months χ² (1, N = 1750) = 2.40, φ = -.04, p < .25, indicating that
men had a higher chance of LTF. However, the phi statistic for both the outcomes indicated
negligible or no association between gender and the two LTF outcomes. Pregnancy was
positively associated with LTF at 6 months χ² (1, N = 1750) = 12.24, φ = .08, p < .001 and LTF
at 12 months χ² (1, N = 1750) = 8.63, φ = .07, p < .01, indicating that pregnant women had a
higher chance of LTF. However, the phi statistic for both the outcomes indicated negligible or no
association between pregnancy and the LTF outcomes. ART regimen type was negatively
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associated with LTF at 6 months χ² (1, N = 1750) = 9.14, φ = -.07, p < .01 and LTF at 12 months
χ² (1, N = 1750) = 2.33, φ = -.04, p < .25, indicating that individuals on ART regimen 1 had a
higher chance of LTF versus individuals on ART regimen 2. However, the phi statistic for both
the outcomes indicated negligible or no association between ART regimen and the LTF
outcomes. Individuals who had transferred in had a negative association with LTF at 6 months χ²
(1, N = 1750) = 3.44, φ = -.04, p < .25, indicating that individuals who had initiated on ART at
another site and transferred to the study site had a lower chance of LTF at 6 months. However,
the phi statistic indicated negligible or no association between the two variables. Peripheral/poly
neuropathy had a negative association with LTF at 12 months χ² (1, N = 1750) = 1.44, φ = -.03, p
< .25, indicating that individuals with peripheral/poly neuropathy had a lower chance of LTF at
12 months. The phi statistic indicated negligible or no association between the two variables.
Herpes Zoster had a negative association with LTF at 12 months χ² (1, N = 1750) = 1.66, φ = .03, p < .25, indicating that individuals with herpes zoster had a lower chance of LTF at 12
months. The phi statistic indicated negligible or no association between the two variables. Opt
out was positively associated with LTF at 12 months χ² (1, N = 1750) = 5.18, φ = .05, p < .05,
indicating that individuals who had opted out of the intervention had a higher chance of LTF at
12 months. However, the phi statistic indicated negligible or no association between the two
variables.
Age was positively associated with LTF at 6 months χ² (51, N = 1750) = 83.40, φc = .22,
p < .01 and at 12 months χ² (51, N = 1750) = 65.03, φc = .19, p < .25, indicating that older
individuals has a higher chance of LTF at both 6 and 12 months. The Cramer’s V statistic
indicated a strong association between the two variables. Current CD4 count was positively
associated with LTF at 6 months χ² (702, N = 1750) = 743.15, φc = .65, p < .25 and LTF at 12

	
  	
  	
  

105

months χ² (702, N = 1750) = 746.66, φc = .65, p < .25, indicating that individuals with higher
current CD4 count had a higher chance of LTF at 6 and 12 months. The Cramer’s V statistic
indicated a very strong positive association between the two variables. Current viral load was
also positively associated with LTF at 6 months χ² (194, N = 1750) = 469.82, φc = .52, p < .001
and LTF at 12 months χ² (194, N = 1750) = 333.88, φc = .44, p < .001, indicating that individuals
with higher viral load had a higher chance of LTF at 6 and 12 months. The Cramer’s V statistic
indicated a very strong positive association between the two variables.
Table 9
Associations Between Nominal and Dichotomous Variables and LTF at 6 and 12 months for the
Entire Study Population (N = 1750)
LTF 6 Months

LTF 12 Months

X2

φ

p

X2

φ

p

Intervention

68.40

-.20

.000

29.43

-.130

.000***

Gender

4.51

-.05

.03

2.40

-.04

.12^

Pregnancy

12.24

.08

.00

8.63

.04

.00**

Transferred in

3.44

-.04

.06

.10

-.01

.75

Current ART Regimen

9.14

-.07

.00

2.33

-.04

.13^

Lipodystrophy

.28

-.01

.60

.38

-.01

.534

Lactic Acidosis

.48

.02

.49

.15

-.01

.70

Peripheral/Poly
Neuropathy

.016

.00

.90

1.44

-.03

.23^

Tuberculosis

.70

.02

.40

.05

-.00

.83

Herpes Zoster

.71

-.02

.40

1.66

-.03

.20^

Kaposi Sarcoma

.18

-.01

.67

.41

-.01

.52

Opt Out

.28

-.01

.60

5.18

.05

.02*

Note. ^p < .25; *p < .05; **p < .01; ***p < .001
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Table 10
Associations Between Nominal Non-Dichotomous Variables and LTF at 6 and 12 months for the
Entire Study Population (N = 1750)
LTF 6 Months

LTF 12 Months

X2

φc

p

X2

φc

p

Age

83.37

.22

.00*

65.03

.19

.09^

First reported CD4

330.05

.43

.77

386.79

.47

.59

Baseline CD4

743.15

.65

.14^

325.01

.43

.83

Current CD4

469.82

.52

.000***

746.56

.65

.12^

Current viral load (zscore)

387.71

.47

.58

333.88

.44

.000***

Note. ^p < .25; *p < .05; **p < .01; ***p < .001

Chi square analyses were conducted for each of the six cohorts to examine which
covariates were relevant predictors (p < .25), of LTF at 6 and/or 12 months in each cohort. The
independent variable, intervention as well as any covariates that were found to be correlated (p <
.25) to LTF at 6 and/or 12 months were included in the subsequent cohort level logistic
regression models. In addition, baseline CD4 count was included in each of the cohort level
regression models based on studies found in the literature, which found correlations between this
covariate and LTF (Larson et al, 2010; Dalal et al, 2007).
Results for Cohort 1
Testing of covariates. Results from the model chi square analyses for cohort 1 are
presented in Tables 11 and 12. Below are the relevant (p < .25) associations found. The
independent variable, intervention, was negatively associated with LTF at 6 months, χ² (1, N =
195) = 3.42, φ = -.13, p = .06 and at 12 months, χ² (1, N=195) = 2.50, φ = -.11, p = .11,
suggesting that individuals in the comparison group had a higher chance of LTF versus
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individuals in the intervention group. However, the phi statistic fell in the category of negligible
or no association between the two variables. Transferred in was positively associated with LTF
at 12 months, χ² (1, N=195) = 2.14, φ = .10, p = .14, indicating that individuals in cohort 1, who
initiated on ART at another facility and transferred into the study site had a higher chance of
being LTF at 12 months. The phi statistic indicated negligible or no association between the two
variables.
Baseline CD4 was positively associated with LTF at 6 months χ² (134, N = 195 ) =
151.23, φc = .88, p = .15, indicating that individuals with higher baseline CD4 count had a higher
chance of LTF at 6 months. The Cramer’s V statistic indicated a very strong association between
the two variables. Current viral load was also positively associated with LTF at 6 months χ² (27,
N=195) = 32.50, φc = .87, p = .21, indicating that individuals with higher viral load had a higher
chance of LTF at 6 months. The Cramer’s V statistic indicated a very strong association between
the two variables.
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Table 11
Cohort 1: Associations Between Nominal Dichotomous Variables and LTF at 6 and 12 Months
(N = 195)
LTF 6 Months
X2

φ

LTF 12 Months

p

X2

φ

p

2.50

.11

.11^

Intervention

3.42

-.13

.06^

Gender

.42

.05

.51

.22

-.03

.64

Pregnancy

.84

.06

.36

.06

.02

.81

Transferred in

.48

-.05

.49

2.14

-.10

.14^

Current ART
Regimen

.64

-.06

.42

1.28

-.08

.26

Peripheral/Poly .16
Neuropathy

.03

.69

.31

-.04

.58

Tuberculosis

.09

.02

.76

.37

.04

.54

Herpes Zoster

.73

-.06

.39

.04

-.01

.84

Opt Out

n/a

n/a

n/a

n/a

n/a

n/a

Note. ^p <.25; *p < .05; **p < .01; ***p < .001

Table 12
Cohort 1: Associations Between Nominal Non-Dichotomous Variables and LTF at 6 and 12
Months (N = 195)
LTF 6 Months

LTF 12 Months

X2

φc

p

X2

Age

42.46

.47

.28

38.99

First reported CD4

144.98

.86

.58

141.35

.85

.66

Baseline CD4

151.23

.88

.15^

126.26

.80

.67

Current CD4

147.61

.87

.52

155.15

.89

.35

Current viral load
(z-score)

32.50

.41

.21^

30.21

.39

.30

φc
.45

p
.42
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Note. ^p < .25; *p< .05; **p < .01; ***p < .001.

Logistic Regression. The first logistic regression for cohort 1 was conducted in relation
to the dependent variable of 6-month loss to follow-up. Variables included in the model were the
independent variable intervention, covariates found to be relevant associated (p < .25) with LTF
at 6 months in the cohort 1 model chi-square analyses. In addition, baseline CD4 covariate was
included in each regression model.
The results from the logistic regression are presented in Table 13. The model chi-square
was significant, χ² (3, N=195) = 8.53, p = .04, indicating that the independent variables
significantly predicted LTF at 6 months in cohort 1. The non-significance of the Hosmer and
Lemeshow chi-square test indicated that the data fit the model, χ² (8) = 8.60, p = .38. The
classification table output for model 1 (which included the various predictor variables) correctly
classified 93.3% of the 6-month loss to follow-up outcome. In comparison, the classification
table for model 0 (the model without the various predictor variables) indicated that the
independent variable - intervention without the confounders correctly classified 92.8% of the 6 –
month loss to follow up outcomes. There was a minimal difference in the classification tables
between model 0 and 1. The Nagelkerke R2 indicated 10.6% variance in the model.
Two variables significantly predicted (p < .05), 6-month loss to follow-up. Intervention
group classification was significant, Wald (1) = 3.95, p = .04. The negative correlation with the
outcome and odds ratio (Exp B) of .22 indicated that the odds of LTF at 6 months among
individuals in the intervention group were .22 times less compared to individuals in the
comparison group. Additionally, current viral load (z-score) was a significant predictor for LTF

	
  	
  	
  

110

at 6 month in cohort 1, Wald (1) = 5.37, p = .02. The odds ratio indicated that increases in viral
load increased the odds of LTF at 6 months by 1.24 times.

Table 13
Cohort 1: Intervention and Predictor Variables for 6 Month LTF (N = 195)
B

SE B

Wald

p

Exp(B)

95% CI
Low

High

Constant

-2.25

.58

14.82

.000

.10

Intervention

-1.53

.77

3.95

.04*

.22

.05

.98

Baseline CD4

.000

.003

.02

.88

1.00

.99

1.01

Current Viral
Load

.21

.09

5.37

.02*

1.24

1.03

1.48

χ²

8.53

Df

3

Correct
Classified

93.3

Note. ^p < .25; *p < .05; **p < .01; ***p < .001.

The second logistic regression for cohort 1was conducted with regards to the dependent
variable of 12-month loss to follow-up. As with the first logistic regression, variables included in
the model were the independent variable – intervention and covariates found to be associated (p
< .25) with LTF at 12 months in the cohort 1 model chi-square analyses. In addition, baseline
CD4 covariate was included in each regression model. The results from the logistic regression
are presented in Table 14. The model chi-square was not significant, χ² (3, N=195) = 4.27, p =
.23, indicating that the independent and covariate variables did not significantly predict LTF at
12 months in cohort 1.
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Table 14
Cohort 1: Intervention and Predictor Variables for 12 Month LTF (N = 195)
B

SE B

Wald

p

Exp(B)

95% CI
Low

High

Constant

-1.49

.44

11.54

.001

.22

Intervention

-.69

.45

2.32

.13

.50

.21

1.22

Transferred in

1.17

.90

1.67

.20

.50

.21

1.22

Baseline CD4

-.001

.002

.22

.64

.99

.99

1.00

χ²

4.27

Df

3

Correct Classified

86.7%

Note. ^p <.25; *p < .05; **p < .01; ***p < .001.

Analysis for Cohort 2.
Testing of Covariates. Results from the model chi square analyses for Cohort 2 are
presented in Tables 15 and 16. Below are the relevant (p < .25) associations found. The
independent variable, intervention, was negatively associated with LTF at 6 months, χ² (1, N =
238) = 7.33, φ = -.17, p = .01 and at 12 months, χ² (1, N = 238) = 4.79, φ = -.14, p = .03,
suggesting that individuals in the comparison group had a higher chance of LTF versus
individuals in the intervention group. However, the phi statistic at both 6 and 12 months LTF
outcomes indicated negligible or no association between the two variables. Pregnancy was
positively associated with LTF at 6 months χ² (1, N = 238) = 11.41, φ = .22, p = .001 and at 12
months, χ² (1, N=238) = 9.22, φ = .20, p = .002, indicating that pregnant women had a higher
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chance of LTF at 6 and 12 months. However, the phi statistic at both 6 and 12 months LTF
outcomes indicated a weak association between the two variables. The covariate, herpes zoster
had a significant negative association with LTF at 12 months, χ² (1, N = 238) = 1.39, φ = -.08, p
= .24, indicating that individuals in cohort who had herpes zoster had a lower chance of LTF at
12 months. However, the phi statistic indicated negligible or no association between the
variables.
Age was positively associated with LTF at 6 months χ² (37, N=238) = 42.50, φc = .42, p
= .25, indicating that older individuals had a higher chance of LTF at 6 months. The Cramer’s V
statistic indicated a strong association between the two variables. Baseline CD4 count was
positively associated with LTF at 12 months, χ² (131, N=238) = 142.22, φc = .77, p = .24,
indicating that individuals in cohort 2 with higher baseline CD4 count had a higher chance of
LTF at 12 months. The Cramer’s V statistic indicated a very strong association between the two
variables. Current viral load was also positively associated with LTF at 6 months χ² (32, N =
238) = 43.89, φc = .43, p = .078 and at 12 months, χ² (32, N = 238) = 39.21, φc = .41, p = .18,
indicating that individuals with higher viral load had a higher chance of LTF at 6 and 12 months.
The Cramer’s V statistic indicated a strong association for between the two variables at both the
6 and 12 months outcomes.
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Table 15
Cohort 2. Associations Between Nominal Dichotomous Variables and LTF at 6 and 12 Months
(N = 238)
LTF 6 Months

LTF 12 Months

X2

φ

p

X2

φ

p

Intervention

7.32

-.17

.007**

4.79

-.14

.03*

Gender

.82

-.06

.36

.12

-.02

.73

11.41

.22

.001**

9.22

.20

.002**

Transferred in

.22

-.03

.64

1.04

-.07

.31

Current ART Regimen

.44

-.04

.51

.02

.01

.88

Peripheral/Poly
Neuropathy

.06

-.02

.81

.59

-.05

.44

Tuberculosis

.06

.02

.80

.00

-.00

.97

Herpes Zoster

.88

-.06

.36

1.39

-.08

.24^

Pregnancy

Note. ^p < .25; *p < .05; **p < .01; ***p < .001.

Table 16
Cohort 2: Associations Between Nominal Non-Dichotomous Variables and LTF at 6 and 12
Months (N = 238)
LTF 6 Months

LTF 12 Months

X2

φc

p

X2

φc

p

Age

42.50

.42

.25^

41.88

.42

.27

First reported CD4

143.83

.78

.71

153.58

.80

.49

Baseline CD4

125.07

.72

.63

142.22

.77

.24^

Current CD4

193.88

.90

.53

193.83

.90

.53

Current viral load (zscore)

43.89

.43

.08^

39.21

.41

.18^

Note. ^p <.25; *p<.05; **p < .01; ***p < .00.
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Logistic Regression. Similar to Cohort 1 analyses, the first logistic regression was
conducted with regards to the dependent variable of 6-month loss to follow-up for Cohort 2.
Variables: intervention, pregnancy, age, baseline CD4 count, and current viral levels were
included in the regression model. The results from the logistic regression are presented in Table
17. The model chi-square was significant, χ² (5, N = 238) = 16.10, p =.01, indicating that the
independent variables significantly predicted LTF at 6 months in Cohort 2. The non-significance
of the Hosmer and Lemeshow chi-square test confirmed that the data fit the model, χ² (8) = 4.41,
p = .82. The classification table output for model 1 (which included the various predictor
variables) correctly classified 86.1% of the 6 month – loss to follow up outcome. The
classification table for model 0 (the model without the various predictor variables) indicated that
the independent variable - intervention without the confounders correctly also classified 86.1%
of the 6 – month loss to follow up outcomes. The Nagelkerke R2 indicated 11.8% variance in the
model.
Two variables were found to significantly (p < .05), predict 6-month loss to follow-up in
Cohort 2. Intervention group classification was significant, Wald (1) = 5.08, p = .02. The
negative correlation with the outcome and odds ratio (Exp B) of .36 indicated that the odds of
LTF at 6 months among individuals in the intervention group was .36 times less likely compared
to individuals in the comparison group. Pregnancy was a significant predictor, Wald (1) = 7.20, p
= .01. The odds of LTF at 6 months was 6.43 times higher among pregnant women.
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Table 17
Cohort 2: Intervention and Predictor Variables for 6 Month LTF (N = 238)
B

S.E.

Wald

p

Exp(B)

95% CI for EXP(B)
Lower

Upper

Constant

-1.46

1.06

1.89

.17

.23

Intervention

-1.03

.46

5.08

.02

.36

.14

.87

Pregnancy

1.86

.69

7.20

.007

6.43

1.65

25.02

Age

-.00

.02

.004

.95

.99

.95

1.05

Baseline CD4
count

-.001

.002

.05

.82

.99

.99

1.00

Current Viral
Load

.41

.32

1.68

.19

1.51

.81

2.83

χ²

16.10**

Df

5

Correct
Classified

86.1%

Note. *p < .05; **p < .01; ***p < .001.

The second logistic regression was conducted with regards to the dependent variable of
12- month loss to follow-up. The results from the logistic regression are presented in Table 17.
The model chi-square was significant, χ²(5, N = 238) = 21.87, p = .001, indicating that the
independent variable significantly predicted LTF at 12 months in Cohort 2. The non-significance
of the Hosmer and Lemeshow chi-square test indicated that the data fit the model, χ²(8) = 4.395,
p = .820. The classification table output for model 1 (which included the various predictor
variables) correctly classified 79.8% of the 12-month loss to follow-up outcome. In comparison,
the classification table for model 0 (the model without the various predictor variables) indicated
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that the independent variable - intervention without the confounders correctly classified 78.6% of
the 12 – month loss to follow up outcomes. There was a minimal difference in the classification
tables between model 0 and 1. The Nagelkerke R2 indicated 13.6% variance in the model.
Only pregnancy status significantly predicted (p < .05) 12- month loss to follow-up
among individuals in Cohort 2 Wald (1) = 7.02, p =.01. The odds of LTF at 12 months were
6.02 times higher among pregnant women.
Table 18
Cohort 2: Intervention and Predictor Variables for 12 Month LTF (N = 238)
B

S.E.

Wald

p

Exp(B)

95% CI
Lower

Upper

Constant

-.74

.38

3.80

.05

.48

Intervention

-.60

.35

2.89

.09

.55

.28

1.10

Pregnancy

1.79

.68

7.02

.01

6.02

1.60

22.71

Herpes
Zoster
Baseline
CD4
Current
Viral Load
χ²

-22.37

15181.68

.00

.99

.00

.00

-

-.002

.002

1.11

.29

.99

.99

1.00

1.19

.62

3.70

.05

3.28

.98

10.99

Df

21.87**
5

Correct
79.8%
Classified
Note. ^p < .25, *p < .05; **p < .01; ***p < .001.
Analysis for Cohort 3
Testing of Covariates. Results from the model chi square analyses for Cohort 3 are
presented in Tables 19 and 20. Below are the relevant (p < .25) associations found. The
independent variable, intervention, was negatively associated with LTF at 6 months, χ² (1,
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N=161) = 3.59, φ = -.15, p = .06 and at 12 months, χ² (1, N = 161) = 1.59, φ = -.10, p = .21,
suggesting that individuals in the comparison group had a higher chance of LTF versus
individuals in the intervention group. However, the phi statistic at both 6 and 12 months LTF
outcomes indicated negligible or no association between the two variables. Current ART
regimen was negatively associated with LTF at 6 months χ² (1, N=161) = 2.48, φ = -.12, p = .11,
indicating that individuals in Cohort 3 on ART regimen 1 had a higher chance of LTF at 6
months versus individuals on ART regimen 2. However, the phi statistic indicated negligible or
no association between the two variables. Individuals in Cohort 3, who had initiated on ART at
another facility and transferred into this clinic had a positive association with LTF at 12 months
χ² (1, N=161) = 2.55, φ = .13, p = .11. However, the phi statistic indicated negligible to no
association between the variables.
Age was positively associated with LTF at 12 months χ² (36, N = 161) = 43.25, φc = .52,
p = .19, indicating that older individuals had a higher chance of LTF at 12 months. The Cramer’s
V statistic indicated a strong association between the two variables. Current viral load was
positively associated with LTF at 6 months χ² (23, N = 161) = 50.18, φc = .56, p = .001 and at 12
months, χ² (23, N = 161) = 42.64, φc = .51, p = .008, indicating that individuals with higher viral
load had a higher chance of LTF at 6 and 12 months. The Cramer’s V statistic indicated a strong
association between the two variables at both the 6 and 12 months outcomes.
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Table 19
Cohort 3: Associations Between Nominal Dichotomous Variables and LTF at 6 and 12 Months
(N = 161)
LTF 6 Months

LTF 12 Months

X2

φ

p

X2

φ

p

Intervention

3.60

-.15

.06^

1.59

-.10

.21^

Gender

.16

-.03

.69

.02

.01

.89

Pregnancy

.22

.04

.64

.00

.00

.95

Transferred in

.07

.02

.79

2.55

.13

.11^

Current ART Regimen

2.48

-.12

.11^

.60

-.06

.44

Peripheral/Poly
Neuropathy

.15

-.03

.70

.27

-.04

.61

Tuberculosis

.52

.06

.47

.04

.01

.85

Herpes Zoster

.46

-.05

.50

.82

-.07

.37

Note. ^p < .25; *p < .05; **p < .01; ***p < .001.

Table 20
Cohort 3: Associations Between Nominal Non-Dichotomous Variables and LTF at 6 and 12
Months (N = 161)
LTF 6 Months

LTF 12 Months

X2

φc

p

X2

φc

p

Age

29.85

.43

.75

43.25

.52

.19^

First reported CD4

107.73

.82

.83

120.73

.87

.54

Baseline CD4

96.34

.77

.85

113.62

.84

.44

Current CD4

137.49

.92

.50

138.99

.93

.46

Current viral load (zscore)

50.18

.56

.001**

42.64

.51

.008**
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Note. ^p <.25; *p<.05; **p < .01; ***p < .001.

Logistic Regression. The first logistic regression was conducted with regards to the
dependent variable of 6-month loss to follow-up for Cohort 3. Variables: intervention, Current
ART regimen, and current viral load were found to be correlated (p < .25) to LTF at 6 months in
Cohort 3 so these were included in the regression model along with the covariate, baseline CD4
count. The results from the logistic regression are presented in Table 21. The model chi-square
was significant, χ² (4, N = 161) = 18.42, p = .001, indicating that the independent and/or
covariate variables significantly predicted LTF at 6 months in Cohort 3. The non-significance of
the Hosmer and Lemeshow chi-square test indicated that the model adequately fit the data, χ² (8)
= 7.45, p = .49. The classification table output for model 1 (which included the various predictor
variables) correctly classified 88.2% of the 6 - month loss to follow-up outcome. In comparison,
the classification table for model 0 (the model without the various predictor variables) indicated
that the independent variable - intervention without the confounders correctly classified 87.0% of
the 6 – month loss to follow up outcomes. There was a minimal difference in the classification
tables between model 0 and 1. The Nagelkerke R2 indicated 20.1% variance in the model. None
of the variables in the regression model significantly predicted LTF at 6 months in Cohort 3.
Table 21
Cohort 3: Intervention and Predictor Variables for 6 Month LTF (N = 161)
B

Constant
Intervention
ART regimen

SE B

Wald

p

Exp(B)

95% CI
Low

High

41.79

6564.45

.00

.99

1.417E+18

-.96

.56

2.95

.09

.38

.13

1.14

-42.37

6564.45

.00

.99

.00

.00

-
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Baseline CD4

-.01

.00

3.01

.083

.99

.99

1.00

Current Viral
Load

1.57

.89

3.14

.08

4.83

.85

27.52

χ²

18.42**

Df

4

Correct
Classified

88.2

Note. *p < .05; **p < .01; ***p < .001.

The second logistic regression was conducted with regards to the dependent variable –
LTF at 12 months. Variables: intervention, transferred in, age and viral load were found to be
correlated (p < .25) to LTF at 12 months in Cohort 3 so these were included in the regression
model along with baseline CD4 count. The results from the logistic regression are presented in
Table 22. The model chi-square was not significant, χ² (5) = 7.67, p = .17, indicating that the
model was not significant and the independent and covariate variables did not significantly
predict LTF at 12 months in cohort.
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Table 22
Cohort 3: Intervention and Predictor Variables for 12 Months LTF (N = 161)
B

SE B

Wald

p

Exp(B)

95% CI
Low

High

Constant

-.01

.99

.00

.99

.99

Intervention

-.63

.42

2.27

.13

.53

.23

1.21

Age

-.02

.02

.51

.47

.98

.94

1.03

Transferred in

1.16

.66

3.13

.08

3.02

.88

11.63

Baseline CD4

-.00

.00

2.11

.15

.99

.99

1.00

Current Viral Load

.06

.12

.29

.59

1.06

.85

1.34

χ²

7.67

Df

5

Correct Classified

77.6%

Note. ^ p <.25; *p < .05; **p < .01; ***p < .001.

Analysis for Cohort 4
Testing of Covariates. Results from the model chi square analyses for Cohort 4 are
presented in Tables 23 and 24. Below are the relevant (p < .25) associations found. The
independent variable, intervention, was negatively associated with LTF at 6 months, χ² (1, N =
380) = 11.31, φ = -.17, p = .001 and at 12 months, χ² (1, N = 380) = 1.80, φ = -.07, p = .18,
suggesting that individuals in the comparison group had a higher chance of LTF versus
individuals in the intervention group. However, the phi statistic at both 6 and 12 months LTF
outcomes indicated negligible or no association between the two variables. Gender was
negatively associated with LTF at 6 months χ² (1, N = 380) = 2.82, φ = -.09, p = .09 and at 12
months χ² (1, N =380) = 1.96 φ = -.07, p = .16, indicating that in Cohort 4, women had a lower
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chance of LTF at 6 and 12 months versus men. However, the phi statistic indicated a negligible
or no association between the variables for both the outcomes.
Age was positively associated with LTF at 6 months χ² (39, N=380) = 50.55, φc = .36, p
= .10, indicating that older individuals had a higher chance of LTF at 6 months. The Cramer’s V
statistic indicated a very strong association between the two variables. First CD4 count was
positively associated with LTF at 6 months χ² (204, N = 380) = 223.60, φc = .77, p = .16,
indicating that individuals with higher first CD4 count had a higher chance of LTF at 6 months.
The Cramer’s V statistic indicated a very strong association between the variables. Baseline CD4
count was positively associated with LTF at 6 months χ² (188, N = 380) = 206.67, φc = .74, p =
.17, indicating that individuals with higher baseline CD4 count had a higher chance of LTF at 6
months. The Cramer’s V statistic indicated a very strong association between the variables.
Current CD4 count was positively associated with LTF at 6 months, χ² (288, N = 380) = 334.16,
φc = .94, p = .03, indicating that individuals in Cohort 2 with higher baseline CD4 count had a
higher chance of LTF at 12 months. The Cramer’s V statistic indicated a very strong association
between the two variables. Current viral load was also positively associated with LTF at 6
months χ²(51, N=238) = 156.98 φc = .64, p < .001 and at 12 months, χ² (51, N = 238) = 77.35, φc
= .45, p = .01, indicating that individuals with higher viral load had a higher chance of LTF at 6
and 12 months. The Cramer’s V statistic indicated a very strong association between the two
variables at both the 6 and 12 months outcomes.
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Table 23
Cohort 4: Associations Between Nominal Dichotomous Variables and LTF at 6 and 12 Months
(N = 380)
LTF 6 Months

LTF 12 Months

X2

φ

p

X2

φ

p

Intervention

11.31

-.17

.001**

1.80

-.07

.18^

Gender

2.83

-.09

.09^

1.96

-.07

.161

Pregnancy

.33

.03

.56

.05

.011

.82

Transferred in

.26

-.03

.61

1.18

.06

.28

Current ART Regimen

.06

-.01

.80

.08

.01

.78

Peripheral/Poly
Neuropathy

.31

-.03

.58

1.065

-.05

.30

Tuberculosis

.25

-.03

.62

.85

-.05

.36

Herpes Zoster

.12

-.02

.72

.42

-.03

.52

Note. ^p <.25; *p < .05; **p < .01; ***p < .001.

Table 24
Cohort 4: Associations Between Nominal Non-Dichotomous Variables and LTF at 6 and 12
months (N = 380)
LTF 6 Months

LTF 12 Months

X2

φc

p

X2

φc

p

Age

50.55

.36

.10^

32.55

.29

.76

First reported CD4 mean

223.60

.77

.16^

191.21

.71

.73

Baseline CD4 mean

206.67

.74

.17^

180.26

.69

.64

Current CD4 mean

334.16

.94

.03*

288.26

.87

.48

Current viral load (zscore)

156.30

.64

.000***

77.35

.45

.01*

Note. ^p <.25; *p<.05; **p < .01; ***p < .001.
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Logistic Regression. The first logistic regression for Cohort 4 was conducted with
regards to the dependent variable of 6- month LTF. Variables: intervention, age, gender, opt out,
first CD4 count, baseline CD4 count, current CD4 count and current viral load were found to be
correlated (p < .25) to LTF at 6 months in Cohort 4 so these were included in the regression
model. The results from the logistic regression are presented in Table 25. The model chi-square
was significant, χ² (7, N = 380) = 34.43, p < .001, indicating that the independent and/or
covariate variables significantly predicted LTF at 6 months in Cohort 4. The non-significance of
the Hosmer and Lemeshow chi-square test indicated that the model adequately fit the data, χ² (8)
= 7.49, p = .48. The classification table output for model 1 (which included the various predictor
variables) correctly classified 93.9% of the 6-month loss to follow-up outcome. In comparison,
the classification table for model 0 (the model without the various predictor variables) indicated
that the independent variable - intervention without the confounders correctly classified 94.2% of
the 6 – month loss to follow up outcomes. There was a minimal difference in the classification
tables between model 0 and 1. The Nagelkerke R2 indicated 24.2% variance in the model.
Three variables significantly predicted (p < .05), 6-month loss to follow-up in Cohort 4.
Intervention group classification was significant, Wald (1) = 8.854, p = .003. The negative
correlation with the outcome and the odds ratio (Exp B) of .15 indicated that the odds of LTF at 6
months among individuals in the intervention group was .15 times less likely compared to the
individuals in the comparison group. Age was negatively correlated to 6 month LTF, Wald (1) =
3.94, p = .04, The odds ratio (Exp B) of .94 indicated that the odds of LTF at 6 months was
marginally lower among older individuals in Cohort 4. Current CD4 was negatively correlated
with LTF at 6 months, Wald (1) = 8.89, p = .003. The odds ratio (Exp B) of .99 indicated that the
odds of LTF at 6 months marginally decreased with increases in current CD4 counts.
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Table 25
Cohort 4: Intervention and Predictor Variables for 6 Month LTF (N = 380)
B

SE B

Wald

p

Exp(B)

95% CI
Low

High

Constant

1.38

1.31

1.11

.29

3.98

Intervention

-1.92

.65

8.85

.003**

.15

.04

.52

Gender

-1.13

.61

3.39

.07

.32

.09

1.08

Age

-.06

.03

3.94

.04*

.94

.88

.99

First CD 4

-.01

.01

.42

.51

.99

.98

1.01

Baseline CD4

.01

.01

1.60

.21

1.01

.99

1.03

Current CD4

-.01

.00

8.90

.003**

.99

.99

.99

Current Viral Load

.43

.31

1.88

.17

1.53

.83

2.83

χ²

34.43***

Df

7

Correct Classified

93.9

Note. *p < .05; **p < .01; ***p < .001.

The second logistic regression for Cohort 4 was conducted with regards to the dependent
variable of 12- month loss to follow up. Variables: intervention and current viral load were found
to be correlated (p < .25) to LTF at 12 months in Cohort 4 so these were included in the
regression model along with baseline CD4 count. Results from the logistic regression are
presented in Table 26. The model chi-square was significant, χ² (3, N=380) = 9.24, p = .03,
indicating that the independent variables significantly predicted LTF at 12 months in Cohort 4.
The non-significance of the Hosmer and Lemeshow chi-square test confirmed that the data fit the
model, χ² (8) = 5.89, p = .66, meaning that the model appropriately predicted the outcome. The
classification table output for model 1 (which included the various predictor variables) correctly
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classified 82.6% of the 12-month loss to follow-up outcome. In comparison, the classification
table for model 0 (the model without the various predictor variables) also indicated that the
independent variable - intervention without the confounders correctly classified 82.6% of the 12
– month loss to follow up outcomes. There was no difference in the classification tables between
model 0 and 1. The Nagelkerke R2 identified 4.0% variance in the model.
One variable significantly predicted (p < .05), 12-month loss to follow-up. Baseline CD4
count was positively correlated to the LTF outcome, Wald (1) = 4.51, p = .03. However, the 95%
confidence interval for baseline CD4 included 1.00, thus the odds ratio was not significant.
Table 26
Cohort 4: Intervention and Predictor Variables for 12 Month LTF (N = 380)
B

SE B

Wald

p

Exp(B)

95% CI
Low

High

Constant

-1.89

.30

39.15

.000

.151

Intervention

-.36

.28

1.66

.20

.70

.40

1.21

Baseline CD4

.00

.00

4.51

.03

1.00

1.00

1.01

Current Viral
Load

.46

.24

3.71

.05

1.58

.99

2.51

χ²
Df
Correct
Classified

9.24*
3
82.6

Note. ^p <.25; *p < .05; **p < .01; ***p < .001.
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Analysis for Cohort 5.
Testing of Covariates. Results from the model chi square analyses for Cohort 5 are
presented in Tables 27 and 28. Below are the relevant (p < .25) associations found. The
independent variable, intervention, was negatively associated with LTF at 6 months, χ² (1, N =
393) = 21.19, φ = -.23, p = .000 and at 12 months, χ² (1, N = 393) = 6.77, φ = -.13, p = .01,
suggesting that individuals in the comparison group had a higher chance of LTF versus
individuals in the intervention group. However, the phi statistic at 6 month indicated a weak
association while the phi statistic at 12 months LTF indicated a negligible or no association
between the variables. Current ART regimen had a negative association with LTF at 6 months χ²
(1, N = 393) = 7.04, φ = -.134, p = .01, and with LTF at 12 months χ² (1, N = 393) = 3.53, φ = .09, p = .06 indicating individuals on ART regimen 1 had a higher chance of LTF compared to
individuals on ART regimen 2. The phi statistic indicated a negligible or no association between
the variables for both the outcomes. Opt out was positively associated with LTF at 12 months χ²
(1, N = 393) = 1.72, φ = .07, p = .19 indicating that individuals who had opted out of the
intervention had a higher chance of LTF at 12 months compared to individuals who had stayed
enrolled in the intervention. However, the phi statistic indicated a negligible or no association
between the two variables.
Current CD4 count was associated with LTF at 6 months χ² (305, N =3 93) = 335.06, φc
= .92, p = .11, indicating that individuals with a higher current CD4 count had a higher chance of
LTF at 6 months. The Cramer’s V statistic indicated a very strong association between the two
variables. Current viral load was associated with LTF at 6 months χ² (53, N=393) = 43.89, φc =
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.63, p = .000 and at 12 months, χ² (53, N=393) = 115.20, φc = .54, p = .000, indicating that
individuals with higher viral load had a higher chance of LTF at 6 and 12 months. The Cramer’s
V statistic indicated a very strong association for between the two variables at both the 6 and 12
months outcomes.
Table 27
Cohort 5: Associations Between Nominal Dichotomous Variables and LTF at 6 and 12 months
(N = 393)
LTF 6 Months

LTF 12 Months

X2

φ

p

X2

φ

p

21.19

.23

.000***

6.77

-.13

.01*

Gender

.26

-.03

.61

.43

-.03

.51

Pregnancy

.12

-.02

.73

.74

.04

.39

Transferred in

.11

-.02

.74

1.25

.06

.26

Current ART Regimen

7.04

-.13

.01*

3.53

-.09

.06^

Peripheral/Poly
Neuropathy

.34

-.03

.56

.70

-.04

.40

Tuberculosis

.36

.03

.55

.02

-.01

.90

Herpes Zoster

.27

-.03

.60

.58

-.04

.45

Opt Out

.18

-.02

.67

1.72

.07

.19^

Intervention

Note. ^p <.25; *p < .05; **p < .01; ***p < .001.
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Table 28
Cohort 5: Associations Between Nominal Non-Dichotomous Variables and LTF at 6 and 12
months (N = 393)
LTF 6 Months

LTF 12 Months

X2

φc

p

X2

φc

p

Age

26.20

.28

.96

37.90

.31

.61

First reported CD4 mean

194.56

.70

.81

206.87

.73

.60

Baseline CD4 mean

175.19

.67

.77

191.07

.70

.46

Current CD4 mean

335.06

.92

.11^

308.80

.89

.43

Current viral load (zscore)

154.80

.63

.000***

115.20

.54

.000***

Note. ^p <.25; *p<.05; **p < .01; ***p < .001.

Logistic Regression. The first logistic regression for Cohort 5 was conducted with
regards to the dependent variable of 6-month loss to follow-up. Variables: intervention, current
ART regimen, baseline CD4, current CD4, and current viral load were found to be correlated (p
< .25) to LTF at 6 months in Cohort 5, so these were included in the regression model. Results
from the logistic regression are presented in Table 29. The model chi-square was significant, χ²
(5) = 39.79, p < .001 indicating that the independent variables significantly predicted LTF at 6
months in Cohort 5. The non-significance of the Hosmer and Lemeshow chi-square test
confirmed that the data did fit the model, χ² (8) = 12.45, p = .13 and the model could predict the
outcomes well. The classification table output for model 1 (which included the various predictor
variables) correctly classified 91.9% of the 6-month loss to follow-up outcome. In comparison,
the classification table for model 0 (the model without the various predictor variables) also
indicated that the independent variable - intervention without the confounders correctly classified
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91.9% of the 6 – month loss to follow up outcomes. The Nagelkerke R2 suggested 22.3%
variance in the model.
Three variables significantly predicted 6-month loss to follow-up in Cohort 5.
Intervention was correlated with LTF at 6 months, Wald (1) = 13.76, p < .001. The negative
correlation with the outcome and odds ratio (Exp B) of .10 indicated that the odds of LTF at 6
months among individuals in the intervention group were .10 times less likely compared to the
individuals in the comparison group. Current ART regimen was also correlated with LTF at 6
months, Wald (1) = 3.90, p = .04. The negative correlation with the outcome and the odds ratio
(Exp B) of .13 indicated that the odds of LTF at 6 months among individuals on ART regimen 2
was .13 times less likely compared to individuals on ART regimen 1. Current CD4 was
negatively correlated with LTF at 6 months, Wald (1) = 4.56, p = .03. The odds ratio (Exp B) of
.99 indicated that the odds of LTF at 6 months marginally decreased with increases in current
CD4 counts. However, the upper bound of 95% confidence interval for baseline CD4 included
1.00, thus the odds ratio was not significant.
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Table 29
Cohort 5: Intervention and Predictor Variables for 6 Month LTF (N = 393)
B

SE B

Wald

p

Exp(B)

95% CI
Low

High

Constant

1.44

1.17

1.52

.22

4.23

Intervention

-2.30

.62

13.76

.000***

.100

.03

.34

ART Regimen

-2.05

1.04

3.90

.04*

.129

.017

.985

Baseline CD4

.00

.00

.00

.99

1.00

.99

1.01

Current CD4

-.00

.00

4.56

.03*

.99

.99

1.00

Current Viral
Load

.06

.21

.07

.79

1.06

.70

1.59

χ²

39.79***

Df

5

Correct
Classified

91.9

Note. ^p<.25;*p < .05; **p < .01; ***p < .001.

The second logistic regression for Cohort 5 was conducted with regards to the dependent
variable of 12-month loss to follow. Variables, intervention, current ART regimen, opt out and
current viral load were found to be correlated (p < .25) to LTF at 6 months in Cohort 5 so these
were included in the regression model along with baseline CD4 count.. The results from the
logistic regression are presented in Table 30. The model chi-square was significant, χ² (5,
N=393) = 21.89, p = .001, indicating that for Cohort 5, the independent variables significantly
predicted the outcome of LTF at 12 months. The non-significance of the Hosmer and Lemeshow
chi-square test confirmed that the data fit the model, χ² (8) = 5.56, p = .70, so the model could
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predict the outcome appropriately. The classification table output for model 1 (which included
the various predictor variables) correctly classified 85% of the 12-month loss to follow-up
outcome. In comparison, the classification table for model 0 (the model without the various
predictor variables) indicated that the independent variable - intervention without the
confounders correctly classified 84% of the 12 – month loss to follow up outcomes. There was
minimal difference in the classification tables between model 0 and 1. The Nagelkerke R2
showed a 9.3% variance in the model.
Two variables significantly predicted 12-month loss to follow-up among individuals in
Cohort 5. Intervention group classification was significant, Wald (1) = 5.51, p = .019. The
negative correlation with the outcome and odds ratio (Exp B) of .50 indicated that the odds of
LTF at 12 months among individuals in the intervention group were .50 times less likely
compared to the individuals in the comparison group. Current viral load was a significant
predictor for LTF at 12 month, Wald (1) = 5.49, p = .02. The odds ratio indicated that increases
in viral load increased the odds of LTF at 6 months by 2.63 times.
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Table 30
Cohort 5: Intervention and Predictor Variables for 12 Month LTF (N = 393)
B

SE B

Wald

P

Exp(B)

95% CI
Low

High

Contrast

-.40

.55

.53

.47

.67

Intervention

-.70

.30

5.51

.02

.50

.28

.89

Current ART
Regimen

-.82

.43

3.68

.06

.44

.20

1.02

Opt Out

2.39

1.60

2.23

.13

10.90

.48

249.81

Base CD4 count

.00

.00

.00

.95

1.00

.99

1.00

Current viral load

.97

.41

5.49

.02

2.63

1.17

5.92

χ²

21.89**

Df

5

Correct Classified

85%

Note. *p < .05; **p < .01; ***p < .001.

Analysis for Cohort 6.
Testing of Covariates. Results from the model chi square analyses for Cohort 6 are
presented in Tables 31 and 32. Below are the relevant (p < .25) associations found. The
independent variable, intervention, was negatively associated with LTF at 6 months, χ² (1, N =
382) = 26.75, φ = -.26, p = .000 and at 12 months, χ² (1, N = 382) = 15.50, φ = -.20, p = .000,
suggesting that individuals in the comparison group had a higher chance of LTF versus
individuals in the intervention group. The phi statistic at both 6 and 12 months LTF outcomes
indicated a weak association between the two variables. Gender was negatively correlated with
LTF at 6 months, χ² (1, N = 382) = 5.55, φ = -.12, p = .02, indicating that females in Cohort 6
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had a lower chance of LTF at 6 months versus males. Pregnancy was positively associated with
LTF at 6 months χ² (1, N = 382) = 10.81, φ = .17, p = .001 and at 12 months, χ² (1, N = 382) =
5.75, φ = .12, p = .02, indicating that pregnant women had a higher chance of LTF at 6 and 12
months. However, the phi statistic for both 6 and 12 months LTF outcomes indicated a negligible
or no association between the two variables. Transferred in has a negative association with LTF
at 6 months, χ² (1, N = 382) = 1.42, φ = -.06, p = .23, indicating that individuals who had
initiated on ART at another clinic and transferred into the study clinic had a lower chance of LTF
at 6 months. However, the phi statistic indicated a negligible or no association. Peripheral/ poly
neuropathy had a positive association with LTF at 6 months, χ² (1, N = 382) = 2.45, φ = .08, p =
.12, indicating that individuals in cohort 6 who had peripheral/poly neuropathy had a higher
chance of LTF at 6 months versus individuals who did not have peripheral/poly neuropathy.
However, the phi statistic indicated negligible or no association between the variables. Herpes
Zoster had a positive association with LTF at 6 months, χ² (1, N = 382) = 2.25, φ = .08, p = .13,
indicating that individuals in Cohort 6 who had herpes zoster had a higher chance of LTF at 6
months versus individuals who did not have herpes zoster. However, the phi statistic indicated
negligible or no association between the variables. Opt out was positively associated with LTF at
12 months, χ² (1, N = 382) = 5.38, φ = .12, p = .02, indicating that individuals in Cohort 6 who
had opted out of the intervention had a higher chance of LTF at 12 months versus individuals
who did not opt out of the intervention. However, the phi statistic indicated negligible or no
association between the variables.
Current CD4 count was positively associated with LTF at 6 months, χ² (300, N=382) =
324.77, φc = .92, p = .16, indicating that individuals in Cohort 6 with higher current CD4 count
had a higher chance of LTF at 6 months. The Cramer’s V statistic indicated a very strong

	
  	
  	
  

135

association between the two variables. Current viral load was also positively associated with LTF
at 6 months χ² (60, N=382) = 152.57, φc = .63, p = .000 and at 12 months, χ² (60, N=382) =
106.03, φc = .53, p = .000 indicating that individuals with higher viral load had a higher chance
of LTF at 6 and 12 months. The Cramer’s V statistic indicated a strong association for between
the two variables at both the 6 and 12 months outcomes.
Table 31
Cohort 6: Associations Between Nominal Dichotomous Variables and LTF at 6 and 12 months
(N = 382)
LTF 6 Months

LTF 12 Months

X2

φ

p

X2

φ

p

Intervention

26.75

-.26

.000***

15.50

-.20

.000***

Gender

5.55

-.12

.02*

.86

-.05

.35

Pregnancy

10.81

.17

.001**

5.75

.12

.02*

Transferred in

1.42

-.06

.23^

4.74

-.11

.03*

Current ART Regimen

.16

-.02

.69

.02

-.01

.88

Peripheral/Poly
Neuropathy

2.45

.08

.12^

.02

.01

.88

Tuberculosis

.35

-.03

.55

.94

.05

.33

Herpes Zoster

2.25

.077

.13^

.26

.03

.61

Opt Out

.07

-.01

.79

5.38

.12

.02*

Note. ^p <.25; *p < .05; **p < .01; ***p < .001.
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Table 32
Cohort 6: Associations Between Nominal Non-Dichotomous Variables and LTF at 6 and 12
months (N = 382)	
  
LTF 6 Months

LTF 12 Months

X2

φc

p

X2

φc

p

Age

24.73

.25

.98

31.72

.29

.85

First reported CD4

171.93

.67

.61

159.45

.65

.84

Baseline CD4

163.78

.66

.49

153.76

.63

.71

Current CD4

324.76

.92

.16^

301.43

.89

.47

Current viral load (zscore)

152.57

.63

.000***

106.03

.53

.000***

Note. ^p <.25; *p<.05; **p < .01; ***p < .001

Logistic Regression. The first logistic regression for Cohort 6 was conducted with
regards to the dependent variable of 6 month LTF. Variables: intervention, gender, pregnancy,
transferred in, peripheral/poly neuropathy, herpes zoster, current CD4 count and current viral
load were found to be associated (p < .25) with LTF at 6 months in Cohort 6 so these were
included in the regression model along with baseline CD4. The results from the logistic
regression are presented in Table 33. The model chi-square was significant, χ² (9) = 58.40, p <
.001, indicating that the independent variables significantly predicted LTF at 6 months in Cohort
6. The non-significance of the Hosmer and Lemeshow chi-square test confirmed that the model
adequately fit the data, χ² (8) = 3.19, p = .92. The classification table output for model 1 (which
included the various predictor variables) correctly classified 94.2% of the 12-month loss to
follow-up outcome. In comparison, the classification table for model 0 (the model without the
various predictor variables) indicated that the independent variable - intervention without the
confounders correctly classified 93.5% of the 12 – month loss to follow up outcomes. There was
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a minimal difference in the classification tables between model 0 and 1. The Nagelkerke R2
indicated 37.0% variance in the model.
Two variables significantly predicted 6 month LTF among Cohort 6. Gender was a
significant predictor, Wald (1) = 4.42, p = .04. There was a negative correlation indicating that
females were .223 times less likely to be LTF at 6 months compared to males. Pregnancy was a
significant predictor, Wald (1) = 6.76, p = .01. Pregnant women were 24.44 times more likely to
be LTF at 6 months follow-up.
Table 33
Cohort 6: Intervention and Predictor Variables for 6 Month LTF (N = 382)	
  
B

SE B

Wald

p

Exp(B)

95% CI
Low

High

Constant

-1.07

.73

2.16

.14

.34

Intervention

-32.61

3256.49

.00

.99

.00

.00

-

Gender

-1.50

.71

4.42

.04*

.22

.05

.90

Pregnancy

3.20

1.23

6.75

.01*

24.44

2.19

272.25

Transferred in

.40

.52

.59

.44

1.50

.54

4.18

Peripheral/Poly
Neuropathy

.26

.65

.16

.69

1.29

.36

4.65

Herpes Zoster

17.70

2321.63

.00

.99

48730578.22

.00

Baseline CD4
count

.00

.00

.06

.81

1.00

.99

1.01

Current CD4
Count

-.00

.00

2.69

.10

.99

.99

1.00

Current Viral
Load

.15

.12

1.65

.20

1.16

.92

1.47

χ²

58.40***
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Df

9

Correct
Classified

94.2

Note. ^p.25; *p < .05; **p < .01; ***p < .001

The second logistic regression for Cohort 6 was conducted with regards to the dependent
variable of 12-month loss to follow-up. Variables: intervention, pregnancy, transferred in, opt
out, and current viral load were found to be correlated (p < .25) to LTF at 12 months in Cohort 6
so these were included in the regression model along with baseline CD4 count.
The results from the logistic regression are presented in Table 34. The model chi-square
was significant, χ² (6, 382) = 25.73, p < .001. The non-significance of the Hosmer and
Lemeshow chi-square test confirmed that the data fit the model, χ² (8) = 6.78, p = .56. That is,
the model predicted the outcome appropriately. The classification table output for model 1
(which included the various predictor variables) correctly classified 84.8% of the 12-month loss
to follow-up outcome. In comparison, the classification table for model 0 (the model without the
various predictor variables) indicated that the independent variable - intervention without the
confounders correctly classified 84.3% of the 12 – month loss to follow up outcomes. There was
a minimal difference in the classification tables between model 0 and 1. The Nagelkerke R2
indicated 11.2% variance in the model.
One variable significantly predicted 12-month loss to follow-up among individuals in
Cohort 6. Intervention was a significant predictor, Wald (1) = 12.24, p < .001. The negative
correlation to the outcome and odds ratio (Exp B) of .31 indicated that individuals in the
intervention group were .31 times less likely to be LTF at 12 months compared to the individuals
in the comparison group.
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Table 34
Cohort 6: Intervention and Predictor Variables for 12 Month LTF (N = 382)
B

SE B

Wald

p

Exp(B)

95% CI
Low

High

Constant

-1.18

.28

17.58

.00

.31

Intervention

-1.17

.33

12.24

.00

.31

.16

.60

Pregnancy

1.29

.79

2.68

.10

3.62

.78

16.89

Transferred
in

-.30

.33

.79

.37

.74

.38

1.43

22.28

40192.97

.00

1.0

4.74E+6

.00

.

Baseline CD4

.00

.00

.00

.99

1.00

.99

1.00

Current Viral
Load

.12

.10

1.31

.25

1.12

.92

1.38

Opt out

χ²

25.73***

Df

6

Correct
Classified

84.8%

Note. ^p<.25; *p < .05; **p < .01; ***p < .001

Treatment and/or Intervention Fidelity
As mentioned in Chapter 3, the intervention was implemented as planned with the
exception that all individuals enrolled in the appointment reminder intervention also received
weekly adherence messages. This may be a major threat to the internal validity of the study as it
is difficult to ascertain if the outcomes observed were a result of the appointment reminder or the
weekly adherence messages that the individuals received in the intervention group. Additionally
the full impact of combining the two interventions could not be ascertained by this study. There
were no adverse events reported by the team.

	
  	
  	
  

140
Summary
In response to the two research questions, yes, there was a difference in 6 and/or 12-

month LTF rates among patient enrolled in the appointment reminder intervention versus the
comparison group in five out of six study cohorts. Regression analyses by each cohort indicated
that individuals in Cohorts 1, 2, 4 & 5 had a lower likelihood of LTF at 6 months compared to
individuals in the comparison group. Similarly, individuals in Cohorts 5 and 6 had a lower
likelihood of LTF at 12 months compared to the individuals in the comparison group.
Other variables that had a positive or a negative correlation with LTF were pregnancy,
age, gender, current ART regimen, current CD4 count, and current viral load. The independent
and covariate variables significantly predicted LTF at 6 months for all the cohorts except for
Cohort 3. In contrast, the independent and covariate variables significantly predicted 12 month
LTF for Cohorts 2, 4, 5 & 6 only.
The next chapter includes a discussion of and conclusions based on the study findings.
Limitations of the study, future recommendations for continued research, and the social change
implications are also included in Chapter 5.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The purpose of this study was to evaluate the effectiveness of a mHealth patient

appointment reminder intervention to improve retention in treatment of patients initiating ART at
a large public sector ART clinic in the inner city of Johannesburg, South Africa. This clinic is
one of the largest ART clinics located at a secondary-level community health facility in SubSaharan Africa, and it has a relatively heterogeneous population accessing HIV care and
treatment. The appointment reminder intervention was one of three mHealth interventions
developed, piloted, and scaled up at this and the surrounding primary health care clinics in the
inner city of Johannesburg, in an effort to reduce the loss to follow up rates among patients on
ART. The appointment reminder intervention was implemented at this clinic in September 2012.
Individuals on ART at the clinic were approached and the intervention was offered to them.
Individuals self-selected to participate in the project. This study was a program evaluation of the
intervention based on a quantitative retrospective cohort design. Retrospective project and
clinical data was used for this study for the period September 1, 2012 to January 31, 2014.
This study was conducted in an effort to find evidence if mHealth can be an effective way
to reduce post-ART LTF. As mentioned in Chapter 2, currently there are only a few studies in
the scientific literature, which look at the effectiveness of interventions to reduce LTF among
patients on ART. Furthermore, since mHealth is an up and coming field, there is a gap in the
literature on studies on the effectiveness of mHealth interventions in reducing LTF, especially in
the context of Sub-Saharan Africa.
The two research questions for this study sought to ascertain whether there were
differences in 6 and 12 - month LTF outcomes between the intervention and the comparison
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groups. The analyses were based on the study design, which included assignment of individuals
in the intervention and comparison groups to one of six cohorts, based on their time on ART
when the intervention was implemented.
The study population was demographically representative of the clinic population. The
mean age and gender disaggregation of the study population were found to be similar to the
clinic population information reported in the HCHC file audit report from 2009 (unpublished
report). The intervention and comparison groups were found to be similar in terms of gender and
age. The study sample size was sufficient to provide responses to the study questions. Individuals
in the intervention group were found to have less likelihood of LTF at 6 months in four of the six
cohorts, and in two of the six cohorts for LTF at 12 months. Thus, the two null hypotheses were
rejected for a subset of the study cohorts. In addition, current CD4 counts, pregnancy status and
current viral load predicted LTF outcome among three cohorts. Age, gender, baseline CD4 count
and ART regimen predicted either 6- or 12-month LTF outcome for one non-mutually exclusive
cohort each.
Opt-out from the intervention was low - only eight - three of whom provided reasons:
transfer to maternity clinic, recognition that the existing support was enough that reminders were
not needed, concern about disclosure of HIV status.
Interpretation of the Findings
The study results indicated a significant correlation (p < .05), between enrollment in the
intervention group and decreased likelihood of LTF at 6 and/or 12 months, compared to
individuals in the comparison group in a subset of the six study cohorts. Other significant
findings among a few of the study cohorts were the links between 6 and/or 12 month LTF and
each of the covariates: pregnancy, current CD4 count and current viral load. Pregnant women
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had a higher likelihood of LTF in four instances among three cohorts. Increases in current CD4
count were correlated with lower LTF outcome, and increases in viral load count were correlated
with higher likelihood of LTF among individuals in three of the study cohorts for both of these
covariates. Age, gender, current ART regimen and baseline CD4 count were correlated with 6 or
12 - month LTF outcomes in one cohort each, whereby, older individuals had a higher likelihood
of LTF, women had a lower likelihood of LTF, and individuals on ART regimen 2 had a lower
likelihood of LTF compared to individuals on ART regimen 1. Baseline CD4 count was found to
be significantly correlated however the odds ratio was not significant.
The median baseline CD4 count of 137 cells/mm3 indicated that the patients were being
initiated on ART at the facility much later than the NDoH 2012 guidance to initiate individuals
with CD4 <350 cells/mm3 on ART within a short duration of HIV diagnosis, and to immediately
initiate all children under 5 years, HIV pregnant women and any patients identified with
tuberculosis, regardless of CD4 count. (South African National Strategic plan on HIV, STIs, and
TB 2012-2016; South African HIV/AIDS treatment and PMTCT guidelines, 2011 and 2013). It
was beyond the scope of this study to conduct in depth analyses on this issue and differentiate if
the delay in ART initiation pertained to individuals who had been initiated on ART a while ago
(Cohorts 3-6), or if it was also the case for individuals who had been recently initiated on ART
(Cohorts 1-2). The median figure of 384 cells/mm3 for the current CD4 count indicated that
regardless of the baseline CD4 count, most of the individuals had an increase in their CD4 count
after initiating ART. A large portion of individuals, who had recent viral load information in
their records, had an undetectable viral load. Among individuals who had a detectable viral load,
increases in viral load values were correlated with increases in the LTF outcomes in two cohorts.
A majority of the individuals in the study were on ART regimen 1. Approximately, 20% of the
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individuals had been switched to regimen 2, and the number of individuals on regimen 2 was
higher for Cohorts 3-6 indicating an increase in ART regimen change with increase in time on
ART. Approximately 11 % of the study sample experienced a side effect of lipodystrophy, lactic
acidosis or peripheral/poly neuropathy during the study period. Similarly, 5% of the study
population had a documented concurrent illness of tuberculosis, herpes zoster or kaposi sarcoma
during the study period.
The appointment reminder intervention was significantly linked to lower likelihood of 6
and/or 12 months LTF among patients who had initiated on ART anywhere from a few days to a
few years prior to enrolling in the intervention. In addition, there were a few covariates that also
significantly impacted LTF outcomes among multiple study cohorts. The correlation between
pregnancy and LTF was a key finding, and this correlation has been previously reported in the
literature (Bateman, 2013; Clouse, 2013; Wang et al, 2011). The current South African guideline
for Prevention of Mother to Child Transmission of HIV (PMTCT) includes providing HIV
positive pregnant women who are not already on ART when they become pregnant, with
antiretrovirals for the duration of the pregnancy up to one-year post pregnancy, to cover the oneyear of breast feeding period. Some women may need to continue on ART for the rest of their
lives if their CD4 count is <350 cell/mm3 (Bateman, 2013). This study confirms the high risk of
LTF outcome among pregnant women and highlights a need to adjust services provided to
pregnant women.
The correlation between increases in viral loads and increased LTF is another key study
finding. Annual viral load monitoring and informing the individuals of their viral load status via
text messaging is a potential intervention that can be recommended to the NDoH to undertake.
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This study confirms and adds evidence to the existing literature about the effectiveness of

using mHealth-based interventions to improve HIV/AIDS care and treatment programs. As
mentioned in Chapter 2, Bahadur & Murray, 2010 had conducted a review of publications to find
the outcomes of SMS in health care settings. The authors concluded that a few studies that
indicated that SMS had improved health service delivery through appointment reminders,
however, most of the research was conducted in developed countries and most of them either
reported on pilots or feasibility studies. A need was identified for studies that are conducted in
low resource countries and/or which report on scaled up projects versus pilots. Another gap
identified from the literature search was that there is a lack of studies, which examine the
association or effectiveness of SMS on improving ART clinic appointment adherence among
patients on ART in South Africa. This study meets the gaps mentioned above as it was
conducted in a low resource setting, at a public sector ART site, and it was an evaluation of a
project that had been implemented as a scale up following the success of an earlier pilot project.
This study extends the knowledge base around use and effectiveness of mHealth based
interventions in the field of HIV/AIDS.
Findings in the Context of the Theoretical Framework
As mentioned in Chapter 2, the theoretical framework that formed the basis of this study
was the “cues to action” construct of the health belief model. The key question stated in Chapter
2, in terms of the theoretical framework was “How effective were the cues to action in leading to
the desired behavior or intervention outcome?” The cues to action for this study were the
appointment reminders sent to the individuals enrolled in the intervention. Some of the
assumptions that were made before the study was conducted were that individuals who agreed to
partake in the appointment reminder intervention perceived: the benefit of initiating ART and the
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benefit that the intervention offered to them. The study data showed that the cues were effective
in leading to reduction in LTF rates among the individuals enrolled in the intervention who
received the cues, versus the individuals in the comparison group who only received the standard
of care at the clinic. The low opt out rate from the intervention may indicate the perceived
benefits and effectiveness of the cues too.
Limitations of the Study
The limitations to validity and reliability that arose from the execution of the study were
in line with the expected limitations mentioned in chapter 1. A major limitation to this study was
the change in the way the intervention was implemented versus the project plan. Instead of
offering only the appointment reminder intervention to individuals newly (< 30 days) initiating
ART, all individuals on ART (regardless of time on ART) were offered the appointment
reminder intervention along with weekly treatment adherence reminder messages for one year.
While this modification was based on the lessons learned, it potentially had an impact on the
study outcomes. It was beyond the scope of this study to ascertain if the differences noted
between the intervention and control groups were due to the appointment reminder or the
adherence reminder intervention. An evaluation of the adherence reminder program may assist to
distinguish the differences between the two interventions.
Another limitation of the study was the non-random selection of individuals to enroll in
the intervention. The participants self-selected to receive the intervention, thus the risk of
selection bias was valid. The comparison group was selected using a partly purposeful, partly
random stratified approach in an effort to lower the effect of the selection bias among the
individuals enrolled in the intervention group. The low difference found between the intervention
and comparison group should have assisted in reducing the impact of the selection bias.
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Another limitation of this study was that a quantitative method of inquiry was used for

the evaluation. A mixed method would have been a more appropriate methodology as a
qualitative component could have assisted in explaining some of the participant behavior,
decisions or nuances leading to the outcomes noted. These items are not easy to ascertain from a
quantitative methodology only. Furthermore, given the quantitative nature of this study, it was
not possible to ascertain how the cues to action affected the perceptions of and led to behavior
change among the individuals enrolled in the intervention. This is a limitation of the study and
could be better answered via a qualitative inquiry.
Data quality was found to be less than ideal. Errors identified in the data included
discrepancies in the ART initiation dates between the intervention database and the HMIS
information available from the clinic. When the dates did not match, the information from the
HMIS was used as that is the archived data used by the clinic. Similarly, if discrepancies were
found in the “last visit date” information, which was the variable used to ascertain the LTF
outcome, the information from the HMIS dataset was used versus the intervention database.
Other limitations as mentioned in Chapter 1, are still valid as they were beyond the
researcher’s control. Given the sheer size of the HIV epidemic in South Africa, HIV is the focus
of the government, donors and other international agencies agendas. For example, the minister of
health started country wide HIV counseling and testing campaigns in 2010. These campaigns are
in their fourth year now and continue to be scaled up as still only 31% of the HIV positive
individuals in South Africa are on ART (HSRC report, 2012). The South African public is
constantly exposed to messages regarding HIV prevention, testing and treatment from the
government, donors, non-government organizations, community based organizations and others.
In addition, it is likely that given the high prevalence of HIV, a large proportion of the
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population in South Africa has been affected by HIV directly or indirectly. Therefore, it is
possible that the other experiences and exposures may act as cues to action for the study
participants, and possibly drive the outcomes towards the null hypothesis.
A limitation that was identified in Chapter 1, but which did not have an effect on the
study outcome was that the South African public has a tendency to change their cell phone
numbers frequently so the intervention participants may not have received the messages as
planned. In actuality, the project was able to successfully dispatch the appointment reminders to
almost all the individuals enrolled in the intervention. The project implementers had instituted
two interventions to reduce this issue. The first intervention pertained to instant verification, that
is, when individuals enrolled in the intervention, the field workers immediately sent a
verification message to make sure the number provided was correct. The second intervention
involved asking the participants if their phone numbers had changed since the last clinic or
pharmacy visit. The above two interventions may have been successful in making sure that the
project always had the most up to date phone numbers for the individuals enrolled in the
intervention.
Recommendations
Recommendations for Further Study
A recommendation based on the outcome of the study is that a qualitative inquiry should
be conducted on the population enrolled in the intervention to find out: the reasons for
individuals enrolling and continuing with the intervention, the reasons for the behavior change
noted, which components of the intervention were most useful and which areas need
improvement, and if the frequency and content of the text messages were sufficient or could be
improved. Qualitative study will also assist in obtaining lessons learned, and ascertaining areas
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of improvement or intervention strengths that could be incorporated in the project before scale up
to other ART facilities.
While the results from this study can be generalized to other clinics in South Africa, there
is a need for this type of intervention and follow up inquiry in a rural health care setting as a
large proportion of individuals on ART in South Africa and other resource limited countries
reside in rural areas. As mentioned in chapter 2, individuals in urban and rural settings may have
different set of barriers, which may hinder retention in ART.
It is important to ascertain what impact the adherence reminder intervention which was
implemented along with the appointment reminders had on the LTF outcomes. It would also be
useful to follow up the patients beyond the 12 month period, ideally for 24 and 36 months to see
if there are changes in LTF rates between the intervention and comparison groups over an
extended period.
Recommendations for Action
The positive correlation between pregnancy and LTF is a key finding and requires
adjustments in ART service delivery to this group of individuals. The outcome highlights the
need to closely monitor pregnant women on ART both during and after their pregnancies to
make sure that they continue to adhere to ART. Specific messaging either via text messages or
in person counseling, which highlight the importance of treatment retention to pregnant women
could be useful. Another option is to incorporate the messages in other Maternal and Child
Health (MCH) related projects. One such instance is the MCH related mHealth project that was
implemented at the MCH clinic located at the study site in 2012. In this project, women enrolled
in the intervention receive weekly messages about their pregnancy, fetal growth, appropriate
nutrition and other items, till the baby is a year old. Women who want messages regarding HIV
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and pregnancy can opt in to receive these messages. At the end of 2014, the South African
government asked for and received funding from USAID & CDC to scale up this MCH related
mHealth project to all public sector sites in the country. Based on the evidence obtained from
this evaluation, it would be useful for the NDoH to include importance of continuation of ART
post pregnancy and appointment retention messages in this MCH project.
The positive correlation between increase in viral loads and LTF is another area
indicating a need for modification in the public sector ART service delivery in South Africa. As
mentioned above, annual viral load monitoring of patients on ART is recommended so that
patients and the caregivers can monitor the patient’s viral load. In addition to this, systems need
to be put in place that raise a red flag to the clinician and other relevant clinic staff when the viral
loads go from undetectable to detectable range. This is important in terms of monitoring
development of ART drug resistance in the patient, identifying possible ART adherence issues,
and providing additional counseling to patient to adhere to their ART appointment as they are at
higher risk of LTF.
Given the high acceptability and feasibility of mHealth related interventions in South
Africa, along with the evaluation outcomes, the appointment reminder intervention can be scaled
up to other sites. In addition, other fields such as MCH, immunizations, and tuberculosis
treatment could benefit from mHealth projects similar to the appointment reminder intervention
as these health service areas require frequent visits to the clinic whether they are for pre-natal
visits for MCH or immunizations which have to be given to children at specific ages or for TB
which usually requires an intensive treatment regimen for six months or longer. Similar to ART,
TB treatment is an area that requires the patients to be strictly adherent to the treatment regimen
for it to be fully effective and to avoid development of drug resistance.
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The appointment reminder interventions was funded by the US Government as a public

private partnership grant in conjunction with the Vodacom Foundation – the not for profit
division of Vodacom, one of the largest cell phone companies in Africa and Europe. Vodacom
had provided subsidized rates for SMS messages for this intervention however, if the South
African Government is going to take this and related mHealth interventions to scale in the
country, then a cost effectiveness study needs to be conducted.
The next steps after the conclusion of this dissertation includes sharing of the information
with the stakeholders including the host institution, individuals enrolled in the intervention, clinic
leadership, funders of the mHealth projects and the South African NDoH. The results will be
disseminated via a formal correspondence to the host institution to share with the NDoH and
presented at public health conferences. The dissertation information will be used to develop an
article for a peer-reviewed journal.
Implications
Positive Social Change
As stated in earlier chapters, the social change impact of this study is substantial at
various levels. At the individual level, the intervention is an effective external cue to action that
reminds and assists the individuals to adhere to their ART appointments. Some individuals found
the appointment reminders motivating. Evidence of this was found from some anecdotal
comments from the study staff, who stated that patients felt that “someone (clinic) cared about
them”. Another instance was an example from the MCH mHealth project when a pregnant
woman shared the weekly SMS message she received regarding her baby’s growth and other
information for that week, with other women in the waiting room. This led to a surge in women
wanting to enroll in the mHealth MCH project.

	
  	
  	
  

152
This intervention and the results from this study are important at the family level too as

studies in the scientific literature, listed in chapter 2, have shown that adherence on ART and
retention in care reduced the risk of HIV related complications and other illnesses. If the
individual is healthy then they can provide for and support their family much better. At the
organizational level, the results from this intervention and study can have a positive impact on
the quality of the services provided by the clinic, and the funding of the services by the DoH. If
individuals are adhering to their appointment date, the clinic can have improved scheduling
leading to reduction in patient waiting times, and the clinic leadership can better plan for their
ARV stocks. Since there is a lower chance of individuals developing treatment resistance when
they are adherent on ART, the clinic can save on the costs of running some of the expensive viral
resistance blood tests.
Loss to follow up is a major issue that the NDoH is struggling with in South Africa and
the results of this study provide an evidence base for an innovative solution to reduce LTF.
Appointment reminders can be included as standard of care and offered to all individuals
initiating ART in the public sector. This study along with the feasibility, acceptability and pilot
studies results provide compelling evidence that mHealth is an effective mode of reducing LTF
and improving retention in care of individuals on ART. At the scientific community level, the
results of this study provide evidence on the effectiveness of mHealth to reduce LTF in a low
resource setting and in the field of HIV/AIDS. The results from this study will be useful to
support some of the mandates of international policy organizations such as the Joint United
Nations Programme on HIV/AIDS (UNAIDS) or for funding programs such as the President’s
Emergency Plan for AIDS Relief (PEPFAR). In the 2014 gap report, UNAIDS set an ambitious
goal of 90/90/90 to end the HIV epidemic by 2020. That is, by 2020: 90% of all people living
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with HIV will know their HIV status, 90% of all people diagnosed with HIV infection will
receive ART, and 90% of all people receiving ART will have viral suppression. (UNAIDS Gap
report, 2014). PEPFAR is currently in its third five-year cycle and the leadership has made
90/90/90 the main objective of PEPFAR 3. This intervention supports the third 90 in the
90/90/90 that is maintenance of viral suppression once individuals have initiated on ART
(OGAC presentation, 2014).
Conclusion
This study responded to the gaps identified in the scientific literature and provided
evidence on the effectiveness of using mHealth interventions to improve post ART retention in
care and treatment in a resource limited setting. Reduction of LTF rates has a positive social
impact from the individual to the international donor level. In the history of man, no other
technology has been accepted and adapted at the level that cell phone use and technology has
achieved. Cell phone coverage is available to population in the richest to the lowest resourced
countries, and cell phones are in use in the largest cities to the remotest parts of the world. The
cell phone coverage continues to increase at a phenomenal rate. Consequently, the acceptability
and feasibility of using cell phones in the field of medicine and public health is also continuing
to strengthen. This study indicates that mHealth interventions have the capability to reach and
lead to behavior change at the individual level, support HIV related public health service goals of
individual countries, and provide solutions to meet the global targets set my policy making and
funding entities.
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